eose-20250930
0001805077
false
12-31
Q3
2025
.5988024
P2Y
0.5988024
0.5988024
384
380
380
383
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
eose:segment
eose:installment
xbrli:pure
eose:tranche
eose:milestone
eose:businessDay
eose:customer
eose:vendor
eose:tradingDay
eose:draw_date
eose:vote
utr:sqft
0001805077
2025-01-01
2025-09-30
0001805077
us-gaap:CommonStockMember
2025-01-01
2025-09-30
0001805077
us-gaap:WarrantMember
2025-01-01
2025-09-30
0001805077
2025-11-03
0001805077
2025-09-30
0001805077
2024-12-31
0001805077
us-gaap:NonrelatedPartyMember
2025-09-30
0001805077
us-gaap:NonrelatedPartyMember
2024-12-31
0001805077
us-gaap:RelatedPartyMember
2025-09-30
0001805077
us-gaap:RelatedPartyMember
2024-12-31
0001805077
2025-07-01
2025-09-30
0001805077
2024-07-01
2024-09-30
0001805077
2024-01-01
2024-09-30
0001805077
us-gaap:NonrelatedPartyMember
2025-07-01
2025-09-30
0001805077
us-gaap:NonrelatedPartyMember
2024-07-01
2024-09-30
0001805077
us-gaap:NonrelatedPartyMember
2025-01-01
2025-09-30
0001805077
us-gaap:NonrelatedPartyMember
2024-01-01
2024-09-30
0001805077
us-gaap:RelatedPartyMember
2025-07-01
2025-09-30
0001805077
us-gaap:RelatedPartyMember
2024-07-01
2024-09-30
0001805077
us-gaap:RelatedPartyMember
2025-01-01
2025-09-30
0001805077
us-gaap:RelatedPartyMember
2024-01-01
2024-09-30
0001805077
us-gaap:CommonStockMember
2024-06-30
0001805077
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
0001805077
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-06-30
0001805077
us-gaap:RetainedEarningsMember
2024-06-30
0001805077
2024-06-30
0001805077
us-gaap:AdditionalPaidInCapitalMember
2024-07-01
2024-09-30
0001805077
us-gaap:CommonStockMember
2024-07-01
2024-09-30
0001805077
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-07-01
2024-09-30
0001805077
us-gaap:RetainedEarningsMember
2024-07-01
2024-09-30
0001805077
us-gaap:CommonStockMember
2024-09-30
0001805077
us-gaap:AdditionalPaidInCapitalMember
2024-09-30
0001805077
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-09-30
0001805077
us-gaap:RetainedEarningsMember
2024-09-30
0001805077
2024-09-30
0001805077
us-gaap:CommonStockMember
2025-06-30
0001805077
us-gaap:AdditionalPaidInCapitalMember
2025-06-30
0001805077
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-06-30
0001805077
us-gaap:RetainedEarningsMember
2025-06-30
0001805077
2025-06-30
0001805077
us-gaap:AdditionalPaidInCapitalMember
2025-07-01
2025-09-30
0001805077
us-gaap:CommonStockMember
2025-07-01
2025-09-30
0001805077
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-07-01
2025-09-30
0001805077
us-gaap:RetainedEarningsMember
2025-07-01
2025-09-30
0001805077
us-gaap:CommonStockMember
2025-09-30
0001805077
us-gaap:AdditionalPaidInCapitalMember
2025-09-30
0001805077
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-09-30
0001805077
us-gaap:RetainedEarningsMember
2025-09-30
0001805077
us-gaap:CommonStockMember
2023-12-31
0001805077
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001805077
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-12-31
0001805077
us-gaap:RetainedEarningsMember
2023-12-31
0001805077
2023-12-31
0001805077
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-09-30
0001805077
us-gaap:CommonStockMember
2024-01-01
2024-09-30
0001805077
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-09-30
0001805077
us-gaap:RetainedEarningsMember
2024-01-01
2024-09-30
0001805077
us-gaap:CommonStockMember
2024-12-31
0001805077
us-gaap:AdditionalPaidInCapitalMember
2024-12-31
0001805077
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31
0001805077
us-gaap:RetainedEarningsMember
2024-12-31
0001805077
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-09-30
0001805077
us-gaap:CommonStockMember
2025-01-01
2025-09-30
0001805077
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-01-01
2025-09-30
0001805077
us-gaap:RetainedEarningsMember
2025-01-01
2025-09-30
0001805077
eose:A2025ConvertibleNotesDue2030Member
2025-01-01
2025-09-30
0001805077
eose:A2025ConvertibleNotesDue2030Member
2024-01-01
2024-09-30
0001805077
eose:AFGConvertibleNotesMember
2025-01-01
2025-09-30
0001805077
eose:AFGConvertibleNotesMember
2024-01-01
2024-09-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:SecuredDebtMember
2024-06-21
0001805077
us-gaap:RevolvingCreditFacilityMember
eose:CreditFacilityMember
us-gaap:LineOfCreditMember
2024-06-21
0001805077
eose:EOSEnergyEnterprisesInc.Member
eose:DelayedDrawTermLoanDDTLMember
eose:CCMDenaliDebtHoldingsLPMember
us-gaap:SecuredDebtMember
2024-06-21
0001805077
eose:DOELoanFacilityMember
us-gaap:LineOfCreditMember
2024-11-26
0001805077
eose:DOELoanFacilityMember
srt:MinimumMember
us-gaap:LineOfCreditMember
2024-11-26
0001805077
eose:DOELoanFacilityMember
srt:MaximumMember
us-gaap:LineOfCreditMember
2024-11-26
0001805077
eose:DOELoanFacilityTranche1Member
eose:DOELoanFacilityMember
2024-11-26
0001805077
eose:DOELoanFacilityTranche2Member
eose:DOELoanFacilityMember
2024-11-26
0001805077
eose:DOELoanFacilityTranche3Member
eose:DOELoanFacilityMember
2024-11-26
0001805077
eose:DOELoanFacilityTranche4Member
eose:DOELoanFacilityMember
2024-11-26
0001805077
eose:DOELoanFacilityMember
eose:DOELoanFacilityTranche1Member
2025-04-16
0001805077
eose:DOELoanFacilityMember
eose:DOELoanFacilityTranche2Member
2025-04-16
0001805077
eose:DOELoanFacilityMember
eose:DOELoanFacilityTranche3Member
2025-04-16
0001805077
eose:DOELoanFacilityMember
eose:DOELoanFacilityTranche4Member
2025-04-16
0001805077
eose:DOELoanFacilityTranche1Member
eose:DOELoanFacilityMember
us-gaap:LineOfCreditMember
2024-11-26
2025-09-30
0001805077
us-gaap:ScenarioPlanMember
us-gaap:PrivatePlacementMember
2025-05-29
2025-05-29
0001805077
us-gaap:ScenarioPlanMember
us-gaap:PrivatePlacementMember
2025-05-29
0001805077
us-gaap:ScenarioPlanMember
us-gaap:OverAllotmentOptionMember
2025-05-29
2025-05-29
0001805077
us-gaap:PrivatePlacementMember
2025-05-29
2025-05-29
0001805077
us-gaap:PrivatePlacementMember
2025-06-02
2025-06-02
0001805077
eose:A2025ConvertibleNotesDue2030Member
us-gaap:ConvertibleDebtMember
2025-06-03
0001805077
eose:A2025ConvertibleNotesDue2030Member
2025-06-03
2025-06-03
0001805077
eose:DelayedDrawTermLoanDDTLInitialDrawMember
us-gaap:SecuredDebtMember
2024-06-21
0001805077
eose:DelayedDrawTermLoanDDTLInitialDrawMember
us-gaap:SecuredDebtMember
2024-06-21
2024-06-21
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:SecuredDebtMember
2024-08-29
2024-08-29
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:SecuredDebtMember
2024-10-31
2024-10-31
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:SecuredDebtMember
2025-01-24
2025-01-24
0001805077
eose:DOELoanFacilityTranche1Member
eose:DOELoanFacilityMember
us-gaap:LineOfCreditMember
2024-11-26
2024-12-06
0001805077
eose:DOELoanFacilityTranche1Member
eose:DOELoanFacilityMember
us-gaap:LineOfCreditMember
2024-11-26
2025-06-04
0001805077
eose:FirstAmendmentToCreditAndGuarantyAgreementMember
2025-04-30
2025-04-30
0001805077
eose:FirstAmendmentToCreditAndGuarantyAgreementMember
us-gaap:PreferredStockMember
2025-04-30
0001805077
eose:FirstAmendmentToCreditAndGuarantyAgreementMember
us-gaap:CommonStockMember
2025-04-30
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:ConvertibleNotesPayableMember
2025-05-28
2025-05-28
0001805077
eose:SecondCreditAgreementAmendmentMember
us-gaap:SecuredDebtMember
2025-05-27
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:SecuredDebtMember
2025-05-28
0001805077
us-gaap:SecuredDebtMember
2025-05-28
2025-05-28
0001805077
us-gaap:RelatedPartyMember
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-05-29
0001805077
us-gaap:SecuredDebtMember
2025-07-29
2025-07-29
0001805077
eose:CerberusWarrantsMember
2025-07-29
0001805077
eose:SPAWarrantMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2024-06-21
0001805077
eose:SPAWarrantMember
eose:CCMDenaliEquityHoldingsLPMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2024-06-21
0001805077
eose:SPAWarrantMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2024-06-21
2024-06-21
0001805077
eose:ContingentWarrantsMember
eose:CCMDenaliEquityHoldingsLPMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2024-06-21
0001805077
eose:CreditAgreementMember
eose:SeriesA1PreferredStockMember
2024-06-21
0001805077
eose:SeriesA1PreferredStockMember
2024-06-21
2024-06-21
0001805077
eose:SeriesA1PreferredStockMember
2024-06-21
0001805077
eose:CreditAgreementMember
eose:SeriesA2PreferredStockMember
2024-08-29
2024-08-29
0001805077
eose:CreditAgreementMember
eose:SeriesA2PreferredStockMember
2024-08-29
0001805077
eose:SeriesB1PreferredStockMember
2024-09-11
0001805077
eose:SeriesB1PreferredStockMember
2025-09-30
0001805077
eose:SeriesB1PreferredStockMember
2025-01-01
2025-09-30
0001805077
eose:SeriesB2PreferredStockMember
2025-09-30
0001805077
eose:SeriesB2PreferredStockMember
2025-01-01
2025-09-30
0001805077
eose:SeriesB3PreferredStockMember
2025-09-30
0001805077
eose:SeriesB3PreferredStockMember
2025-01-01
2025-09-30
0001805077
eose:SeriesB4PreferredStockMember
2025-09-30
0001805077
eose:SeriesB4PreferredStockMember
2025-01-01
2025-09-30
0001805077
2024-09-11
2024-09-11
0001805077
eose:SeriesB4PreferredStockMember
2025-06-29
0001805077
eose:SeriesB4PreferredStockMember
2025-06-30
0001805077
us-gaap:SeriesBPreferredStockMember
2024-06-21
2024-06-21
0001805077
eose:AtlasCreditAgreementMember
eose:SeniorSecuredTermLoanAgreementMember
us-gaap:SecuredDebtMember
2024-06-21
0001805077
eose:AtlasCreditAgreementMember
eose:SeniorSecuredTermLoanAgreementMember
us-gaap:SecuredDebtMember
2024-06-21
2024-06-21
0001805077
eose:InsurerLetterAgreementMember
eose:SeniorSecuredTermLoanAgreementMember
us-gaap:SecuredDebtMember
2024-12-31
2024-12-31
0001805077
eose:InsurerLetterAgreementMember
eose:SeniorSecuredTermLoanAgreementMember
us-gaap:SecuredDebtMember
2025-06-30
2025-06-30
0001805077
us-gaap:TransferredAtPointInTimeMember
2025-07-01
2025-09-30
0001805077
us-gaap:TransferredAtPointInTimeMember
2024-07-01
2024-09-30
0001805077
us-gaap:TransferredAtPointInTimeMember
2025-01-01
2025-09-30
0001805077
us-gaap:TransferredAtPointInTimeMember
2024-01-01
2024-09-30
0001805077
us-gaap:TransferredOverTimeMember
2025-07-01
2025-09-30
0001805077
us-gaap:TransferredOverTimeMember
2024-07-01
2024-09-30
0001805077
us-gaap:TransferredOverTimeMember
2025-01-01
2025-09-30
0001805077
us-gaap:TransferredOverTimeMember
2024-01-01
2024-09-30
0001805077
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
2025-07-01
2025-09-30
0001805077
eose:OneCustomerMember
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
2025-07-01
2025-09-30
0001805077
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
2025-01-01
2025-09-30
0001805077
eose:ThreeCustomersMember
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
2025-01-01
2025-09-30
0001805077
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
2024-07-01
2024-09-30
0001805077
eose:TwoCustomerMember
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
2024-07-01
2024-09-30
0001805077
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
2024-01-01
2024-09-30
0001805077
eose:TwoCustomerMember
us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember
2024-01-01
2024-09-30
0001805077
2025-10-01
2025-09-30
0001805077
eose:DOECleanEnergyFinancingProgramMember
2025-09-30
0001805077
eose:DOECleanEnergyFinancingProgramMember
2025-01-01
2025-09-30
0001805077
eose:DOECleanEnergyFinancingProgramMember
us-gaap:SecuredDebtMember
2024-09-29
0001805077
srt:MinimumMember
us-gaap:EquipmentMember
2025-09-30
0001805077
srt:MaximumMember
us-gaap:EquipmentMember
2025-09-30
0001805077
us-gaap:EquipmentMember
2025-09-30
0001805077
us-gaap:EquipmentMember
2024-12-31
0001805077
eose:FinanceLeaseMember
2025-09-30
0001805077
eose:FinanceLeaseMember
2024-12-31
0001805077
srt:MinimumMember
us-gaap:FurnitureAndFixturesMember
2025-09-30
0001805077
srt:MaximumMember
us-gaap:FurnitureAndFixturesMember
2025-09-30
0001805077
us-gaap:FurnitureAndFixturesMember
2025-09-30
0001805077
us-gaap:FurnitureAndFixturesMember
2024-12-31
0001805077
us-gaap:LeaseholdImprovementsMember
2025-09-30
0001805077
us-gaap:LeaseholdImprovementsMember
2024-12-31
0001805077
srt:MinimumMember
us-gaap:ToolsDiesAndMoldsMember
2025-09-30
0001805077
srt:MaximumMember
us-gaap:ToolsDiesAndMoldsMember
2025-09-30
0001805077
us-gaap:ToolsDiesAndMoldsMember
2025-09-30
0001805077
us-gaap:ToolsDiesAndMoldsMember
2024-12-31
0001805077
us-gaap:ConstructionInProgressMember
2025-09-30
0001805077
us-gaap:ConstructionInProgressMember
2024-12-31
0001805077
us-gaap:PatentsMember
2025-09-30
0001805077
us-gaap:PatentsMember
2025-07-01
2025-09-30
0001805077
us-gaap:PatentsMember
2024-07-01
2024-09-30
0001805077
us-gaap:PatentsMember
2025-01-01
2025-09-30
0001805077
us-gaap:PatentsMember
2024-01-01
2024-09-30
0001805077
eose:SoftwareMember
2025-09-30
0001805077
us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember
2024-12-31
0001805077
us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember
2025-09-30
0001805077
eose:ProductionTaxCreditsMember
2025-04-01
2025-06-30
0001805077
2025-04-01
2025-06-30
0001805077
eose:ProductionTaxCreditsMember
2025-07-01
2025-09-30
0001805077
eose:ProductionTaxCreditsMember
2024-07-01
2024-09-30
0001805077
eose:ProductionTaxCreditsMember
2025-01-01
2025-09-30
0001805077
eose:ProductionTaxCreditsMember
2024-01-01
2024-09-30
0001805077
eose:ProductionTaxCreditsMember
2025-09-30
0001805077
eose:ProductionTaxCreditsMember
2024-12-31
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:RelatedPartyMember
2021-07-31
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:RelatedPartyMember
2021-07-01
2021-07-31
0001805077
us-gaap:RelatedPartyMember
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2023-01-31
0001805077
eose:ManufacturingCostsMember
us-gaap:RelatedPartyMember
2025-07-01
2025-09-30
0001805077
eose:ManufacturingCostsMember
us-gaap:RelatedPartyMember
2025-01-01
2025-09-30
0001805077
eose:AdvisoryFeesMember
us-gaap:RelatedPartyMember
2025-07-01
2025-09-30
0001805077
eose:AdvisoryFeesMember
us-gaap:RelatedPartyMember
2025-01-01
2025-09-30
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-09-30
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2024-12-31
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:SecuredDebtMember
2025-09-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:SecuredDebtMember
2024-12-31
0001805077
eose:AFGConvertibleNoteMember
us-gaap:ConvertibleDebtMember
2025-09-30
0001805077
eose:AFGConvertibleNoteMember
us-gaap:ConvertibleDebtMember
2024-12-31
0001805077
eose:NotesPayableRelatedPartyMember
2025-09-30
0001805077
eose:NotesPayableRelatedPartyMember
2024-12-31
0001805077
eose:A2025ConvertibleNotesDue2030Member
us-gaap:ConvertibleDebtMember
2025-09-30
0001805077
eose:A2025ConvertibleNotesDue2030Member
us-gaap:ConvertibleDebtMember
2024-12-31
0001805077
eose:EquipmentFinancingFacilityMember
us-gaap:LineOfCreditMember
2025-09-30
0001805077
eose:EquipmentFinancingFacilityMember
us-gaap:LineOfCreditMember
2024-12-31
0001805077
eose:DOELoanFacilityMember
us-gaap:LineOfCreditMember
2025-09-30
0001805077
eose:DOELoanFacilityMember
us-gaap:LineOfCreditMember
2024-12-31
0001805077
eose:A2025ConvertibleNotesDue2030Member
us-gaap:ConvertibleDebtMember
2025-06-03
2025-06-03
0001805077
eose:A2025ConvertibleNotesDue2030Member
us-gaap:ConvertibleDebtMember
2025-07-01
2025-09-30
0001805077
eose:A2025ConvertibleNotesDue2030Member
us-gaap:ConvertibleDebtMember
2025-01-01
2025-09-30
0001805077
eose:A2025ConvertibleNotesDue2030Member
us-gaap:ConvertibleDebtMember
2025-06-13
0001805077
eose:A2025ConvertibleNotesDue2030Member
us-gaap:ConvertibleDebtMember
2025-06-11
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:SecuredDebtMember
2024-06-21
2024-06-21
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:SecuredDebtMember
2025-01-01
2025-09-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:SecuredDebtMember
2024-06-20
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:SecuredDebtMember
2024-08-31
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:SecuredDebtMember
2024-10-31
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:SecuredDebtMember
2025-01-31
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:SecuredDebtMember
2025-07-01
2025-09-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
2025-05-28
2025-05-28
0001805077
eose:DelayedDrawTermLoanDDTLMember
2025-05-28
0001805077
eose:ModificationOfTheDDTLMember
2025-05-28
0001805077
eose:ModificationOfTheDDTLMember
2025-05-28
2025-05-28
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2021-07-06
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-07-01
2025-09-30
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2024-07-01
2024-09-30
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-01-01
2025-09-30
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2024-01-01
2024-09-30
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-06-03
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-06-03
2025-06-03
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-06-13
2025-06-13
0001805077
eose:DOELoanFacilityMember
us-gaap:LineOfCreditMember
2024-11-26
2024-11-26
0001805077
eose:DOELoanFacilityMember
us-gaap:LineOfCreditMember
2024-12-06
0001805077
eose:DOELoanFacilityMember
us-gaap:LineOfCreditMember
2025-06-04
0001805077
eose:DOELoanFacilityMember
us-gaap:LineOfCreditMember
2025-07-01
2025-09-30
0001805077
eose:DOELoanFacilityMember
us-gaap:LineOfCreditMember
2025-01-01
2025-09-30
0001805077
eose:DOELoanFacilityMember
eose:PIKInterestMember
2025-09-30
0001805077
eose:DOELoanFacilityMember
eose:PIKInterestMember
2025-06-30
0001805077
eose:DOELoanFacilityMember
eose:PIKInterestMember
2024-12-31
0001805077
us-gaap:UsTreasuryUstInterestRateMember
eose:DOELoanFacilityMember
us-gaap:LineOfCreditMember
2024-11-26
2024-11-26
0001805077
us-gaap:RelatedPartyMember
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2023-01-18
0001805077
eose:AFGConvertibleNotesMember
2025-07-29
2025-07-29
0001805077
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2023-01-18
0001805077
us-gaap:RelatedPartyMember
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-09-30
0001805077
us-gaap:RelatedPartyMember
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2024-12-31
0001805077
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-07-29
2025-07-29
0001805077
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-07-01
2025-09-30
0001805077
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-01-01
2025-09-30
0001805077
us-gaap:RelatedPartyMember
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-07-01
2025-09-30
0001805077
us-gaap:RelatedPartyMember
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2024-07-01
2024-09-30
0001805077
us-gaap:RelatedPartyMember
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-01-01
2025-09-30
0001805077
us-gaap:RelatedPartyMember
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2024-01-01
2024-09-30
0001805077
eose:AFGConvertibleNotesMember
us-gaap:RelatedPartyMember
2025-09-30
0001805077
eose:AFGConvertibleNotesMember
us-gaap:RelatedPartyMember
2024-12-31
0001805077
eose:AFGConvertibleNotesMember
us-gaap:RelatedPartyMember
2025-01-01
2025-09-30
0001805077
eose:AFGConvertibleNotesMember
us-gaap:RelatedPartyMember
2024-01-01
2024-12-31
0001805077
us-gaap:CommonStockMember
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-07-01
2025-09-30
0001805077
eose:SeniorSecuredTermLoanAgreementMember
us-gaap:SecuredDebtMember
2022-07-29
0001805077
eose:SeniorSecuredTermLoanAgreementMember
us-gaap:SecuredDebtMember
2022-07-29
2022-07-29
0001805077
us-gaap:SecuredOvernightFinancingRateSofrMember
eose:SeniorSecuredTermLoanAgreementMember
srt:MinimumMember
2022-07-29
2022-07-29
0001805077
eose:FederalReserveBankOfNewYorkFinancingRateNYFRBMember
eose:SeniorSecuredTermLoanAgreementMember
srt:MinimumMember
2022-07-29
2022-07-29
0001805077
eose:SeniorSecuredTermLoanAgreementMember
eose:SOFRLoansMember
2022-07-29
2022-07-29
0001805077
eose:SeniorSecuredTermLoanAgreementMember
eose:ABRLoansMember
2022-07-29
0001805077
eose:AtlasCreditAgreementMember
eose:SeniorSecuredTermLoanAgreementMember
us-gaap:SecuredDebtMember
2024-06-20
0001805077
us-gaap:NonrelatedPartyMember
eose:SeniorSecuredTermLoanAgreementMember
us-gaap:SecuredDebtMember
2024-07-01
2024-09-30
0001805077
us-gaap:NonrelatedPartyMember
eose:SeniorSecuredTermLoanAgreementMember
us-gaap:SecuredDebtMember
2024-01-01
2024-09-30
0001805077
eose:EquipmentFinancingFacilityMember
us-gaap:LineOfCreditMember
2021-09-30
0001805077
eose:EquipmentFinancingFacilityMember
us-gaap:LineOfCreditMember
2021-09-01
2021-09-30
0001805077
eose:EquipmentFinancingFacilityMember
us-gaap:LineOfCreditMember
2022-09-01
2022-09-30
0001805077
eose:EquipmentFinancingFacilityMember
us-gaap:LineOfCreditMember
2022-09-30
0001805077
eose:EquipmentFinancingFacilityMember
us-gaap:LineOfCreditMember
2021-09-01
2025-09-30
0001805077
eose:EquipmentFinancingFacilityMember
2025-09-30
0001805077
eose:EquipmentFinancingFacilityMember
2024-12-31
0001805077
eose:EquipmentFinancingFacilityMember
2025-07-01
2025-09-30
0001805077
eose:EquipmentFinancingFacilityMember
2025-01-01
2025-09-30
0001805077
eose:EquipmentFinancingFacilityMember
2024-07-01
2024-09-30
0001805077
eose:EquipmentFinancingFacilityMember
2024-01-01
2024-09-30
0001805077
eose:IPOWarrantsMember
us-gaap:NonrelatedPartyMember
us-gaap:CommonStockMember
2025-09-30
0001805077
eose:IPOWarrantsMember
us-gaap:NonrelatedPartyMember
us-gaap:CommonStockMember
2024-12-31
0001805077
eose:April2023PrivateWarrantsMember
us-gaap:NonrelatedPartyMember
us-gaap:CommonStockMember
2025-09-30
0001805077
eose:April2023PrivateWarrantsMember
us-gaap:NonrelatedPartyMember
us-gaap:CommonStockMember
2024-12-31
0001805077
eose:May2023PrivateWarrantsMember
us-gaap:NonrelatedPartyMember
us-gaap:CommonStockMember
2025-09-30
0001805077
eose:May2023PrivateWarrantsMember
us-gaap:NonrelatedPartyMember
us-gaap:CommonStockMember
2024-12-31
0001805077
eose:December2023WarrantsMember
us-gaap:NonrelatedPartyMember
us-gaap:CommonStockMember
2025-09-30
0001805077
eose:December2023WarrantsMember
us-gaap:NonrelatedPartyMember
us-gaap:CommonStockMember
2024-12-31
0001805077
us-gaap:NonrelatedPartyMember
us-gaap:CommonStockMember
2025-09-30
0001805077
us-gaap:NonrelatedPartyMember
us-gaap:CommonStockMember
2024-12-31
0001805077
eose:SPAWarrantMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2025-09-30
0001805077
eose:SPAWarrantMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2024-12-31
0001805077
eose:ContingentWarrantsMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2025-09-30
0001805077
eose:ContingentWarrantsMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2024-12-31
0001805077
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2025-09-30
0001805077
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2024-12-31
0001805077
eose:IPOWarrantsMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2025-01-01
2025-03-31
0001805077
eose:April2023PrivateWarrantsMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2023-04-01
2023-04-30
0001805077
eose:April2023PrivateWarrantsMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2023-04-30
0001805077
eose:May2023PrivateWarrantsMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2023-05-01
2023-05-31
0001805077
eose:May2023PrivateWarrantsMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2023-05-31
0001805077
eose:December2023WarrantsMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2023-12-01
2023-12-31
0001805077
eose:December2023WarrantsMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2025-07-01
2025-09-30
0001805077
eose:December2023WarrantsMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2025-01-01
2025-09-30
0001805077
eose:December2023WarrantsMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2024-07-01
2024-09-30
0001805077
eose:December2023WarrantsMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2024-01-01
2024-09-30
0001805077
eose:SPAWarrantMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2024-06-20
0001805077
eose:ContingentWarrantsMember
eose:CCMDenaliEquityHoldingsLPMember
us-gaap:RelatedPartyMember
us-gaap:CommonStockMember
2024-06-20
0001805077
eose:SPAWarrantMember
us-gaap:FairValueInputsLevel1Member
2025-09-30
0001805077
eose:SPAWarrantMember
us-gaap:FairValueInputsLevel2Member
2025-09-30
0001805077
eose:SPAWarrantMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0001805077
eose:SPAWarrantMember
us-gaap:FairValueInputsLevel1Member
2024-12-31
0001805077
eose:SPAWarrantMember
us-gaap:FairValueInputsLevel2Member
2024-12-31
0001805077
eose:SPAWarrantMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001805077
eose:ContingentWarrantsMember
us-gaap:FairValueInputsLevel1Member
2025-09-30
0001805077
eose:ContingentWarrantsMember
us-gaap:FairValueInputsLevel2Member
2025-09-30
0001805077
eose:ContingentWarrantsMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0001805077
eose:ContingentWarrantsMember
us-gaap:FairValueInputsLevel1Member
2024-12-31
0001805077
eose:ContingentWarrantsMember
us-gaap:FairValueInputsLevel2Member
2024-12-31
0001805077
eose:ContingentWarrantsMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001805077
eose:IPOAprilMayAndDecember2023WarrantsMember
us-gaap:FairValueInputsLevel1Member
2025-09-30
0001805077
eose:IPOAprilMayAndDecember2023WarrantsMember
us-gaap:FairValueInputsLevel2Member
2025-09-30
0001805077
eose:IPOAprilMayAndDecember2023WarrantsMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0001805077
eose:IPOAprilMayAndDecember2023WarrantsMember
us-gaap:FairValueInputsLevel1Member
2024-12-31
0001805077
eose:IPOAprilMayAndDecember2023WarrantsMember
us-gaap:FairValueInputsLevel2Member
2024-12-31
0001805077
eose:IPOAprilMayAndDecember2023WarrantsMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:FairValueInputsLevel1Member
2025-09-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:FairValueInputsLevel2Member
2025-09-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:FairValueInputsLevel1Member
2024-12-31
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:FairValueInputsLevel2Member
2024-12-31
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:FairValueInputsLevel1Member
2025-09-30
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:FairValueInputsLevel2Member
2025-09-30
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:FairValueInputsLevel1Member
2024-12-31
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:FairValueInputsLevel2Member
2024-12-31
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001805077
eose:April2023PrivateWarrantsMember
us-gaap:MeasurementInputExpectedTermMember
2025-09-30
0001805077
eose:April2023PrivateWarrantsMember
us-gaap:MeasurementInputExpectedTermMember
2024-12-31
0001805077
eose:April2023PrivateWarrantsMember
us-gaap:MeasurementInputSharePriceMember
2025-09-30
0001805077
eose:April2023PrivateWarrantsMember
us-gaap:MeasurementInputSharePriceMember
2024-12-31
0001805077
eose:April2023PrivateWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2025-09-30
0001805077
eose:April2023PrivateWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2024-12-31
0001805077
eose:April2023PrivateWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
2025-09-30
0001805077
eose:April2023PrivateWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
2024-12-31
0001805077
eose:May2023PrivateWarrantsMember
us-gaap:MeasurementInputExpectedTermMember
2025-09-30
0001805077
eose:May2023PrivateWarrantsMember
us-gaap:MeasurementInputExpectedTermMember
2024-12-31
0001805077
eose:May2023PrivateWarrantsMember
us-gaap:MeasurementInputSharePriceMember
2025-09-30
0001805077
eose:May2023PrivateWarrantsMember
us-gaap:MeasurementInputSharePriceMember
2024-12-31
0001805077
eose:May2023PrivateWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2025-09-30
0001805077
eose:May2023PrivateWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2024-12-31
0001805077
eose:May2023PrivateWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
2025-09-30
0001805077
eose:May2023PrivateWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
2024-12-31
0001805077
eose:December2023PrivateWarrantsMember
us-gaap:MeasurementInputExpectedTermMember
2025-09-30
0001805077
eose:December2023PrivateWarrantsMember
us-gaap:MeasurementInputExpectedTermMember
2024-12-31
0001805077
eose:December2023PrivateWarrantsMember
us-gaap:MeasurementInputSharePriceMember
2025-09-30
0001805077
eose:December2023PrivateWarrantsMember
us-gaap:MeasurementInputSharePriceMember
2024-12-31
0001805077
eose:December2023PrivateWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2025-09-30
0001805077
eose:December2023PrivateWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2024-12-31
0001805077
eose:December2023PrivateWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
2025-09-30
0001805077
eose:December2023PrivateWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
2024-12-31
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2024-01-01
2024-12-31
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:MeasurementInputExpectedDividendRateMember
us-gaap:ConvertibleDebtMember
2025-06-03
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:MeasurementInputExpectedDividendRateMember
us-gaap:ConvertibleDebtMember
2024-12-31
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
us-gaap:ConvertibleDebtMember
2025-06-03
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
us-gaap:ConvertibleDebtMember
2024-12-31
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:MeasurementInputPriceVolatilityMember
us-gaap:ConvertibleDebtMember
2025-06-03
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:MeasurementInputPriceVolatilityMember
us-gaap:ConvertibleDebtMember
2024-12-31
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:MeasurementInputSharePriceMember
us-gaap:ConvertibleDebtMember
2025-06-03
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:MeasurementInputSharePriceMember
us-gaap:ConvertibleDebtMember
2024-12-31
0001805077
eose:A2021ConvertibleNotesMember
eose:MeasurementInputDebtYieldMember
us-gaap:ConvertibleDebtMember
2025-06-03
0001805077
eose:A2021ConvertibleNotesMember
eose:MeasurementInputDebtYieldMember
us-gaap:ConvertibleDebtMember
2024-12-31
0001805077
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2025-07-28
2025-07-28
0001805077
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
2024-01-01
2024-12-31
0001805077
eose:AFGConvertibleNotesMember
us-gaap:MeasurementInputExpectedDividendRateMember
us-gaap:ConvertibleDebtMember
2025-09-30
0001805077
eose:AFGConvertibleNotesMember
us-gaap:MeasurementInputExpectedDividendRateMember
us-gaap:ConvertibleDebtMember
2025-07-28
0001805077
eose:AFGConvertibleNotesMember
us-gaap:MeasurementInputExpectedDividendRateMember
us-gaap:ConvertibleDebtMember
2024-12-31
0001805077
eose:AFGConvertibleNotesMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
us-gaap:ConvertibleDebtMember
2025-09-30
0001805077
eose:AFGConvertibleNotesMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
us-gaap:ConvertibleDebtMember
2025-07-28
0001805077
eose:AFGConvertibleNotesMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
us-gaap:ConvertibleDebtMember
2024-12-31
0001805077
eose:AFGConvertibleNotesMember
us-gaap:MeasurementInputPriceVolatilityMember
us-gaap:ConvertibleDebtMember
2025-09-30
0001805077
eose:AFGConvertibleNotesMember
us-gaap:MeasurementInputPriceVolatilityMember
us-gaap:ConvertibleDebtMember
2025-07-28
0001805077
eose:AFGConvertibleNotesMember
us-gaap:MeasurementInputPriceVolatilityMember
us-gaap:ConvertibleDebtMember
2024-12-31
0001805077
eose:AFGConvertibleNotesMember
us-gaap:MeasurementInputSharePriceMember
us-gaap:ConvertibleDebtMember
2025-09-30
0001805077
eose:AFGConvertibleNotesMember
us-gaap:MeasurementInputSharePriceMember
us-gaap:ConvertibleDebtMember
2025-07-28
0001805077
eose:AFGConvertibleNotesMember
us-gaap:MeasurementInputSharePriceMember
us-gaap:ConvertibleDebtMember
2024-12-31
0001805077
eose:AFGConvertibleNotesMember
eose:MeasurementInputDebtYieldMember
us-gaap:ConvertibleDebtMember
2025-09-30
0001805077
eose:AFGConvertibleNotesMember
eose:MeasurementInputDebtYieldMember
us-gaap:ConvertibleDebtMember
2025-07-28
0001805077
eose:AFGConvertibleNotesMember
eose:MeasurementInputDebtYieldMember
us-gaap:ConvertibleDebtMember
2024-12-31
0001805077
2024-06-20
0001805077
eose:DelayedDrawTermLoanInitialDrawMember
2024-06-21
0001805077
eose:SPAWarrantMember
2024-06-21
0001805077
eose:ContingentWarrantsMember
2024-06-21
0001805077
eose:DelayedDrawTermLoanAugustDrawMember
2024-08-29
0001805077
eose:DelayedDrawTermLoanOctoberDrawMember
2024-10-31
0001805077
eose:JanuaryDrawOfTheDelayedDrawTermLoanMember
2025-01-24
0001805077
us-gaap:FairValueInputsLevel3Member
eose:DelayedDrawTermLoanDDTLMember
eose:MeasurementInputDebtYieldMember
2024-06-21
0001805077
us-gaap:FairValueInputsLevel3Member
eose:DelayedDrawTermLoanDDTLMember
eose:MeasurementInputDebtYieldMember
2024-12-31
0001805077
us-gaap:FairValueInputsLevel3Member
eose:DelayedDrawTermLoanDDTLMember
eose:MeasurementInputDebtYieldMember
2025-09-30
0001805077
eose:ContingentWarrantsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputPriceVolatilityMember
2024-06-21
0001805077
eose:ContingentWarrantsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputPriceVolatilityMember
2024-12-31
0001805077
eose:SPAWarrantMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember
2024-06-21
0001805077
eose:SPAWarrantMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember
2024-12-31
0001805077
eose:SPAWarrantMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember
2025-09-30
0001805077
us-gaap:FairValueInputsLevel3Member
eose:DelayedDrawTermLoanDDTLMember
eose:MeasurementInputDebtYieldMember
2024-08-31
0001805077
us-gaap:FairValueInputsLevel3Member
eose:DelayedDrawTermLoanDDTLMember
eose:MeasurementInputDebtYieldMember
2024-10-31
0001805077
us-gaap:FairValueInputsLevel3Member
eose:DelayedDrawTermLoanDDTLMember
eose:MeasurementInputDebtYieldMember
2025-01-24
0001805077
us-gaap:FairValueInputsLevel3Member
eose:DelayedDrawTermLoanDDTLMember
eose:MeasurementInputDebtYieldMember
2025-06-04
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:DebtMember
2025-06-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:DebtMember
2024-06-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:DebtMember
2024-12-31
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:DebtMember
2023-12-31
0001805077
us-gaap:DebtMember
eose:DelayedDrawTermLoanDDTLMember
eose:DrawOneMember
2025-07-01
2025-09-30
0001805077
us-gaap:DebtMember
eose:DelayedDrawTermLoanDDTLMember
eose:DrawOneMember
2024-07-01
2024-09-30
0001805077
us-gaap:DebtMember
eose:DelayedDrawTermLoanDDTLMember
eose:DrawOneMember
2025-01-01
2025-09-30
0001805077
us-gaap:DebtMember
eose:DelayedDrawTermLoanDDTLMember
eose:DrawOneMember
2024-01-01
2024-09-30
0001805077
us-gaap:DebtMember
eose:DelayedDrawTermLoanDDTLMember
eose:DrawThreeMember
2025-07-01
2025-09-30
0001805077
us-gaap:DebtMember
eose:DelayedDrawTermLoanDDTLMember
eose:DrawThreeMember
2024-07-01
2024-09-30
0001805077
us-gaap:DebtMember
eose:DelayedDrawTermLoanDDTLMember
eose:DrawThreeMember
2025-01-01
2025-09-30
0001805077
us-gaap:DebtMember
eose:DelayedDrawTermLoanDDTLMember
eose:DrawThreeMember
2024-01-01
2024-09-30
0001805077
us-gaap:DebtMember
eose:DelayedDrawTermLoanDDTLMember
eose:DrawTwoMember
2025-07-01
2025-09-30
0001805077
us-gaap:DebtMember
eose:DelayedDrawTermLoanDDTLMember
eose:DrawTwoMember
2024-07-01
2024-09-30
0001805077
us-gaap:DebtMember
eose:DelayedDrawTermLoanDDTLMember
eose:DrawTwoMember
2025-01-01
2025-09-30
0001805077
us-gaap:DebtMember
eose:DelayedDrawTermLoanDDTLMember
eose:DrawTwoMember
2024-01-01
2024-09-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:DebtMember
2025-07-01
2025-09-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:DebtMember
2024-07-01
2024-09-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:DebtMember
2025-01-01
2025-09-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:DebtMember
2024-01-01
2024-09-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:DebtMember
2025-09-30
0001805077
eose:DelayedDrawTermLoanDDTLMember
us-gaap:DebtMember
2024-09-30
0001805077
eose:SPAWarrantsAndContingentWarrantsMember
us-gaap:WarrantMember
2025-06-30
0001805077
eose:SPAWarrantsAndContingentWarrantsMember
us-gaap:WarrantMember
2024-06-30
0001805077
eose:SPAWarrantsAndContingentWarrantsMember
us-gaap:WarrantMember
2024-12-31
0001805077
eose:SPAWarrantsAndContingentWarrantsMember
us-gaap:WarrantMember
2023-12-31
0001805077
eose:SPAWarrantsAndContingentWarrantsMember
us-gaap:WarrantMember
2025-07-01
2025-09-30
0001805077
eose:SPAWarrantsAndContingentWarrantsMember
us-gaap:WarrantMember
2024-07-01
2024-09-30
0001805077
eose:SPAWarrantsAndContingentWarrantsMember
us-gaap:WarrantMember
2025-01-01
2025-09-30
0001805077
eose:SPAWarrantsAndContingentWarrantsMember
us-gaap:WarrantMember
2024-01-01
2024-09-30
0001805077
eose:SPAWarrantsAndContingentWarrantsMember
us-gaap:WarrantMember
2025-09-30
0001805077
eose:SPAWarrantsAndContingentWarrantsMember
us-gaap:WarrantMember
2024-09-30
0001805077
eose:AprilMayAndDecember2023WarrantsMember
us-gaap:WarrantMember
2025-06-30
0001805077
eose:AprilMayAndDecember2023WarrantsMember
us-gaap:WarrantMember
2024-06-30
0001805077
eose:AprilMayAndDecember2023WarrantsMember
us-gaap:WarrantMember
2024-12-31
0001805077
eose:AprilMayAndDecember2023WarrantsMember
us-gaap:WarrantMember
2023-12-31
0001805077
eose:AprilMayAndDecember2023WarrantsMember
us-gaap:WarrantMember
2025-07-01
2025-09-30
0001805077
eose:AprilMayAndDecember2023WarrantsMember
us-gaap:WarrantMember
2024-07-01
2024-09-30
0001805077
eose:AprilMayAndDecember2023WarrantsMember
us-gaap:WarrantMember
2025-01-01
2025-09-30
0001805077
eose:AprilMayAndDecember2023WarrantsMember
us-gaap:WarrantMember
2024-01-01
2024-09-30
0001805077
eose:AprilMayAndDecember2023WarrantsMember
us-gaap:WarrantMember
2025-09-30
0001805077
eose:AprilMayAndDecember2023WarrantsMember
us-gaap:WarrantMember
2024-09-30
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2025-06-30
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2024-06-30
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2024-12-31
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2023-12-31
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2025-07-01
2025-09-30
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2024-07-01
2024-09-30
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2025-01-01
2025-09-30
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2024-01-01
2024-09-30
0001805077
eose:AFGConvertibleNotesMember
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2025-07-01
2025-09-30
0001805077
eose:AFGConvertibleNotesMember
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2024-07-01
2024-09-30
0001805077
eose:AFGConvertibleNotesMember
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2025-01-01
2025-09-30
0001805077
eose:AFGConvertibleNotesMember
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2024-01-01
2024-09-30
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2025-07-01
2025-09-30
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2024-07-01
2024-09-30
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2025-01-01
2025-09-30
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2024-01-01
2024-09-30
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2025-09-30
0001805077
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2024-09-30
0001805077
us-gaap:NotesReceivableMember
2025-09-30
0001805077
us-gaap:NotesReceivableMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0001805077
us-gaap:NotesReceivableMember
2024-12-31
0001805077
us-gaap:NotesReceivableMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001805077
eose:LoanCommitmentAssetsMember
2025-09-30
0001805077
eose:LoanCommitmentAssetsMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0001805077
eose:LoanCommitmentAssetsMember
2024-12-31
0001805077
eose:LoanCommitmentAssetsMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001805077
eose:A2021ConvertibleNotesMember
2025-09-30
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0001805077
eose:A2021ConvertibleNotesMember
2024-12-31
0001805077
eose:A2021ConvertibleNotesMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001805077
eose:A2025ConvertibleNotesDue2030Member
2025-09-30
0001805077
eose:A2025ConvertibleNotesDue2030Member
us-gaap:FairValueInputsLevel3Member
2025-09-30
0001805077
eose:A2025ConvertibleNotesDue2030Member
2024-12-31
0001805077
eose:A2025ConvertibleNotesDue2030Member
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001805077
eose:AFGConvertibleNotesMember
2025-09-30
0001805077
eose:AFGConvertibleNotesMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0001805077
eose:AFGConvertibleNotesMember
2024-12-31
0001805077
eose:AFGConvertibleNotesMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001805077
eose:EquipmentFinancingFacilityMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0001805077
eose:EquipmentFinancingFacilityMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001805077
eose:SeriesA1PreferredStockMember
2025-09-30
0001805077
eose:SeriesA1PreferredStockMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0001805077
eose:SeriesA1PreferredStockMember
2024-12-31
0001805077
eose:SeriesA1PreferredStockMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001805077
eose:DOELoanFacilityMember
2025-09-30
0001805077
eose:DOELoanFacilityMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0001805077
eose:DOELoanFacilityMember
2024-12-31
0001805077
eose:DOELoanFacilityMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001805077
us-gaap:FairValueInputsLevel3Member
2025-09-30
0001805077
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001805077
2024-10-01
2024-12-31
0001805077
us-gaap:RestrictedStockUnitsRSUMember
2025-07-01
2025-09-30
0001805077
us-gaap:RestrictedStockUnitsRSUMember
2024-07-01
2024-09-30
0001805077
us-gaap:RestrictedStockUnitsRSUMember
2025-01-01
2025-09-30
0001805077
us-gaap:RestrictedStockUnitsRSUMember
2024-01-01
2024-09-30
0001805077
us-gaap:PerformanceSharesMember
2025-07-01
2025-09-30
0001805077
us-gaap:PerformanceSharesMember
2024-07-01
2024-09-30
0001805077
us-gaap:PerformanceSharesMember
2025-01-01
2025-09-30
0001805077
us-gaap:PerformanceSharesMember
2024-01-01
2024-09-30
0001805077
us-gaap:EmployeeStockOptionMember
2025-07-01
2025-09-30
0001805077
us-gaap:EmployeeStockOptionMember
2024-07-01
2024-09-30
0001805077
us-gaap:EmployeeStockOptionMember
2025-01-01
2025-09-30
0001805077
us-gaap:EmployeeStockOptionMember
2024-01-01
2024-09-30
0001805077
us-gaap:RestrictedStockUnitsRSUMember
2025-09-30
0001805077
srt:MinimumMember
us-gaap:PerformanceSharesMember
2024-07-01
2024-09-30
0001805077
srt:MaximumMember
us-gaap:PerformanceSharesMember
2024-07-01
2024-09-30
0001805077
eose:A2025TSRAwardsMember
2024-07-01
2024-09-30
0001805077
eose:A2024TSRAwardsMember
2024-07-01
2024-09-30
0001805077
us-gaap:PerformanceSharesMember
2025-09-30
0001805077
2020-05-22
0001805077
eose:PublicWarrantsMember
2025-07-01
2025-09-30
0001805077
eose:PublicWarrantsMember
2025-01-01
2025-09-30
0001805077
eose:PublicWarrantsMember
2024-07-01
2024-09-30
0001805077
eose:PublicWarrantsMember
2024-01-01
2024-09-30
0001805077
eose:IPOWarrantsMember
us-gaap:CommonStockMember
2025-01-01
2025-09-30
0001805077
eose:PublicWarrantsMember
2025-09-30
0001805077
eose:PublicWarrantsMember
2024-12-31
0001805077
eose:AtTheMarketProgramMember
2025-09-30
0001805077
eose:AtTheMarketProgramMember
2024-07-01
2024-09-30
0001805077
eose:AtTheMarketProgramMember
2024-01-01
2024-09-30
0001805077
eose:AtTheMarketProgramMember
2025-07-01
2025-09-30
0001805077
eose:AtTheMarketProgramMember
2025-01-01
2025-09-30
0001805077
us-gaap:ScenarioPlanMember
eose:PublicOfferingMember
2025-05-29
2025-05-29
0001805077
us-gaap:ScenarioPlanMember
eose:PublicOfferingMember
2025-05-29
0001805077
eose:PublicOfferingMember
2025-05-29
2025-05-29
0001805077
eose:PublicOfferingMember
2025-06-02
2025-06-02
0001805077
us-gaap:StockCompensationPlanMember
2025-07-01
2025-09-30
0001805077
us-gaap:StockCompensationPlanMember
2025-01-01
2025-09-30
0001805077
us-gaap:StockCompensationPlanMember
2024-07-01
2024-09-30
0001805077
us-gaap:StockCompensationPlanMember
2024-01-01
2024-09-30
0001805077
us-gaap:WarrantMember
2025-07-01
2025-09-30
0001805077
us-gaap:WarrantMember
2025-01-01
2025-09-30
0001805077
us-gaap:WarrantMember
2024-07-01
2024-09-30
0001805077
us-gaap:WarrantMember
2024-01-01
2024-09-30
0001805077
us-gaap:ConvertibleDebtSecuritiesMember
2025-07-01
2025-09-30
0001805077
us-gaap:ConvertibleDebtSecuritiesMember
2025-01-01
2025-09-30
0001805077
us-gaap:ConvertibleDebtSecuritiesMember
2024-01-01
2024-09-30
0001805077
us-gaap:ConvertibleDebtSecuritiesMember
2024-07-01
2024-09-30
0001805077
us-gaap:SeriesBPreferredStockMember
2025-07-01
2025-09-30
0001805077
us-gaap:SeriesBPreferredStockMember
2025-01-01
2025-09-30
0001805077
us-gaap:SeriesBPreferredStockMember
2024-07-01
2024-09-30
0001805077
us-gaap:SeriesBPreferredStockMember
2024-01-01
2024-09-30
0001805077
us-gaap:ProductMember
eose:ReportableSegmentMember
2025-07-01
2025-09-30
0001805077
us-gaap:ProductMember
eose:ReportableSegmentMember
2024-07-01
2024-09-30
0001805077
us-gaap:ProductMember
eose:ReportableSegmentMember
2025-01-01
2025-09-30
0001805077
us-gaap:ProductMember
eose:ReportableSegmentMember
2024-01-01
2024-09-30
0001805077
us-gaap:ServiceMember
eose:ReportableSegmentMember
2025-07-01
2025-09-30
0001805077
us-gaap:ServiceMember
eose:ReportableSegmentMember
2024-07-01
2024-09-30
0001805077
us-gaap:ServiceMember
eose:ReportableSegmentMember
2025-01-01
2025-09-30
0001805077
us-gaap:ServiceMember
eose:ReportableSegmentMember
2024-01-01
2024-09-30
0001805077
eose:ReportableSegmentMember
2025-07-01
2025-09-30
0001805077
eose:ReportableSegmentMember
2024-07-01
2024-09-30
0001805077
eose:ReportableSegmentMember
2025-01-01
2025-09-30
0001805077
eose:ReportableSegmentMember
2024-01-01
2024-09-30
0001805077
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
us-gaap:SubsequentEventMember
2025-11-04
2025-11-04
0001805077
eose:PittsburghPennsylvaniaMember
us-gaap:SubsequentEventMember
2025-10-20
0001805077
eose:MarshallTownshipPennsylvaniaMember
us-gaap:SubsequentEventMember
2025-10-20
0001805077
us-gaap:CommonStockMember
eose:AFGConvertibleNotesMember
us-gaap:ConvertibleDebtMember
us-gaap:SubsequentEventMember
2025-11-04
2025-11-04
0001805077
eose:NathanKroekerMember
2025-07-01
2025-09-30
0001805077
eose:SumeetPuriMember
2025-07-01
2025-09-30
0001805077
eose:JosephMastrangeloMember
2025-07-01
2025-09-30
0001805077
eose:MichaelSilbermanMember
2025-07-01
2025-09-30
0001805077
eose:MichaelSilbermanMember
eose:MichaelSilbermanPreviousExistingPlanMember
2025-07-01
2025-09-30
0001805077
eose:NathanKroekerMember
eose:NathanKroekerPreviousExistingPlanMember
2025-07-01
2025-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 
10-Q

☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended 
September 30, 2025
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from  

  to  

Commission file number 
001-39291
EOS ENERGY ENTERPRISES, INC.
(Exact name of registrant as specified in its charter)  
Delaware
84-4290188
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
3920 Park Avenue
Edison
NJ
08820
(Address of Principal Executive Offices)
(Zip Code)
(
732
) 
225-8400
Registrant’s telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, par value $0.0001 per share
EOSE
The Nasdaq Stock Market LLC
Warrants, each exercisable for one share of common stock
EOSEW
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    
Yes

☒
    No  
☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  
Yes

☒
  No  
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
☐
Accelerated filer
☐
Non-accelerated filer
☒
Smaller reporting company
☒
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     Yes   ☐     No  
☒
The registrant had outstanding 
288,242,532
 shares of common stock as of November 3, 2025.
Table of Contents
Table of Contents
Page
PART I - FINANCIAL INFORMATION
Item 1. 
Financial Statements 
4
Unaudited 
Condensed Consolidated Balance Sheets as of 
September 30, 2025
 and 
December 31, 2024
4
Unaudited 
Condensed Consolidated Statements of Operations and Comprehensive Loss for the 
Three and Nine
 Months Ended 
September 30, 2025
 and 
2024
6
Unaudited 
Condensed Consolidated Statements of Shareholders’ Deficit for the 
Three and Nine
 Months Ended 
September 30, 2025 
and 
2024

7
Unaudited Condensed Consolidated Statements of Cash Flows for the
 Nine Months Ended September 30, 2025 and 2024

9
Notes to the Unaudited Condensed Consolidated Financial Statements
11
Item 2.
Management
’
s Discussion and Analysis of Financial Condition and Results of Operations
51
Item 3. 
Quantitative and Qualitative Disclosures About Market Risk
61
Item 4. 
Controls and Procedures
61
PART II - OTHER INFORMATION
Item 
1. 
Legal Proceedings
62
Item 1a. 
Risk Factors
62
Item 2. 
Unregistered Sales of Equity Securities and Use of Proceeds
62
Item 3. 
Defaults Upon Senior Securities
62
Item 4
. 
Mine Safety Disclosures
62
Item 5. 
Other Information
62
Item 6. 
Exhibits
63
Signatures
65
1
Table of Contents
FORWARD-LOOKING INFORMATION
All statements included in this Quarterly Report on Form 10-Q (“Quarterly Report”), other than statements or characterizations of historical fact, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us, are intended to identify forward-looking statements. These statements appear in a number of places in this Quarterly Report and include statements regarding the intent, belief or current expectations of Eos Energy Enterprises, Inc. Forward-looking statements are based on our management’s beliefs, as well as assumptions made by and information currently available to, them. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected. Factors which may cause actual results to differ materially from current expectations include, but are not limited to:    
•
changes adversely affecting the business in which we are engaged;
•
our ability to forecast trends accurately; 
•
our ability to generate cash, service indebtedness and incur additional indebtedness;
•
our ability to raise financing in the future;
•
our customer’s ability to secure project financing;
•
risks associated with the Credit Agreement (defined below), including risks of default, dilution of outstanding common stock, consequences for failure to meet milestones and contractual lockup of shares;
•
the amount of final tax credits available to our customers or to Eos pursuant to the Inflation Reduction Act;
•
the timing and availability of future funding under the Department of Energy Loan Facility;
•
our ability to continue to develop efficient manufacturing processes to scale and to forecast related costs and efficiencies accurately;
•
fluctuations in our revenue and operating results;
•
competition from existing or new competitors;
•
our ability to convert firm order backlog and pipeline to revenue;
•
risks associated with security breaches in our information technology systems;
•
risks related to legal proceedings or claims;
•
risks associated with evolving energy policies in the United States and other countries and the potential costs of regulatory compliance;
•
risks associated with changes to the U.S. trade environment;
•
our ability to maintain the listing of our shares of common stock on NASDAQ;
•
our ability to grow our business and manage growth profitably, maintain relationships with customers and suppliers and retain our management and key employees;
•
risks related to adverse changes in general economic conditions, including inflationary pressures and increased interest rates; 
•
risk from supply chain disruptions and other impacts of geopolitical conflict;
•
changes in applicable laws or regulations; and
•
other factors detailed under the section titled “Risk Factors” herein.
2
Table of Contents
Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. See also Part I, Item 1A, 
“Risk Factors”
 disclosures contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 for additional discussion of the risks and uncertainties that could cause the Company’s actual results to differ materially from those expressed or implied in its forward-looking statements.
3
Table of Contents
Part I - Financial Information
EOS ENERGY ENTERPRISES, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
September 30,
2025
December 31,
2024
ASSETS

Current assets:

Cash and cash equivalents
$
58,733

$
74,292

Restricted cash
36,946

14,070

Loan commitment assets - related party
—

21,731

Accounts receivable, net 
4,817

3,038

Inventory
47,554

32,826

Vendor deposits
12,541

17,419

Contract assets, current
11,982

13,096

Prepaid expenses
2,378

938

Grant receivable, net
12,248

2,283

Other current assets
1,536

219

Total current assets
188,735

179,912

Property, plant and equipment, net
86,025

45,660

Intangible assets, net
1,079

240

Goodwill
4,331

4,331

Operating lease right-of-use asset, net
2,311

2,909

Long-term restricted cash
31,120

15,000

Other assets, net
14,609

12,266

Total assets
$
328,210

$
260,318

LIABILITIES 
Current liabilities:
Accounts payable 
$
51,643

$
16,723

Accrued expenses
31,391

22,032

Operating lease liability, current 
2,203

1,879

Long-term debt, current 
730

2,014

Contract liabilities, current 
16,703

22,039

Other current liabilities
683

288

Total current liabilities
103,353

64,975

Long-term liabilities:
Operating lease liability
389

1,628

Long-term debt
330,407

65,823

Notes payable - related party
117,317

249,059

Interest payable - related party 
247

—

Contract liabilities, long-term
2,480

4,310

Warrants liability
402,799

189,591

Warrants liability - related party
467,837

266,630

Other liabilities
382

69

Total long-term liabilities
1,321,858

777,110

Total liabilities
1,425,211

842,085

4
Table of Contents
EOS ENERGY ENTERPRISES, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
September 30,
2025
December 31,
2024
COMMITMENTS AND CONTINGENCIES (NOTE 16)
SERIES B PREFERRED STOCK (NOTE 3) - related party
1,223,364

488,696

SHAREHOLDERS' DEFICIT
Common stock, $
0.0001
 par value, 
600,000,000
 shares authorized, 
281,688,395
 and 
221,791,205
 shares outstanding on September 30, 2025 and December 31, 2024, respectively
27

23

Additional paid in capital
162,460

534,726

Accumulated deficit
(
2,415,366
)
(
1,561,716
)
Accumulated other comprehensive loss - related party
(
67,498
)
(
43,490
)
Accumulated other comprehensive income (loss)
12

(
6
)
Total shareholders' deficit
(
2,320,365
)
(
1,070,463
)
Total liabilities, preferred stock and shareholders' deficit
$
328,210

$
260,318

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
5
Table of Contents
EOS ENERGY ENTERPRISES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(In thousands, except share and per share amounts)

Three Months Ended
September 30,
Nine Months Ended
September 30,

2025
2024
2025
2024
Revenue
$
30,512

$
854

$
56,205

$
8,353

Cost of goods sold
64,437

25,764

145,622

68,114

Gross profit (loss)
(
33,925
)
(
24,910
)
(
89,417
)
(
59,761
)
Operating expenses
Research and development expenses
6,925

7,428

20,963

16,878

Selling, general and administrative expenses
19,786

17,796

66,269

43,331

Loss from write-down of property, plant and equipment
585

3,192

1,351

3,528

Total operating expenses
27,296

28,416

88,583

63,737

Operating Loss
(
61,221
)
(
53,326
)
(
178,000
)
(
123,498
)
Other (expense) income
Interest expense, net
(
4,846
)
(
133
)
(
7,139
)
(
7,915
)
Interest income (expense) - related party
840

(
5,291
)
(
9,451
)
(
15,054
)
Change in fair value of debt - related party
(
3,570
)
(
3,036
)
22,112

(
3,276
)
Change in fair value of warrants
(
240,825
)
(
66,469
)
(
252,836
)
(
71,510
)
Change in fair value of derivatives - related parties
(
327,841
)
(
213,034
)
(
369,710
)
(
260,227
)
(Loss) gain on debt extinguishment
(
3,589
)
—

(
52,652
)
68,478

Other expense
(
337
)
(
1,593
)
(
1,503
)
(
4,727
)
Loss before income taxes
$
(
641,389
)
$
(
342,882
)
$
(
849,179
)
$
(
417,729
)
Income tax expense (benefit)
4

(
16
)
15

17

Net Loss attributable to shareholders
$
(
641,393
)
$
(
342,866
)
$
(
849,194
)
$
(
417,746
)
Remeasurement of Preferred Stock - related party
(
691,094
)
(
41,267
)
(
632,483
)
(
64,938
)
Down round deemed dividend
—

—

(
4,456
)
—

Net Loss attributable to common shareholders
$
(
1,332,487
)
$
(
384,133
)
$
(
1,486,133
)
$
(
482,684
)
Other Comprehensive Loss
Change in fair value of debt - credit risk - related party
$
(
17,784
)
$
(
4,642
)
$
(
24,008
)
$
(
4,642
)
Foreign currency translation adjustment
(
3
)
3

18

(
1
)
Comprehensive Loss attributable to common shareholders
$
(
1,350,274
)
$
(
388,772
)
$
(
1,510,123
)
$
(
487,327
)
Basic and diluted Loss per share attributable to common shareholders
Basic
$
(
4.91
)
$
(
1.77
)
$
(
6.06
)
$
(
2.30
)
Diluted
$
(
4.91
)
$
(
1.77
)
$
(
6.06
)
$
(
2.30
)
Weighted average shares of common stock
Basic
271,618,045

216,898,374

245,090,793

209,820,480

Diluted
271,618,045

216,898,374

245,090,793

209,820,480

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
6
Table of Contents
EOS ENERGY ENTERPRISES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT
(In thousands, except share and per share amounts)
Common Stock
Additional Paid in capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Shares
Amount
Balances on June 30, 2024
216,491,215

$
23

$
759,881

$
3

$
(
950,726
)
$
(
190,819
)
Stock-based compensation
— 
— 
6,142

— 
— 
6,142

Exercise of warrants
289,654

— 
463

— 
— 
463

Release of restricted stock units
913,774

— 
— 
— 
— 
— 
Cancellation of shares used to settle payroll tax withholding
(
416,239
)
— 
(
771
)
— 
— 
(
771
)
Remeasurement of Preferred Stock - related party
— 
— 
(
41,267
)
— 
— 
(
41,267
)
Foreign currency translation adjustment
— 
— 
— 
3

— 
3

Change in fair value of debt - credit risk - related party
— 
— 
— 
(
4,642
)
— 
(
4,642
)
Net loss
— 
— 
— 
— 
(
342,866
)
(
342,866
)
Balances on September 30, 2024
217,278,404

23

724,449

(
4,636
)
(
1,293,592
)
(
573,756
)
Balances on June 30, 2025
256,476,521

$
25

$
720,680

$
(
49,699
)
$
(
1,773,973
)
$
(
1,102,967
)
Stock-based compensation
— 
— 
4,768

— 
— 
4,768

Exercise of warrants
3,991,254

— 
25,212

— 
— 
25,212

Exercise of stock options
325,000

— 
439

— 
— 
439

Release of restricted stock units and performance-based restricted stock units
4,316,810

— 
— 
— 
— 
— 
Issuance of common stock 
16,578,810

2

102,455

— 
— 
102,457

Remeasurement of Preferred Stock - related party
— 
— 
(
691,094
)
— 
— 
(
691,094
)
Foreign currency translation adjustment
— 
— 
— 
(
3
)
— 
(
3
)
Change in fair value of debt - credit risk - related party
— 
— 
— 
(
17,784
)
— 
(
17,784
)
Down round deemed dividend
— 
— 
—

—

— 
Net loss
— 
— 
— 
— 
(
641,393
)
(
641,393
)
Balances on September 30, 2025
281,688,395

$
27

$
162,460

$
(
67,486
)
$
(
2,415,366
)
$
(
2,320,365
)
7
Table of Contents

EOS ENERGY ENTERPRISES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT
(In thousands, except share and per share amounts)
Common Stock
Additional Paid in capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Shares
Amount
Balances on December 31, 2023
199,133,827

$
21

$
765,018

$
7

$
(
875,846
)
$
(
110,800
)
Stock-based compensation
— 
— 
10,940

— 
— 
10,940

Exercise of warrants
289,654

— 
463

— 
— 
463

Release of restricted stock units
1,941,965

— 
— 
— 
— 
— 
Cancellation of shares used to settle payroll tax withholding
(
714,565
)
— 
(
1,122
)
— 
— 
(
1,122
)
Issuance of common stock
16,627,523

2

14,087

— 
— 
14,089

Remeasurement of Preferred Stock - related party
— 
— 
(
64,938
)
— 
— 
(
64,938
)
Foreign currency translation adjustment
— 
— 
— 
(
1
)
— 
(
1
)
Change in fair value of debt - credit risk - related party
— 
— 
— 
(
4,642
)
— 
(
4,642
)
Net loss
— 
— 
— 
— 
(
417,746
)
(
417,746
)
Balances on September 30, 2024
217,278,404

$
23

$
724,449

$
(
4,636
)
$
(
1,293,592
)
$
(
573,756
)
Balances on December 31, 2024
221,791,205

$
23

$
534,726

$
(
43,496
)
$
(
1,561,716
)
$
(
1,070,463
)
Stock-based compensation
— 
— 
18,879

— 
— 
18,879

Exercise of warrants
8,884,356

1

53,445

— 
— 
53,446

Exercise of stock options
523,398

— 
758

— 
— 
758

Release of restricted stock units and performance-based restricted stock units
12,430,564

— 
— 
— 
— 
— 
Cancellation of shares used to settle payroll tax withholding
(
82,438
)
— 
(
488
)
— 
— 
(
488
)
Issuance of common stock 
38,141,310

3

183,167

— 
— 
183,170

Remeasurement of Preferred Stock - related party
— 
— 
(
632,483
)
— 
— 
(
632,483
)
Foreign currency translation adjustment
— 
— 
— 
18

— 
18

Change in fair value of debt - credit risk - related party
— 
— 
— 
(
24,008
)
— 
(
24,008
)
Down round deemed dividend
— 
— 
4,456

— 
(
4,456
)
— 
Net loss
— 
— 
— 
— 
(
849,194
)
(
849,194
)
Balances on

September 30, 2025
281,688,395

$
27

$
162,460

$
(
67,486
)
$
(
2,415,366
)
$
(
2,320,365
)

8
Table of Contents
EOS ENERGY ENTERPRISES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 
(In thousands, except share and per share amounts)
Nine Months Ended
September 30,

2025
2024
Cash flows from operating activities

Net Loss
$
(
849,194
)
$
(
417,746
)
Adjustment to reconcile net loss to net cash used in operating activities
Stock-based compensation
19,664

10,940

Depreciation and amortization
8,980

5,259

Loss (gain) on debt extinguishment
52,652

(
68,478
)
Loss from write-down of property, plant and equipment 
1,351

3,528

Amortization of right-of-use assets
1,270

974

Non-cash interest expense
4,263

5,117

Non-cash interest expense - related parties
9,204

11,181

Change in fair value of debt - related party
(
22,112
)
3,276

Change in fair value of warrants
252,836

71,510

Change in fair value of derivatives - related parties
369,710

260,227

Other
(
6,133
)
4,858

Changes in operating assets and liabilities:
Prepaid expenses
(
1,440
)
7

Inventory
(
6,704
)
(
8,838
)
Accounts receivable
(
1,991
)
189

Vendor deposits
(
4,958
)
(
449
)
Contract assets
(
945
)
(
4,729
)
Grant receivable
(
9,965
)
1,750

Accounts payable
22,166

1,136

Accrued expenses
9,132

1,038

Interest payable - related parties
247

3,097

Operating lease liabilities
(
1,587
)
(
1,117
)
Contract liabilities
(
7,166
)
5,414

   Other 
(
206
)
604

Net cash used in operating activities
(
160,926
)
(
111,252
)
Cash flows from investing activities
Purchases of intangible assets
(
15
)
(
8
)
Investment in internally developed software
(
897
)
—

Purchases of property, plant and equipment
(
28,804
)
(
20,054
)
Net cash used in investing activities
(
29,716
)
(
20,062
)
Cash flows from financing activities
Principal payments on finance lease obligations
(
39
)
(
89
)
Proceeds from exercise of stock options 
758

—

Proceeds from exercise of warrants
14,215

463

Proceeds received from DOE Loan
22,666

—

Proceeds from the issuance of 2025 Convertible Notes, net of discount
240,000

—

9
Table of Contents
EOS ENERGY ENTERPRISES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 
(In thousands, except share and per share amounts)
Nine Months Ended
September 30,

2025
2024
Proceeds received from Credit and Securities Purchase Transaction, net - related party
38,475

98,575

Payment of debt and equity issuance costs 
(
4,607
)
—

Payment of debt issuance costs - related party
—

(
12,238
)
Payoff of notes payable - related parties
(
180,940
)
—

Payment of debt extinguishment costs
(
781
)
—

Return of debt repurchase premium
5,000

—

Payoff of Senior Secured Term Loan
—

(
19,946
)
Repayment of equipment financing facility
(
1,255
)
(
2,447
)
Proceeds from issuance of common stock 
81,075

14,089

Repurchase of shares from employees for income tax withholding purposes
(
488
)
(
1,122
)
Net cash provided by financing activities
214,079

77,285

Effect of exchange rate changes on cash, cash equivalents and restricted cash
—

2

Net increase (decrease) in cash, cash equivalents and restricted cash
23,437

(
54,027
)
Cash, cash equivalents and restricted cash, beginning of the period
103,362

84,667

Cash, cash equivalents and restricted cash, end of the period
$
126,799

$
30,640

Non-cash investing and financing activities
Accrued and unpaid capital expenditures
$
12,441

$
3,216

Paid-in kind interest added to principal
5,433

5,783

Accrued and unpaid financing costs
1,910

—

Down round deemed dividend
4,456

—

Remeasurement of preferred stock - related party
632,483

64,938

Fixed assets acquired with finance lease
181

—

Right-of-use operating lease assets in exchange for lease liabilities
672

—

Issuance of common stock from conversion of AFG Notes
102,457

—

Supplemental disclosures
Cash paid for interest
$
166

$
4,279

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
10
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
1.
Overview
Nature of Operations
Eos Energy Enterprises, Inc. (the “Company,” “we,” “us,” “our,” and “Eos”) designs, develops, manufactures and markets innovative energy storage solutions for utility-scale, microgrid and commercial & industrial (“C&I”) applications. Eos developed a broad range of intellectual property with multiple patents covering unique battery chemistry, mechanical product design, energy block configuration and a software operating system (Battery Management System). The Company has only 
one
 operating and reportable segment.
Liquidity and Going Concern
As a growth company in the early commercialization stage of its lifecycle, Eos is subject to inherent risks and uncertainties associated with the development of an enterprise. In this regard, substantially all of the Company’s efforts to date have been devoted to the development and manufacturing of battery energy storage systems and complementary products and services, recruitment of management and technical staff, deployment of capital to expand the Company’s operations to meet customer demand and raising capital to fund the Company’s development. However, as a result of these efforts, the Company has incurred significant losses and negative cash flows from operations since its inception and expects to continue to incur such losses and negative cash flows for the foreseeable future until such time that the Company can reach a scale of profitability to sustain its operations.
In order to execute its development strategy, the Company has historically relied on outside capital through the issuance of equity, debt and borrowings under financing arrangements (collectively “outside capital”) to fund its cost structure. While the Company believes its recent entry into new credit facilities as discussed below has significantly improved its capital position and provides a path to sustainable operations and profitability, there can be no assurance the Company will be able to achieve such profitability or do so in a manner that does not require additional outside capital. Moreover, while the Company has historically been successful in raising outside capital, there can be no assurance the Company will be able to continue to obtain outside capital in the future or do so on terms that are acceptable to the Company. 
As disclosed in Note 3, 
Credit and Securities Purchase Transaction, 
on June 21, 2024, the Company entered into a financing transaction with CCM Denali Debt Holdings, LP, an affiliate of Cerberus Capital Management LP (herein after referred to as “Cerberus”, “Denali”, “Lender”, “Holder”). As a result of this transaction, Cerberus agreed to provide a $
210,500
 secured multi-draw facility, to be made in 
four
 installments (the “Delayed Draw Term Loan”) as well as a $
105,000
 revolving credit facility (“Revolving Facility”), to be made available beginning June 21, 2026, at  Cerberus’ sole discretion and only if the Delayed Draw Term Loan is fully funded. As of the date the accompanying Unaudited Condensed Consolidated Financial Statements were issued (the “issuance date”), the Delayed Draw Term Loan was fully funded. As part of the Credit and Securities Purchase Transaction, Cerberus received warrants and preferred stock resulting in a 
33
% ownership position in the Company, as of January 24, 2025, the most recent milestone measurement date.
11
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
1. Overview
 (cont.)
As disclosed in Note 13, 
Borrowings,
 on November 26, 2024, the Company successfully closed on the DOE Loan Facility, which provides the Company with up to $
303,450
 in funding, including capitalized interest, subject to the achievement of certain funding conditions. The DOE Loan Facility provides for a multi draw term loan facility under a series of at least 
two
 tranches and, if the Company elects, up to 
four
 tranches, subject to the achievement of certain conditions. Each tranche corresponds to the production, maintenance and development, and operation of a given production line to be funded using the proceeds of such tranche. The DOE Loan Facility specifies the maximum amount subject to each tranche (Tranche 1: $
101,979
; Tranche 2: $
117,326
; Tranche 3: $
71,836
; and Tranche 4: $
12,309
), and any amounts which are not withdrawn under a specified tranche cannot be allocated to another tranche. On April 16, 2025, the Company amended the DOE Loan Facility in order to clarify the maximum Tranche Commitment principal amounts by excluding capitalized interest (Tranche 1: $
90,945
; Tranche 2: $
106,733
; Tranche 3: $
67,529
; and Tranche 4: $
12,290
). The Amendment does not materially alter rights, obligations, or meaning of the DOE Loan Facility. Through September 30, 2025, the Company had drawn down $
90,945
 under Tranche 1. 
As disclosed in Note 19, 
Shareholders’ Deficit, 
the Company entered into an underwriting agreement on May 29, 2025, with Jefferies LLC and J.P. Morgan Securities LLC as representatives of the several underwriters (collectively, the “Underwriters”) pursuant to which the Company agreed to sell 
18,750,000
 shares of the Company’s common stock at a public offering price of $
4.00
 per share. In addition, the Company granted the Underwriters an option, exercisable within 30 days after May 29, 2025, to purchase up to an additional 
2,812,500
 shares of the Company’s common stock. On May 30, 2025, the Underwriters exercised such option to purchase additional shares in full. The issuance and sale of 
21,562,500
 shares of the Company’s common stock was completed on June 2, 2025, raising proceeds of $
81,075
, net of fees paid to Jefferies LLC and J.P. Morgan Securities LLC.
As disclosed in Note 13, 
Borrowings
, on June 3, 2025, the Company issued $
225,000
 principal amounts of Convertible Notes due 2030 (herein after referred to as the “2025 Convertible Notes”). The Company granted initial purchasers an option to purchase, for settlement within a period of thirteen days from the date the 2025 Convertible Notes were first issued, up to an additional $
25,000
 principal amounts, which was exercised in full. The 2025 Convertible Notes accrues interest at a rate of 
6.75
% per annum, payable semi-annually in arrears on June 15 and December 15. The 2025 Convertible Notes will mature on June 15, 2030, subject to earlier conversion, redemption or repurchase. 
As of the issuance date, management evaluated the significance of the following negative financial conditions in accordance with Accounting Standard Codification 205-40, Going Concern:  
•
Since its inception, the Company has incurred significant losses and negative cash from operations in order to fund its development. During the nine months ended September 30, 2025, the Company had incurred a net loss of $
849,194
. Adjustments to reconcile net loss to cash used in operations are primarily from non-cash items on the Unaudited Condensed Consolidated Statements of Cash Flows. The non-cash items totaled $
691,685
. During the nine months ended September 30, 2025, the Company incurred negative cash flows from operations of $
160,926
 and had an accumulated deficit of $
2,415,366
 as of September 30, 2025.
•
As of September 30, 2025, the Company had $
58,733
 of unrestricted cash and cash equivalents available to fund the Company’s operations

and working capital of $
85,382
.
•
On June 21, 2024, upon closing of the Credit and Securities Purchase Transaction, Cerberus funded the Company $
75,000
 of the initial draw, and the Company received $
71,250
 net of the 
5.0
% original issue discount. On August 29, 2024, Cerberus funded the Company $
30,000
 (“August Draw”), and the Company received $
28,500
, net of the 
5.0
% original issue discount. On November 1, 2024, Cerberus funded the Company $
65,000
 related to the October 31, 2024 tranche (“October Draw” or “October Tranche”), and the Company received $
61,750
, net of the 
5.0
% original issue discount. On January 24, 2025, Cerberus funded the Company the final $
40,500
 and the Company received $
38,475
, net of the 
5.0
% original issue discount, related to the January 31, 2025 tranche (“January 2025 Draw”). Subsequent to the January 2025 Draw, the Delayed Draw Term Loan has been fully funded.
12
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
1. Overview
 (cont.)
•
As of September 30, 2025, the Company had drawn down $
90,945
 under the DOE Loan Facility, utilizing the full commitment available for Tranche 1. The initial draw of $
68,279
 was made to cover eligible project costs incurred through December 6, 2024, followed by a second draw of $
22,666
 for eligible project costs incurred through June 4, 2025. Tranche 1 provided funding for eligible costs in connection with the design, construction, installation, startup and shakedown of a battery automation line and related tools. In the event the Company does not achieve certain funding milestone conditions and the DOE chooses not to continue funding for the remaining tranches, the Company would need to seek alternative sources of capital, which may not be available on favorable terms or at all. 
•
The Credit and Securities Purchase Transaction and the DOE Loan Facility contain certain quarterly financial covenants which include (a) Minimum Liquidity, (b) Minimum Consolidated EBITDA, and (c) Minimum Consolidated Revenue (collectively, the “financial covenants”). As of September 30, 2025, the only financial covenant in effect was Minimum Liquidity. As of September 30, 2025, the Company was in compliance with this covenant and non-financial covenants, and the Company expects to remain in compliance with the Minimum Liquidity covenant over the next twelve months beyond the issuance date. The applicability of the Consolidated Revenue and EBITDA financial covenants were deferred until March 31, 2027.
•
In the event the Company’s ongoing efforts to raise additional outside capital are unsuccessful, the Company will be unable to meet its obligations as they come due over the next twelve months beyond the issuance date. In such an event, management will be required to seek other strategic alternatives, which may include, among others, a significant curtailment in the Company’s operations, a sale of certain of the Company’s assets, a sale of the entire Company to strategic or financial investors and/or allowing the Company to become insolvent.  
These uncertainties raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying Unaudited Condensed Consolidated Financial Statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying Unaudited Condensed Consolidated Financial Statements do not include any adjustments that may result from the outcome of these uncertainties.
2. 
Summary of Significant Accounting Policies

Basis of Presentation
The accompanying Unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its 
100
% owned, direct and indirect subsidiaries and have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). All intercompany transactions and balances have been eliminated in the preparation of the Unaudited Condensed Consolidated Financial Statements. These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The interim financial statements should be read in conjunction with the audited consolidated financial statements, including the notes thereto, included in our 2024 Annual Report on Form 10-K. These interim results are not necessarily indicative of results for the full year.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
13
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
2. Summary of Significant Accounting Policies
 (cont.)
Change to Prior Year Presentation
In the Unaudited Condensed Consolidated Statements of Operations, Gross profit (loss) has been introduced, reflecting Total revenue less Cost of goods sold. This addition does not impact the reported Net income (loss).
Series A and B Preferred Stock
As discussed in Note 3, 
Credit and Securities Purchase Transaction, 
the Company issued shares of (1) Series A-1 Preferred Stock and Series A-2 Preferred Stock (collectively "Series A Preferred Stock") in June 2024 and August 2024, respectively, which were subsequently converted into shares of Series B-1 Preferred Stock and Series B-2 Preferred Stock, respectively, in September 2024, (2) Series B-3 Preferred Stock in November 2024 and Series B-4 Preferred Stock in January 2025 (collectively, with the Series B-1 Preferred Stock, Series B-2 Preferred Stock, Series B-3 Preferred Stock and Series B-4 Preferred Stock, the “Series B Preferred Stock” and together with Series A Preferred Stock, “the Preferred Stock”). The Preferred Stock is redeemable based upon the passage of time and therefore meets the criteria to be classified within temporary equity. Management has elected to recognize changes in the redemption value pursuant to ASC 480-10-S99-3A-15(b). As a result, the Company will remeasure the Preferred Stock to the maximum redemption value at each reporting date but will never be adjusted below its initial carrying value. Adjustments are reflected in Additional paid in capital on the Company’s Unaudited Condensed Consolidated Balance Sheets.
Production Tax Credits under Internal Revenue Code 45X (“PTC”)
Since the PTC is a refundable credit (i.e., a credit with a direct-pay option available), the PTC is outside the scope of ASC 740. Therefore, the Company accounts for the PTC under a government grant model. GAAP does not address the accounting for government grants received by a business entity that are outside the scope of ASC 740. The Company’s accounting policy is to analogize to IAS 20, 
Accounting for Government Grants and Disclosure of Government Assistance,
 under IFRS Accounting Standards. Under IAS 20, once it is reasonably assured that the entity will comply with the conditions of the grant, the grant money is recognized on a systematic basis over the periods in which the entity recognizes the related expenses or losses for which the grant money is intended to compensate. The Company recognizes grants once it is probable that both of the following conditions will be met: (1) the Company is eligible to receive the grant and (2) the Company is able to comply with the relevant conditions of the grant. The PTC is a non-monetary asset since the Company’s intention is to sell the tax credit to a third-party and is recorded at the value that is expected to be received from the sale in Grant Receivable, net on the Company’s Unaudited Condensed Consolidated Balance Sheets and is subsequently recognized in Cost of goods sold in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss when the inventory is sold. In the event the PTC is sold, upon the receipt of the cash payments, 
the Company will record offsets to Grant Receivable, net
. Differences in the recorded value of the PTC and the sale price will be recognized as an adjustment to cost of goods sold in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss.
Fair Value Option
The Company has elected the option under ASC 825-10, 
Financial Instruments 
("ASC 825"), to measure the Delayed Draw Term Loan, including all tranches of fundings received (see Note 3, C
redit and Securities Purchase Transaction
) at fair value. The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. When the fair value option is elected for an instrument, unrealized gains and losses for such instrument is reported in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss at each subsequent reporting date. Upfront costs and fees related to items for which the fair value option is elected shall be recognized in earnings as incurred and not deferred. These amounts are included in Other expense in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss. The gains or losses attributable to changes in instrument-specific risk are included in Change in fair value of debt - credit risk - related party in Accumulated other comprehensive loss.
14
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
2. Summary of Significant Accounting Policies
 (cont.)
Recent Accounting Pronouncements
In October 2023, the FASB issued ASU 2023-06, 
Disclosure Agreements - Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative
. This amendment will impact various disclosure areas, including the statement of cash flows, accounting changes and error corrections, earnings per share, debt, equity, derivatives, and transfers of financial assets. The amendments in this ASU 2023-06 will be effective on the date the related disclosures are removed from Regulation S-X or Regulation S-K by the SEC. If the SEC has not removed the applicable disclosure requirement by June 30, 2027, these amendments will not be effective. Early adoption is prohibited. The Company is currently assessing the potential impact this amendment could have on its disclosures.
In December 2023, the FASB issued ASU 2023-09, 
Improvements to Income Tax Disclosures,
 which requires additional disclosures related to the effective tax rate reconciliation and taxes paid. The amendment is effective for annual periods beginning after December 15, 2024, and the Company does not anticipate a material change in the financial statements and related disclosure. 
In November 2024, the FASB issued ASU 2024-03, 
Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40). 
The amendments in this update require disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. This update is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, though early adoption is permitted. The Company is currently assessing the potential impact this amendment could have on its financial statements and disclosures.
In November 2024, the FASB issued ASU 2024-04, 
Debt-Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments.
 The amendments in this update clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as induced conversions rather than as debt extinguishments. This update is effective for annual periods beginning after December 15, 2025, including interim periods within those fiscal years, though early adoption is permitted. The Company is currently evaluating the impact of this amendment and does not expect that the adoption of this guidance will have a material impact on its financial position, results of operations, or cash flows.
In January 2025, the FASB issued ASU 2025-01, 
Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date 
(“ASU 2025-01”), which requires disaggregated disclosure of income statement expenses for public business entities. The ASU does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. ASU 2025-01 is effective for fiscal years beginning after December 15, 2027. Early adoption is permitted. Entities should apply the amendments in ASU 2023-07 retrospectively to all prior periods presented in the financial statements. The Company is currently assessing the potential impact this ASU could have on its financial statements and disclosures.
In July 2025, the FASB issued ASU 2025-05, 
Financial Instruments - Credit Losses (Topic 326). 
The amendments in this update introduce a practical expedient aimed at simplifying the estimation of expected credit losses for current accounts receivable and current contract assets. The update is effective for annual periods beginning after December 15, 2025, including interim periods within those fiscal years, though early adoption is permitted. The Company is currently assessing the potential impact this amendment could have on its financial statements and disclosures.
In September 2025, the FASB issued ASU 2025-06, 
Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40)
: Improvements to the Accounting for Internal-Use Software. The amendments in this update clarify and refine the guidance for capitalizing costs related to internal-use software, including development phases and implementation activities. The update is effective for annual periods beginning after December 15, 2027, including interim periods within those fiscal years. Early adoption is permitted beginning in fiscal year 2026. The Company is currently assessing its plans for adoption and evaluating the potential impact this amendment could have on its financial statements and related disclosures.
15
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
3. 
Credit and Securities Purchase Transaction
Credit and Guaranty Agreement (“Credit Agreement”)
Delayed Draw Term Loan
On June 21, 2024, the Company entered into a credit and guaranty agreement (the “Credit Agreement”) with CCM Denali Debt Holdings, LP, an affiliate of Cerberus Capital Management LP (herein after referred to as “Cerberus”, “Denali”, “Lender”, “Holder”). As a result of this transaction, Cerberus agreed to provide a $
210,500
 secured multi-draw facility to be made in 
four
 installments (“tranches”, and collectively, the (“Delayed Draw Term Loan” or “DDTL”) as well as a $
105,000
 revolving credit facility (“Revolving Facility”), to be made available at the Lenders’ sole discretion and only if the Delayed Draw Term Loan is fully funded. On June 21, 2024 the initial $
75,000
 installment was funded (the “Initial Draw”). On August 29, 2024, the full amount of the August tranche of $
30,000
 was funded. On October 31, 2024, the full amount of the October tranche of $
65,000
 was funde
d. The final tranche in the amount of $
40,500
 was funded on January 24, 2025, completing the scheduled fundings under the Delayed Draw Term Loan.
On November 26, 2024, the Company amended the Credit Agreement (the “Credit Agreement Amendment”), by and among the Company, certain of the Company’s subsidiaries as guarantors party thereto and the Lender, pursuant to which among other things, the applicability of the Consolidated Revenue and EBITDA financial covenants were deferred until December 31, 2025 and certain provisions were amended to conform with comparable provisions in the DOE Loan Facility. 
On April 30, 2025, the Company entered into that certain First Amendment to the Credit Agreement (“First Credit Agreement Amendment”), with Cerberus US Servicing LLC as Administrative Agent under the Credit Agreement and the lenders party thereto, pursuant to which, the measurement period for achieving Sales Milestone 4 (as defined in the Credit Agreement) was extended until July 31, 2025. On April 30, 2025, the Company and Cerberus mutually agreed that the Company achieved 
three
 of the 
four
 Fourth Milestone Components (as defined in the Credit Agreement) related to the Company’s materials cost, Z3 technology and automated line. No additional Preferred Stock or Warrants will be issued to Cerberus related to the three Fourth Milestone Components achieved by the Company. If the Company had failed to meet Sales Milestone 4 on July 31, 2025, then the Applicable Percentage would have been subject to up to a final 
1
% increase, and as a result Cerberus would have been entitled to receive Preferred Stock or Warrants aggregating to a maximum aggregate Applicable Percentage of 
34
% (as compared to the original maximum adjustment for all 
four
 Milestones of up to 
49
%). 
On May 28, 2025, the Company entered into that certain Second Amendment to Credit Agreement (the “Second Credit Agreement Amendment”), with Cerberus US Servicing LLC as Administrative Agent under the Credit Agreement and the lenders party thereto. The Second Credit Agreement Amendment permitted the Company to raise proceeds by the issuance and sale of common stock and/or convertible notes (called a “Specified Refinancing Transaction’) under the following conditions: (a) $
50,000
 of the net cash proceeds be applied to prepay the obligations under the Credit Agreement, (b) the Specified Refinancing Transaction result in the full repurchase, tender, redemption. exchange or other refinancing or retirement in full of the Company’s outstanding 2021 Convertible Note Payable and (c) other legal and contractual requirements. Upon closing of the Specified Refinancing Transaction and the satisfaction of certain other conditions precedent set forth in the Second Credit Agreement Amendment, three significant modifications to the Credit Agreement became effective: (i) the interest rate on outstanding borrowings reduced from 
15
% to 
7
% per annum, (ii) the Consolidated Revenue and EBITDA financial covenants were deferred until March 31, 2027 and (iii) the equity to be issued to Cerberus in the event the Company fails to meet the final component of the last milestone under the Credit Agreement would be limited to warrants for shares of common stock or shares of convertible preferred stock equal to 
1
% of the fully diluted outstanding shares of the Company on the final milestone measurement date (including the securities issued pursuant to the Specified Refinancing Transaction).
16
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
3. Credit Agreement and Securities Purchase Transaction
 (cont.)
On May 29, 2025, the Company entered into that certain Third Amendment to Credit Agreement (the “Third Credit Agreement Amendment”), with Cerberus US Servicing LLC as Administrative Agent under the Credit Agreement and the lenders party thereto, pursuant to which, among other things, the Credit Agreement was further amended to modify the definition of Specified Refinancing Transaction by increasing the maximum cash component of consideration that may be given for the repurchase, tender, redemption, exchange or other refinancing or retirement of the Company’s outstanding 2021 Convertible Note Payable to $
115,000
.
On July 29, 2025, the Company entered into that certain Fourth Amendment to Credit Agreement, (the “Fourth Credit Agreement Amendment”), with Cerberus US Servicing LLC as Administrative Agent under the Credit Agreement and the lenders party thereto, pursuant to which the measurement period for achieving Sales Milestone 4 (as defined in the Credit Agreement) was extended until October 31, 2025. If the Company fails to meet Sales Milestone 4 on October 31, 2025, then the applicable percentage is subject to up to a final 
1
% increase, and as a result Cerberus would be entitled to Preferred Stock or Warrants equal to 
1
% of the fully diluted outstanding shares of the Company on the final milestone measurement date (including the securities already issued to Cerberus and securities issued pursuant to the Specified Refinancing Transaction). Refer to Note 22,
 Subsequent Events
 for further discussion on the final measurement date. 
Refer to Note 13, 
Borrowings
 for further information on the DDTL accounting treatment from the First Credit Agreement Amendment, Second Credit Agreement Amendment and Third Credit Agreement Amendment (collectively, the “Cerberus Amendments”).
Securities Purchase Agreement
On June 21, 2024, the Company entered into a Securities Purchase Agreement (the “SPA”) with CCM Denali Equity Holdings, LP (the “Purchaser”).
SPA Warrant
Under the SPA, the Company issued a warrant to purchase 
43,276,194
 shares of common stock representing a collective ownership of 
19.9
% (the “SPA Warrant”) of our outstanding shares of (inclusive of Series A-1 Preferred Stock – see below) common stock prior to the issuance. The SPA Warrant has a 
ten-year
 term and an exercise price of $
0.01
 per share. The SPA Warrant includes anti-dilutive rights, subject to certain excluded issuances, in the event any shares of common stock, options, warrants, convertible securities or other equity or equity equivalent securities payable in common stock are issued at a price per share of less than the fair market value (as defined in the Warrant) of a share of common stock on the issuance date of the Warrant, subject to adjustment. Until the Company received stockholder approval on September 10, 2024, the Company could not issue additional shares of common stock exceeding 
19.99
% of shares of common stock issued and outstanding as of the date of the Initial Draw (such percentage, as may be adjusted in accordance with the terms of the Warrant, the “Conversion Cap”) upon exercise of the Warrant, and would have been required to issue, at the option of the Lender, Series A Preferred Stock or additional warrants on common stock upon a draw under the Delayed Draw Term Loan. Following shareholder approval received, the Conversion Cap increased to 
49.9
% of the number of shares of common stock issued and outstanding as of the applicable measurement date; and the holder of the Warrant has the option to amend the Conversion Cap to any percentage less than 
49.9
%.
The SPA Warrant is exercisable at the holder’s discretion for cash or on a cashless basis. The SPA Warrant is subject to automatic cashless exercise on the expiration date if the fair market value of one share is greater than the exercise price then in effect. Upon an acceleration under the Credit Agreement, the Company may be required to purchase the SPA Warrant from the holder at an amount equal to the closing sale price of underlying common stock less the SPA Warrant exercise price at the request of the holder. The SPA Warrant meets the criteria for liability classification under ASC 480 and is recognized at fair value with changes in fair value included in Change in fair value of derivatives - related parties in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss.
17
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
3. Credit Agreement and Securities Purchase Transaction
 (cont.)
Contingent Warrants
Upon the achievement of performance milestones on dates specified in the Credit Agreement, the Company  received additional funds and issued at the option of the Lender, Preferred Stock (Series A Preferred Stock, if prior to shareholder approval or Series B Preferred Stock if after shareholder approval) or warrants on common stock (collectively “Contingent Warrants”) under the SPA in an amount equal to the applicable percentage, up to an aggregate of 
33.0
% ownership limitation on a fully diluted basis at such time the Delayed Draw Term Loan is fully drawn. As of the balance sheet date, in the event the Company fails to meet the final component of the last milestone under the Credit Agreement, the equity to be issued to Cerberus would be limited to warrants for shares of common stock or shares of convertible preferred stock equal to 
1
% of the fully diluted outstanding shares of the Company on the final milestone measurement date. See Note 22, 
Subsequent Events
, for further discussion of the final measurement date. The Contingent Warrants meet the criteria for liability classification under ASC 480. The change in fair value of the Contingent warrants is included in Change in fair value of derivatives - related parties on the Company’s Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss. See Note 14, 
Warrants Liability
, for further discussion of the SPA Warrant and Contingent Warrants.
Series A-1 Preferred Stock
On June 21, 2024, the Company filed with the Secretary of State of the State of Delaware the Series A-1 Certificate of Designation and issued 
59
 shares of Series A-1 Preferred Stock to satisfy the terms of the Credit Agreement. Under the terms of the Series A-1 Certificate of Designation, each share of Series A-1 Preferred Stock had an original issue price of $
455,822.59
 (the “A-1 Original Issue Price”) and a liquidation value, payable with the common stock, as if such shares were convertible into an aggregate of 
31,940,063
 shares of common stock, subject to adjustment. The Series A-1 Preferred Stock was non-voting and non-convertible into common stock. Holders of the Series A-1 Preferred Stock were entitled to receive dividends or distributions on each share of Series A-1 Preferred Stock equal to dividends or distributions actually paid on each share of common stock, multiplied by the number of shares of common stock represented by the Series A-1 Preferred Stock Liquidation Value (as defined in the Series A-1 Certificate of Designation).
The 
59
 shares of Series A-1 Preferred Stock issued to Cerberus converted into shares of Series B-1 Preferred Stock once stockholder approval was obtained on September 10, 2024. See Series B Preferred Stock discussion below.
Series A-2 Preferred Stock
On August 29, 2024, the Company filed with the Secretary of State of the State of Delaware the Series A-2 Certificate of Designation (the “Series A-2 Certificate of Designation”) and the shares issuable thereunder, the “Series A-2 Preferred Stock”).
Under the terms of the Series A-2 Certificate of Designation, each share of Series A-2 Preferred Stock had an original issue price of $
9,555,515.30
 (the “A-2 Original Issue Price”) and a liquidation value, payable pari passu with the common stock, as if such share was convertible into an aggregate of 
28,806,463
 shares of common stock, subject to adjustment. The Series A-2 Preferred Stock was non-voting and non-convertible into common stock. Holders of the Series A-2 Preferred Stock are entitled to receive dividends or distributions on each share of Series A-2 Preferred Stock equal to dividends or distributions actually paid on each share of common stock, multiplied by the number of shares of common stock represented by the Series A-2 Preferred Stock Liquidation Value (as defined in the Series A-2 Certificate of Designation). The Series A-2 Preferred Stock terms were substantially identical to the Series A-1 Preferred Stock.  
On August 29, 2024, in connection with the August Draw, and pursuant to the terms and conditions of the Credit Agreement between the Company and Cerberus, the applicable percentage increased by 
4.9
%, and as a result the Company issued to Cerberus 
7
 shares of Series A-2 Preferred Stock.
The 
7
 shares of Series A-2 Preferred issued to Cerberus converted into shares of Series B-2 Preferred Stock once stockholder approval was obtained on September 10, 2024. See Series B Preferred Stock discussion below.
Series B Preferred Stock
18
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
3. Credit Agreement and Securities Purchase Transaction
 (cont.)
On September 11, 2024, the Company filed with the Secretary of State of the State of Delaware the Certificate of Designation of Series B-1 Non-Voting Convertible Preferred Stock (the “Series B-1 Certificate of Designation” and the shares issuable thereunder, the “Series B-1 Preferred Stock”) and the Certificate of Designation of Series B-2 Non-Voting Convertible Preferred Stock (the “Series B-2 Certificate of Designation” and the shares issuable thereunder, the “Series B-2 Preferred Stock”). On November 1, 2024, the Company filed with the Secretary of State of the State of Delaware the Certificate of Designation of Series B-3 Non-Voting Convertible Preferred Stock (the “Series B-3 Certificate of Designation” and the shares issuable thereunder, the “Series B-3 Preferred Stock”). On January 24, 2025, the Company filed with the Secretary of State of the State of Delaware the Certificate of Designation of Series B-4 Non-Voting Convertible Preferred Stock (the “Series B-4 Certificate of Designation” and the shares issuable thereunder, the “Series B-4 Preferred Stock”). 
Each Series B Preferred Stock has a par value of $
0.0001
 per share. 
The table below summarizes the Company’s outstanding Series B Preferred Stock as of September 30, 2025.
Preferred Stock
Issuance Date
Shares Issued
Original Issue Price
Shares Outstanding
Common Stock Equivalent
Series B-1 Preferred Stock
9/12/2024
31.940063
$
841,999.99

31.940063
31,940,063

Series B-2 Preferred Stock
9/12/2024
28.806463
$
2,322,000

28.806463
28,806,463

Series B-3 Preferred Stock
11/1/2024
38.259864
$
3,358,000

38.259864
38,259,864

Series B-4 Preferred Stock
1/24/2025
16.150528
$
5,990,000

16.150528
17,305,070

Conversion rights: The Series B Preferred Stock is convertible into common stock at a conversion ratio of 
1.0
 million shares of common stock per share of Series B Preferred Stock (“Conversion Ratio”). The Conversion Ratio is subject to antidilution protection that is triggered if the Company issues equity for a price per share that is less than the conversion price then in effect, subject to certain exceptions. 
During the second quarter of 2025, the Company’s issuance of the 2025 Convertible Notes and common stock through the public offering triggered an adjustment to the Series B-4 Preferred Stock liquidation value under the terms of the Securities Purchase Agreement. The number of common shares issuable upon conversion of the Series B-4 increased by 
1,154,542
 to 
17,305,070
. The Company recorded a down round deemed dividend of $
4,456
 increasing additional paid-in capital and accumulated deficit on the Unaudited Condensed Statements of Shareholders' Deficit.
Dividends: Holders of the Series B Preferred Stock are entitled to receive dividends or distributions on each share of Series B Preferred Stock equal to dividends or distributions actually paid on each share of common stock on an as-converted basis.
Appointment of Directors: At all times when the holders of the Preferred Stock beneficially own at least 
10
%, 
15
% or 
30
% of the capital stock of the Company, the Preferred Stock shareholders, exclusively and voting together as a separate class, will have the right to appoint a maximum of 1, 2 or 3 Directors to the Board of Directors of the Company (the “Board”), respectively. At all times when the holders of the Preferred Stock beneficially own at least 
40
% of the capital stock of the Company, the Preferred Stock shareholders, exclusively and voting together as a separate class, will have the right to nominate a fourth director, who shall be nominated by the Board or the nominating committee of the Board to a class of common directors and thereafter stand for election as a common director on the Board. The Preferred Stock shareholders will have the right to nominate a fourth director to the Board only if such appointment does not result in a change of control under any Company governing documents or violate any applicable laws, including requirements of the SEC and Nasdaq, and any such fourth director appointment shall be subject to and conditioned upon compliance by the holders of the Preferred Stock with the Hart-Scott-Rodino Antitrust Improvements Act of 1976, including the submission of any required filings and the expiration or termination of any applicable waiting periods.
19
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
3. Credit Agreement and Securities Purchase Transaction
 (cont.)
Preemptive rights: The Series B Certificates of Designation contain customary preemptive rights that permit the Holders of Series B Preferred Stock to participate in certain future equity offerings by the Company.
Rights to distributions upon liquidation of the Company: In the event of a voluntary or involuntary liquidation, dissolution, or winding up of the Company, the holders of the Series B Preferred Stock are entitled to receive distribution of any of the assets or surplus funds of the Company pro rata with the holders of the common stock and any other holders of the preferred stock of the Company issued pursuant to the SPA and the Credit Agreement (the “Investor Preferred Stock”), including the Series B Preferred Stock, in an amount equal to such amount per share as would have been payable had all shares of Series B Preferred Stock been converted to common stock.
Protective provisions: The Company is prohibited from taking certain actions that could adversely affect the rights of the Preferred Stock without the affirmative vote of a majority of the outstanding shares of Preferred Stock until the later of (i) such time when the holders of Investor Preferred Stock shall no longer beneficially own at least 
5
% of the outstanding capital stock of the Corporation and (ii) June 21, 2029, in the case of the Series B-1 Preferred Stock, August 29, 2029, in the case of the Series B-2 Preferred Stock, November 1, 2029 in the case of the Series B-3 Preferred Stock or January 24, 2030 in the case of Series B-4 Preferred Stock.
Redemption Rights: At any time after June 21, 2029, in the case of the Series B-1 Preferred Stock, August 29, 2029, in the case of the Series B-2 Preferred Stock, November 1, 2029 in the case of the Series B-3 Preferred Stock or January 24, 2030 in the case of Series B-4 Preferred Stock, the outstanding shares of Series B Preferred Stock held by any holder become redeemable for cash at the redemption price. The redemption price will be an amount per share equal to the greater of (i) the B-1 Original Issue Price, the B-2 Original Issue Price, the B-3 Original Issue Price or the Series B-4 Preferred Stock Original Issue, as applicable, plus all accrued and unpaid dividends thereon, up to and including the date of redemption and (ii) the number of shares of common stock issuable upon conversion of the applicable Series B Preferred Stock multiplied by the average of the closing sale price of the common stock for the five (
5
) business days immediately prior to the date of redemption plus all accrued and unpaid dividends thereon, up to and including the date of redemption. 
As of September 30, 2025, all then outstanding shares of Series B Preferred Stock were classified as mezzanine equity on the Unaudited Condensed Consolidated Balance Sheets at its redemption value because it is probable of becoming redeemable. The Company recorded remeasurement of the Series B Preferred Stock, which reduces additional paid-in capital, on the Unaudited Condensed Statements of Shareholders' Deficit.
Atlas Payoff Letter and Insurer Letter Agreement
On June 21, 2024 (the “Atlas Facility Termination Date”), the Company entered into a payoff letter agreement (the “Atlas Payoff Letter”), by and among the Company, ACP Post Oak Credit I LLC (“Atlas”) and the Atlas Lenders (as defined below) relating to the Company’s Senior Secured Term Loan (see Note 13, 
Borrowings)
, dated as of July 29, 2022 (the “Atlas Credit Agreement”), by and among the Company and Atlas, as lender, administrative agent and collateral agent, and the lenders from time to time party thereto (collectively with Atlas, the “Atlas Lenders”). Pursuant to the Atlas Payoff Letter, as of the Atlas Facility Termination Date, all outstanding obligations under the Atlas Credit Agreement and the related facility documents were deemed paid and satisfied in full and all security interests and other liens granted to or held by the Atlas Lenders were terminated and released. Under the Atlas Payoff Letter, the Company agreed to pay to the Atlas Lenders on the Atlas Facility Termination Date (a) approximately $
11,900
 (which was released from the interest escrow account maintained pursuant to the Atlas Credit Agreement, and (b) $
8,000
. Atlas also agreed, in lieu of amounts due from the Company, to receive a $
1,000
 participation in the Credit Agreement, as negotiated between Atlas and the Lender. The Company has no obligation under the participation agreement between Atlas and the Lender. The payoff of the Senior Secured Term Loan resulted in a restructuring gain. See Note 13, 
Borrowings
, for further discussion.
20
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
3. Credit Agreement and Securities Purchase Transaction
 (cont.)
In connection with the termination of the Atlas Credit Agreement, the Company entered into an insurer letter agreement, dated as of June 21, 2024 (the “Insurer Letter Agreement”), with the insurance companies that issued insurance policies to certain Atlas Lenders in connection with the Atlas Credit Agreement (the “Atlas Insurers”) pursuant to which the Company and the Atlas Insurers agreed that the Company will pay to the Atlas Insurers, subject to the terms and conditions of the Insurer Letter Agreement, $
3,000
 on December 31, 2024, and on June 30, 2025, subject to the absence of certain events of default under the Credit Agreement, an additional $
4,000
. The Company paid $
3,000
 in December 2024 and $
4,000
 in June 2025 to the Atlas Insurers.

4. 
Revenue Recognition
The Company primarily earns revenue from sales of its energy storage systems and services including installation, commissioning and extended warranty services. 
Product revenues, which are generally recognized at a point in time, and service revenues, which are generally recognized over time, are as follows:
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
2025
2024
2025
2024
Product revenue
$
30,209

$
368

$
54,191

$
7,465

Service revenue
303

486

2,014

$
888

Total revenues
$
30,512

$
854

$
56,205

$
8,353

For the three months ended September 30, 2025, the Company had 
one
 customer who individually accounted for greater than 10% of total revenue. This customer collectively accounted for approximately 
82.1
% of the total revenue. For the nine months ended September 30, 2025, the Company had 
three
 customers who individually accounted for greater than 10% of total revenue and collectively accounted for approximately 
73.0
% of the total revenue. 
For the three months ended September 30, 2024, the Company had 
two
 customers who individually accounted for greater than 10% of total revenue and collectively accounted for approximately 
87.4
% of the total revenue. For the nine months ended September 30, 2024, the Company had 
two
 customers who individually accounted for greater than 10% of total revenue and collectively accounted for approximately 
90.4
% of the total revenue. 
Contract assets and Contract liabilities
The following table provides information about contract assets and contract liabilities from contracts with customers. Contract assets, current, Contract liabilities, current and Contract liabilities, long-term are included separately on the Unaudited Condensed Consolidated Balance Sheets and contract assets expected to be recognized in greater than twelve months are included under Other assets, net. 

September 30, 2025
December 31, 2024
Contract assets
$
14,756

$
14,059

Contract liabilities
$
19,183

$
26,349

Contract assets increased by $
697
, net, during the nine months ended September 30, 2025, due to recognition of revenues for which invoicing has not yet occurred.
21
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
4. Revenue Recognition 
(cont.)
The following table provides information about changes in Contract liabilities:
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
2025
2024
2025
2024
Contract liabilities, beginning of the period
$
39,537

$
9,202

$
26,349

$
6,610

Amounts in beginning balance recognized in revenue
(
10,989
)
(
254
)
(
22,102
)
(
794
)
Revenue recognized in current period
(
20,102
)
(
1,456
)
(
31,353
)
(
2,779
)
Advance payments received from customers
10,737

4,532

46,289

8,987

Contract liabilities, end of the period
$
19,183

$
12,024

$
19,183

$
12,024

Contract liabilities of $
16,703
 as of September 30, 2025, are expected to be recognized within the next twelve months and long-term contract liabilities of $
2,480
 are expected to be recognized as revenue in greater than twelve months. Contract assets of $
11,982
 as of September 30, 2025, are expected to be recognized within the next twelve months and long-term contract assets of $
2,774
 are expected to be recognized as accounts receivable in greater than twelve months.
Remaining Performance Obligations
Remaining performance obligations (“RPO”) represent the allocated transaction price of unsatisfied or partially unsatisfied performance obligations. The Company expects to recognize revenue related to the RPOs as the performance obligations are satisfied in accordance with the Company’s revenue recognition policy, which can be found in Note 2, 
Summary of Significant Accounting Policies,
 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. As of September 30, 2025, the Company's remaining performance obligations were approxi
mately $
77,154
. The Company expects to recognize revenue of approxim
ately 
76
% 
of the remaining performance obligations over the next 
twelve months
, with the remainder recognized thereafter.
5. 
Cash, Cash Equivalents and Restricted Cash
Restricted cash - current as of September 30, 2025, consists of accounts related to the DOE Loan Facility for reserves related to warranty claims, debt servicing, the Davis Bacon Act, secured letters of credit, escrow deposits related to U.S. Custom Bonds insurance, escrow deposits related to our credit card program agreements and interest reserve account maintained pursuant to the DOE Limited Consent Agreement equivalent to one year of interest expense of the 2025 Convertible Notes.
Restricted cash - current as of September 30, 2024, consists of escrow deposits related to U.S. Custom Bonds insurance and escrow deposits related to our credit card program agreements. 
Long-term restricted cash as of September 30, 2025, relates to, as defined in the Credit Agreement, the Minimum Liquidity covenant. Prior to the first tranche funding, the Minimum Liquidity covenant, as defined in the Credit Agreement and the DOE Loan Facility, the Company shall not permit cash and cash equivalents at any time be less than $
15,000
. The remainder of Long-term restricted cash relates to an interest reserve account maintained pursuant to the DOE Limited Consent Agreement equivalent to one year of interest expense of the 2025 Convertible Notes. Restricted cash per the DOE Limited consent Agreement shall be reduced by the amounts of any actual interest payments made for the 2025 Convertible Notes, but shall not be less than all interest payments on the 2025 Convertible Notes due within 
12
 months.
Long-term restricted cash as of September 30, 2024, relates to a minimum liquidity requirement in the Credit Agreement. Prior to the first tranche funding, the Company was required to maintain cash and cash equivalents of no less than $
2,500
. Following the first tranche funding, this minimum liquidity requirement increased to $
5,000
.
22
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
5. Cash, Cash Equivalents and Restricted Cash 
(cont.)
The following table reconciles reported amounts from the Unaudited Condensed Consolidated Balance Sheets to Cash, Cash Equivalents and Restricted Cash reported within the Unaudited Condensed Consolidated Statements of Cash Flows:
September 30, 2025
September 30, 2024
Cash and cash equivalents
$
58,733

$
23,015

Restricted cash - current
36,946

2,625

Long-term restricted cash
31,120

5,000

    Total cash, cash equivalents and restricted cash 
$
126,799

$
30,640

6. 
Inventory
The following table provides information about Inventory balances:

September 30, 2025
December 31, 2024
Raw materials
$
34,377

$
25,126

Work-in-process
12,712

6,665

Finished goods
465

1,035

     Total Inventory
$
47,554

$
32,826

7. 
Property, Plant and Equipment, Net
The following table provides information about Property, plant and equipment, net balances:

Estimated Useful lives
September 30, 2025
December 31, 2024
Equipment
5
-
10
 years
$
54,149

$
51,874

Finance lease
5

years
560

504

Furniture
5
-
10
 years
2,900

2,369

Leasehold improvements
Lesser of useful life/
remaining lease
12,086

9,674

Tooling
2
-
3
 years
12,430

9,955

Construction in progress (“CIP”)
38,387

—

     Total
120,512

74,376

Less: Accumulated depreciation 
(
34,487
)
(
28,716
)
Total property, plant and equipment, net
$
86,025

$
45,660

Depreciation expense related to property, plant and equipment was $
3,341
 and $
2,669
 for the three months ended September 30, 2025, and 2024 and $
8,907
 and $
5,193
 for the nine months ended September 30, 2025, and 2024, respectively. 
The Company recorded a loss from write-down of property, plant and equipment of $
585
 and $
3,192
 for the three months ended September 30, 2025, and 2024, and $
1,351
 and $
3,528
 for the nine months ended September 30, 2025, and 2024, respectively. The write-downs were mainly due to design changes from the Z3™-Phase 1 to Z3™-Phase 2 production in which the Phase 1 production assets could not be utilized or repurposed for Phase 2 production. Additionally, the loss from write-down of property, plant and equipment contains costs for disposal of miscellaneous equipment and tooling that cannot be repurposed.
23
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
7. Property, Plant and Equipment, Net 
(cont.)
For the three and nine months ended September 30, 2025, capitalized interest costs recognized were $
300
 and $
657
 respectively. At September 30, 2025, CIP consisted of costs related to sub-assembly, bipolar automation and the second automated line. On June 28, 2024, the Company successfully began commercial operations on the first manufacturing line. Accordingly, the assets classified as construction in progress were reclassified to equipment, leasehold improvements, furniture and tooling as of June 28, 2024. Included in construction in progress prior to the reclassification were capitalized interest costs of $
1,841
 for the nine months ended September 30, 2024. There were 
no
 capitalized interest costs recognized for the three months ended September 30, 2024.
8. 
Intangible Assets
Intangible assets includes various patents valued at $
400
, which represents the cost to acquire the patents. These patents are determined to have useful lives and are amortized into the results of operations over 
ten years
. The Company recorded amortization expense of $
10
 for the three months ended September 30, 2025, and 2024  and $
30
 for the nine months ended September 30, 2025, and 2024, respectively, related to patents.
The Company capitalized $
1,084
 of costs for internal-use software, including $
912
 of costs capitalized during the three and nine months ended September 30, 2025. The software has a useful life and is amortized into the results of operations over 
three years
. The Company recorded amortization expense of $
15
 and $
12
 for the three months ended September 30, 2025 and 2024 and $
44
 and $
36
 for the nine months ended September 30, 2025, and 2024, respectively, related to software.
9. 
Notes Receivable, Net and Variable Interest Entities (“VIEs”) Consideration
Notes receivable, net, relates to financing the Company offered to a customer. The Company reports the notes receivable at the principal balance outstanding less an allowance for losses. The estimate of credit losses is based on historical trends, the customer’s financial condition and current economic trends. The Company charges interest at a fixed rate and calculates interest income by applying the effective rate to the outstanding principal balance.
As of December 31, 2024, the Company had notes receivable, net, outstanding of $
847
, included in Other assets, net and Other current assets in the accompanying Unaudited Condensed Consolidated Balance Sheets. During the second quarter of 2025, the Company recorded a full allowance against the notes receivable, resulting in a 
zero
 balance as of September 30, 2025. 
As of September 30, 2025 and December 31, 2024, the allowance for expected credit loss related to the notes receivable amounted to $
884
 and $
37
, respectively. This allowance is 
included in Selling, general and administrative expenses in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss. 
The customer to whom the Company offers financing through notes receivable is a VIE. However, the Company is not the primary beneficiary, because the Company does not have power to direct the activities of the VIE that most significantly impact the VIE’s economic performance. Therefore, the VIE is not consolidated into the Company’s  Unaudited Condensed Consolidated Financial Statements
.
 The maximum loss exposure is limited to the carrying value of notes receivable as of the balances sheet dates.
24
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
10. 
Accrued Expenses
Accrued expenses were as follows:
September 30, 2025
December 31, 2024
Accrued payroll
$
9,836

$
4,811

Warranty reserve 
(1)
5,669

5,102

Accrued legal and professional expenses
961

1,709

Provision for contract losses
5,657

4,724

Accrued Interest
5,546

41

Other 
3,722

5,645

Total accrued expenses
$
31,391

$
22,032

(1)
 Refer to the table below for the warranty reserve activity for the nine months ended September 30, 2025.
The following table summarizes warranty reserve activity:
Three Months Ended September 30,
Nine Months Ended September 30,
2025
2024
2025
2024
Warranty reserve - beginning of period
$
5,917

$
5,054

$
5,102

$
6,197

Additions for current period deliveries
802

61

1,898

326

Changes in the warranty reserve estimate
—

—

543

(
1,150
)
Warranty costs incurred
(
1,050
)
(
420
)
(
1,874
)
(
678
)
Warranty reserve - end of period
$
5,669

$
4,695

$
5,669

$
4,695

11. 
Government Grants
Inflation Reduction Act of 2022 (“IRA”)
On August 16, 2022, President Biden signed the Inflation Reduction Act of 2022 into law. The IRA has significant economic incentives for both energy storage customers and manufacturers for projects placed in service after December 31, 2022. Starting in 2023, there are PTCs, which can be claimed on battery components manufactured in the U.S. and sold to U.S. or foreign customers. The tax credits available to manufacturers include a credit for ten percent of qualified costs incurred to make electrode active materials in addition to credits of $35 per kWh of capacity for eligible battery cells and $10 per kWh of capacity for eligible battery modules. These credits are cumulative, meaning that companies will be able to claim each of the available tax credits based on the battery components produced and sold through 2029, after which the PTC will begin to gradually phase down through 2032. 
One Big Beautiful Bill Act (“OBBBA”)
On July 4, 2025, President Trump signed the One Big Beautiful Bill Act into law, introducing several modifications to the energy-related tax incentives originally established under the Inflation Reduction Act. The OBBBA introduces new limitations related to the sourcing of materials from a prohibited foreign entity starting after December 31, 2025. These provisions restrict eligibility for credits where material assistance is received from such entities. Additionally, the OBBBA includes ownership and effective control related provisions concerning 'specified foreign entities' and 'foreign-influenced entities. The Company has evaluated the OBBBA enacted during the quarter and determined there is no impact on the financial statements. The Company is evaluating the future impact of the OBBBA; however, it does not anticipate a material impact from either the material sourcing or ownership-related provisions. The Company will evaluate additional guidance as it becomes available. 
25
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
11. Government Grants 
(cont.)
Since the PTC is a refundable credit (i.e., a credit with a direct-pay option available), the PTC is outside the scope of ASC 740. Therefore, the Company accounts for the PTC under a government grant model. GAAP does not address the accounting for government grants received by a business entity that are outside the scope of ASC 740. The Company’s accounting policy is to analogize to IAS 20, 
Accounting for Government Grants and Disclosure of Government Assistance,
 under IFRS Accounting Standards. Under IAS 20, once it is reasonably assured that the entity will comply with the conditions of the grant, the grant money is recognized on a systematic basis over the periods in which the entity recognizes the related expenses or losses for which the grant money is intended to compensate. The Company recognizes grants once it is probable that both of the following conditions will be met: (1) the Company is eligible to receive the grant and (2) the Company is able to comply with the relevant conditions of the grant.  
The PTC is recorded as the applicable items become finished goods and the conditions in the preceding paragraph are met.
During the second quarter of 2025, the Company entered into tax credit purchase agreement to sell and transfer all of the remaining PTCs related to the production and sale of battery cells and battery modules and electrode active materials produced in calendar year 2024, that were eligible to be claimed on the Company’s tax return. The transferred tax credits were sold at 
90
% of their value and the cash purchase price of the PTCs was $
2,055
. 
Cash was received from the buyer in April 2025, after the completed registration requirements were filed through the IRS‑provided electronic portal, inclusive of registration numbers needed to claim the credit on the Buyer’s tax return. Upon the receipt of the cash payment, 
the Company recorded offsets to the PTC/G
rant Receivable account. There were minimal differences between the recorded fair value of the PTC receivable and the amount of consideration received. Future differences, if any, will be recognized as an adjustment to cost of goods sold. 
The Company recognized PTC credits of $
5,660
 and $
170
 for three months ended September 30, 2025 and 2024 and $
12,020
 and $
1,837
 for the nine months ended September 30, 2025 and 2024, respectively, as a reduction of cost of goods sold on the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss. As of September 30, 2025, and December 31, 2024, grant receivable related to the PTC in the amount of $
12,248
 and $
2,283
, respectively, is recorded in the Unaudited Condensed Consolidated Balance Sheets.
12. 
Related Party Transactions
2021 Convertible Notes Payable
In July 2021, the Company issued $
100,000
 aggregate principal amount of convertible notes to Spring Creek Capital, LLC, a wholly-owned, indirect subsidiary of Koch Industries, Inc. (the “2021 Convertible Notes”). In connection with these 2021 Convertible Notes, the Company paid $
3,000
 to B. Riley Securities, Inc., a related party, who acted as a placement agent. Refer to Note 13, 
Borrowing
s
,
 for additional information.
AFG Convertible Notes
In January 2023, the Company issued and sold $
13,750
 of 
26.5
% Convertible Senior PIK Notes due 2026 (“AFG Convertible Notes”) to Great American Insurance Company, Ardsley Partners Renewable Energy, LP, CCI SPV III, LP, Denman Street LLC, John B. Berding Irrevocable Children’s Trust, John B. Berding and AE Convert, LLC (together, the “Purchasers”). AE Convert LLC, a Delaware limited liability company is managed by Russell Stidolph who is a related party as a director of the Company (the “Affiliated Purchaser”). On July 29, 2025, the Company entered into the First Supplemental Indenture (as defined herein) dated as of July 28, 2025, providing for certain amendments to the terms of the AFG Convertible Notes. Refer to Note 13, 
Borrowing
s
,
 for additional information.
26
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
12. Related Party Transactions 
(cont.)
Credit and Securities Purchase Transaction
Pursuant to the terms and conditions of Credit and Securities Purchase Transaction, Cerberus and CCM Denali Equity Holdings, LP, are considered related parties as result of the transactions. During the second quarter of 2025, the Company entered into the Cerberus Amendments, with Cerberus US Servicing LLC acting as the Administrative Agent to the Cerberus Amendments. Refer to Note 3, 
Credit and Securities Purchase Transaction 
for detailed discussion.
During the 
three
 and 
nine 
months ended September 30, 2025, the Company incurred manufacturing costs of $
528
 and $
1,902
 and advisory fees of $
249
 and $
2,740
, respectively, from 
four
 vendors affiliated with Cerberus. As of September 30, 2025, $
4,496
 of the costs were paid and the remaining $
146
 of the costs are included in Accounts payable in the Unaudited Condensed Consolidated Balance Sheets. The fees are included in Cost of goods sold, Selling, general and administrative expenses in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss and Intangible assets, net in the Unaudited Condensed Consolidated Balance Sheets.
13. 
Borrowings
The Company’s debt obligations consist of the following:
September 30, 2025
December 31, 2024
Maturity Date
  Principal Outstanding
Carrying Value*
Principal Outstanding
Carrying Value*
2021 Convertible Note Payable
June 2026
$
—

$
—

$
122,868

$
109,838

Delayed Draw Term Loan
June 2034
(1)
190,972

83,058

179,542

76,188

AFG Convertible Notes
September 2034
3,728

34,259

22,353

63,033

Notes payable - related party
194,700

117,317

324,763

249,059

2025 Convertible Notes
June 2030
250,000

239,704

—

—

Equipment financing facility
April 2026
730

730

2,386

2,385

DOE Loan Facility
June 2034
(1)
93,596

90,704

68,386

65,452

    Total borrowings
539,026

448,455

395,535

316,896

Current portion
730

730

2,014

2,014

Total borrowings, non-current
$
538,296

$
447,725

$
393,521

$
314,882

*
Carrying value includes unamortized deferred financing costs, unamortized discounts and fair value of embedded derivative liabilities, except for the Delayed Draw Term Loan, which is carried at fair value.
(1) 
The DDTL and DOE Loan Facility contain Springing Maturity dates that could make the debt due March 14, 2030.
2025 Convertible Notes
On June 3, 2025, the Company issued $
225,000
 principal amounts of its Convertible Notes due 2030. The Company granted initial purchasers an option to purchase, for settlement within a period of thirteen days from the date the 2025 Convertible Notes were first issued, up to an additional $
25,000
 principal amounts which were exercised in full. 
Contractual Interest Rates 
- The 2025 Convertible Notes will accrue interest at a rate of 
6.75
% per annum, payable semi-annually in arrears on June 15 and December 15, beginning on December 15, 2025.
Maturity-
 The 2025 Convertible Notes will mature on June 15, 2030, absent conditions described below.
Conversion Rights - 
The 2025 Convertible Notes can be converted into shares of our common stock under certain conditions before March 15, 2030:
•
Stock Price Trigger:
 If, during any calendar quarter starting after September 30, 2025, our stock price closes above 
130
% of the conversion price for at least 
20
 out of the last 
30
 trading days of that quarter.
27
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
13. Borrowings 
(cont.)
•
Trading Price Condition:
 If, during a 
10
-day period, the trading price of the notes falls below 
98
% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day, then conversion is allowed during the five business days that follow.
•
Corporate Events:
 Upon the occurrence of certain corporate events or distributions on our common stock, as described in this offering memorandum.
•
Redemption:
 If the Company calls such notes for redemption on or after June 20, 2028, then the holders may choose to convert them at that time.
Beginning March 15, 2030, the notes can be converted at any time until two trading days prior to maturity.
The initial conversion price is approximately $
5.10
 per share, and the Company may choose to settle conversions in stock, cash, or a mix of both. The conversion price is subject to customary adjustments upon the occurrence of certain events. If a make-whole fundamental change (as defined in the 2025 Convertible Notes Indenture) occurs, the conversion rate may temporarily increase to provide additional value.
Redemption 
- The 2025 Convertible Notes will be redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after June 20, 2028 and on or before the 41st scheduled trading day immediately before the maturity date, but only if certain liquidity conditions are satisfied and the last reported sale price per shares of the Company’s common stock exceeds 
130
% of the conversion price on (i) each of at least 20 trading days, whether or not consecutive, during the thirty consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii) the trading day immediately before the date the Company sends such redemption notice. However, the Company may not redeem less than all of the outstanding notes unless at least $
75,000
 aggregate principal amount of notes are outstanding and not called for redemption as of the time the Company sends the related redemption notice. The redemption price is equivalent to the principal amount of the 2025 Convertible Notes called for redemption, plus accrued and unpaid interest. In addition, calling any note for redemption will constitute a make-whole fundamental change with respect to that note, in which case the conversion rate applicable to the conversion of that note will be increased in certain circumstances if it is converted after it is called for redemption.
Embedded Derivatives 
- The 2025 Convertible Notes include certain embedded features, such as provisions for fundamental change, additional interest, special interest and indemnification. In accordance with ASC 815, the Company assessed these embedded features to determine whether bifurcation and separate accounting as derivatives was required. Although these features are not clearly and closely related to the host debt contract and meet the definition of a derivative under ASC 815, the Company determined that the combined fair value of these embedded derivatives is de minimis. Accordingly, these features have not been bifurcated from the host contract and are not accounted for separately. The Company will continue to evaluate these features for any changes in facts or circumstances that may warrant reconsideration of this assessment.
Additionally, the conversion feature embedded in the 2025 Convertible Notes qualifies for the scope exception under ASC 815-40 and, therefore, is not required to be bifurcated and accounted for separately.
Interest expense recognized on the 2025 Convertible Notes is as follows:
For the Three Months Ended 
September 30, 2025
For the Nine Months Ended 
September 30, 2025
Contractual interest expense
$
4,313

$
5,536

Amortization of debt discount
417

532

Amortization of debt issuance costs
36

46

    Total
$
4,766

$
6,114

28
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
13. Borrowings 
(cont.)
The carrying value for the 2025 Convertible Notes is as follows:
September 30, 2025
June 13, 2025
June 11, 2025
June 03, 2025
Principal
$
250,000

$
250,000

$
237,500

$
225,000

Unamortized debt discount
(
9,468
)
(
10,000
)
(
9,500
)
(
9,000
)
Unamortized debt issuance costs
(
828
)
(
874
)
(
874
)
(
874
)
     Aggregate carrying value
$
239,704

$
239,126

$
227,126

$
215,126

The Company is obligated to repay all contractual interest attributable to the 2025 Convertible Notes on a semi-annual basis in cash. As of September 30, 2025, $
5,536
 of interest payable attributable for the 2025 Convertible Notes was included in Accrued expenses in the Unaudited Condensed Consolidated Balance Sheets.
Delayed Draw Term Loan (“DDTL”)
As discussed in Note 3, Credit and Securities Purchase Transaction, the Company borrowed an Initial Draw of $
75,000
, and received $
70,075
, net of the 
5.0
% original issue discount and lender fees paid from Delayed Draw Term Loan facility on June 21, 2024. On August 29, 2024, the Company met the first tranche milestones and submitted a borrowing request under the Credit Agreement for the scheduled $
30,000
, and received $
28,500
, net of the 
5.0
% original issue discount. On October 31, 2024, the Company met the second tranche milestones and submitted a borrowing request under the Credit Agreement for the scheduled $
65,000
, and received $
61,750
, net of the 
5.0
% original issue discount. On January 24, 2025, the Company announced the achievement of all four of the third tranche milestones previously agreed upon between Eos and Cerberus. Achieving these performance milestones enabled the Company to draw an additional $
40,500
 and received $
38,475
, net of the 
5.0
% original issue discount on January 24, 2025, completing the scheduled fundings under the Delayed Draw Term Loan. See Note 3, 
Credit Agreement and Securities Purchase Transaction
 for additional information on this transaction.
Each tranche under the Delayed Draw Term Loan is subject to a 
5.0
% original issue discount payable at the time of each draw. Borrowings under the Credit Agreement are subject to certain fees, including (i) an exit fee equal to 
5.0
% of the aggregate principal amount of Loans, or Revolving Loans being paid, repaid, prepaid, refinanced or replaced in a prepayment event, (ii) a make-whole payment for certain prepayments prior to March 31, 2028, as amended on November 26, 2024 and (iii) a prepayment premium for any prepayments prior to the scheduled maturity date. The Credit and Guaranty Agreement includes a Minimum Liquidity requirement under which the Company shall not permit liquidity at any time be less than $
15,000
 following the Company's first indebtedness incurred through the DOE LPO in December 2024.
Milestones
In the event the Company failed to achieve any milestones on any predetermined tranche date or the one additional milestone measurement date, the Company would not have received the specific tranche unless waived by the Lenders, and would be subject to a penalty represented by an up to 
1
% increase in the applicable percentage in the form of additional warrants or preferred shares at each missed milestone measurement date. As of the balance sheet date, in the event the Company fails to meet the final component of the last milestone under the Credit Agreement, the equity to be issued to Cerberus would be limited to warrants for shares of common stock or shares of convertible preferred stock equal to 
1
% of the fully diluted outstanding shares of the Company on the final milestone measurement date. See Note 22, 
Subsequent Events
, for further discussion of the final measurement date.
Covenants
On May 28, 2025, the Company amended the Credit Agreement, by and among the Company, certain of the Company’s subsidiaries as guarantors party thereto and the Lender, pursuant to which among other things, the applicability of the Consolidated Revenue and EBITDA financial covenants were deferred until March 31, 2027 and certain provisions were amended to conform with comparable provisions in the DOE Loan Facility.
29
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
13. Borrowings 
(cont.)
The Credit Agreement, as amended, contains the following financial covenants, including (each as defined in the Credit Agreement, as amended):
•
Minimum Consolidated EBITDA - not applicable for September 30, 2025.
•
Minimum Consolidated Revenue - not applicable for September 30, 2025.
•
Minimum Liquidity
As of and for the three months ended September 30, 2025, the Company was in compliance with the Minimum Liquidity financial covenant.
The facilities are subject to certain events of default which can be triggered by, among other things, (i) breach of payment obligations and other obligations and representations in the Credit Agreement or related documents, (ii) default under other debt facilities with a principal above a predetermined amount, (iii) failure to perform or comply with certain covenants in the Credit Agreement, (iv) entry into a decree or order for relief in respect of the Company or any of its subsidiaries in an involuntary case under the Bankruptcy Code of the United States or under any other debtor relief law, (v) any money judgment, writ or warrant of attachment or similar process involving in the aggregate at any time an amount in excess of $
2,500
, (vi) any order, judgment or decree entered against the Company or the Guarantors decreeing the dissolution or split up of such entity, (vii) the failure of the common stock to be listed on an internationally recognized stock exchange in the United States and (viii) a change of control.
The Company elected the fair value option to account for all draws under the Delayed Draw Term Loan for operational purposes. The financial liability was initially measured at its issue-date fair value and is subsequently remeasured at fair value on a recurring basis at each reporting period date. The Company also elected the fair value option for the August Draw, October Draw and January Draw. The Initial Draw fair value, the August Draw fair value, the October Draw fair value and the January Draw fair value (collectively the "DDTL"), were $
25,653
, $
12,528
, $
28,340
 and $
17,312
 respectively, at issuance. As of September 30, 2025, the fair value for the DDTL was $
83,058
. A loss of $
3,570
 and a gain of $
22,112
 was recognized for the three and nine months ended September 30, 2025, and a loss of $
3,036
 and $
3,276
 was recognized for the three and nine months ended September 30, 2024, respectively and is included in Change in fair value of debt - related party on the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss. 
For the three months ended September 30, 2025, the Company recorded a loss of  $
17,784
 in Change in fair value of debt - credit risk - related party. For the nine months ended September 30, 2025, the Company recorded a loss of $
24,008
 in Change in fair value of debt - credit risk - related party. This included a $
40,253
 loss attributable to changes in instrument-specific risk, partially offset by a $
16,245
 gain from reclassifying accumulated other comprehensive income into earnings following the partial extinguishment of the Delayed Draw Term Loan.  The Company also recorded a loss of $
4,642
 attributable to changes in instrument-specific risk for the three and nine months ended September 30, 2024. This is included in Change in fair value of debt - credit risk - related party in Accumulated Other Comprehensive Loss.
The Company did not separately report interest expense attributable to the DDTL because such interest was included in the determination of the fair value of the Note. See Note 15, 
Fair Value Measurement
 for the assumptions used to determine the fair value the Delayed Draw Term Loan at issuance and at September 30, 2025.
Contractual Interest Rates 
- Borrowings under the Credit Agreement bear interest at an annual rate equal to 
7.0
% per annum (as amended), subject to the following increases: (i) an additional 
5.0
% per annum upon the occurrence of an event of default under the Credit Agreement. The Company may elect to add accrued and unpaid interest on the loans to the principal amount of the loans (capitalized interest).
30
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
13. Borrowings 
(cont.)
Maturity 
- The Maturity Date is defined as the earlier of (i) June 15, 2034, and (ii) the date that all the loans shall become due and payable in full, whether by acceleration or otherwise; provided that, if on any Springing Maturity Date any Convertible Notes remain outstanding, the Maturity Date shall instead be the Springing Maturity. The Springing Maturity Date is defined as the 91st day prior to the date on which any convertible note may be redeemed, repurchased, converted, or exchanged in satisfaction of the obligations (“Convertible Note Maturity”). As of September 30, 2025, the 2025 Convertible Notes and AFG Convertible Notes, remain outstanding and are scheduled to mature on June 15, 2030 and September 30, 2034, respectively. See Note 3, 
Credit Agreement and Securities Purchase Transaction
 for additional information on this transaction.
Prepayments 
- On May 28, 2025, the Company made a prepayment of $
47,619
 on the Delayed Draw Term Loan, net of an end of term fee of $
2,381
, as in accordance with the terms the Delayed Draw Term Loan, as amended May 28, 2025.
Modification of the DDTL
 - In accordance with applicable accounting standards, the prepayment and Cerberus Amendments were evaluated under the debt modification and extinguishment guidance in ASC 470-50, 
Debt - Modification and Extinguishments.
 The Cerberus Amendments did not qualify for the extinguishment accounting under ASC 470-50 as a whole, and were accounted for as a modification. The total prepayment of $
50,000
 as required by Second Credit Agreement Amendment was accounted for as a partial extinguishment. The loss on partial extinguishment was $
38,375
 after reclassification of accumulated other comprehensive income through earnings for $
16,245
.
2021 Convertible Note Payable – Related Party
On July 6, 2021, the Company entered into an investment agreement with Spring Creek Capital, LLC, a wholly-owned, indirect subsidiary of Koch Industries, Inc. The investment agreement provides for the issuance and sale to Koch Industries of the 2021 Convertible Note in the aggregate principal amount of $
100,000
. The maturity date of the 2021 Convertible Notes was June 30, 2026, subject to earlier conversion, redemption or repurchase.
The 2021 Convertible Note contains an embedded derivative feature, which is presented on the Unaudited Condensed Consolidated Balance Sheets as a component of Notes payable - related party. See Note 15, 
Fair Value Measurement
 for the assumptions used to determine the fair value of the embedded derivative as of December 31, 2024. 
Interest expense recognized on the 2021 Convertible Note is as follows:
Three Months Ended September 30,
Nine Months Ended September 30,
2025
2024
2025
2024
Contractual interest expense
$
—

$
1,789

$
3,072

$
5,264

Amortization of debt discount
—

1,713

3,230

4,832

Amortization of debt issuance costs
—

165

311

467

    Total
$
—

$
3,667

$
6,613

$
10,563

The balances for the 2021 Convertible Note are as follows:
December 31, 2024
Principal
$
122,868

Unamortized debt discount
(
13,045
)
Unamortized debt issuance costs
(
1,257
)
Embedded conversion feature
1,272

     Aggregate carrying value
$
109,838

31
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
13. Borrowings 
(cont.)
The Company was obligated to repay all contractual interest attributable to the 2021 Convertible Note in-kind on a semi-annual basis, in accordance with the terms under the Delayed Draw Term Loan. The contractual interest in-kind was recorded as an increase to the 2021 Convertible Notes’ principal balance, therefore 
no
 interest was payable as of December 31, 2024.
Termination of the 2021 Convertible Notes
On June 3, 2025, the Company repurchased the full $
122,868
 aggregate principal amount, in addition to $
3,072
 of interest payable outstanding for $
131,000
 inclusive of a repurchase premium in a privately negotiated transaction. The holder of the 2021 Convertible Notes was contingently required to reimburse the Company for up to $
5,000
 of the repurchase premium based on the holders overall return on its investment in the Company. On June 13, 2025 the Company received the $
5,000
 repurchase premium. Neither the holder of the 2021 Convertible Notes, nor the Company have any outstanding contractual obligations. Absent termination, the 2021 Convertible Notes would have matured on June 30, 2026.
The Company accounted for the termination of the 2021 Convertible Notes in accordance with ASC 470-50, 
Debt- Modifications and Extinguishment
s. As a result, the Company recognized a loss on debt extinguishment for the 2021 Convertible Notes of $
10,688
 in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the  nine months ended September 30, 2025.
DOE Loan Facility 
On November 26, 2024, the Company entered into a loan agreement with the United States Federal Financing Bank ("FFB") and the United States DOE Loan Programs Office (“LPO”) (“the DOE Loan Facility"). The loan provides for a principal amount of up to $
277,497
 of borrowings and capitalized interest amount of up to $
25,953
.
The DOE Loan Facility provides for a multi draw term loan facility under a series of at least 
two
 tranches and, if the Company elects, up to 
four
 tranches of the loan (each, a “Tranche”), subject to the achievement of certain funding conditions. Each Tranche corresponds to the production, maintenance, development, and operation of a given production line to be funded using the proceeds of such Tranche. The principal amount of each Tranche consists of a maximum principal amount designated for such Tranche in the DOE Loan Facility. Each Tranche provides the Company funding for 
80
% of the Eligible Project Costs. Eligible Project Costs means Project Costs that satisfy each of the following conditions: (a) DOE has determined the Project Costs to be eligible costs in accordance with Sections 609.2 and 609.10 of the Applicable Regulations; (b) the Project Costs have not been paid and are not expected to be paid any time after the First Advance Date with: (i) any federal grants, assistance, or loans (excluding the DOE Loan Facility); or (ii) other funds guaranteed by the Federal Government; (c) the Project Costs are identified in the Construction Budget; (d) the Project Costs do not constitute Cost Overruns; and (e) the Project Costs were incurred after the Eligibility Effective Date.) associated with the corresponding production line, with the Company responsible for funding the remaining 
20
% of the Project Costs. 
The DOE Loan Facility specifies the maximum amount subject to each tranche (Tranche 1: $
101,979
; Tranche 2: $
117,326
; Tranche 3: $
71,836
; and Tranche 4: $
12,309
), and any amounts not withdrawn under a specified tranche cannot be allocated to another tranche. 
On April 16, 2025, the Company amended the DOE Loan Facility in order to clarify the maximum Tranche Commitment principal amounts by excluding capitalized interest (Tranche 1: $
90,945
; Tranche 2: $
106,733
; Tranche 3: $
67,529
; and Tranche 4: $
12,290
). The Amendment does not materially alter rights, obligations, or meaning of the DOE Loan Facility. 
As of September 30, 2025, the Company had drawn down $
90,945
 under the DOE Loan Facility, utilizing the full commitment available for Tranche 1. The initial draw of $
68,279
 was made at an interest rate of 
4.791
%, for eligible project costs incurred through December 6, 2024. The second draw of $
22,666
 was made at an interest rate of 
4.286
%, for eligible project costs incurred through June 4, 2025. These costs represent Tranche 1 that provided $
90,945
 for eligible costs in connection with the design, construction, installation, startup and shakedown of a battery automation line and related tools, with a projected annual production capacity of approximately 1.25 GWh ("Line 1"), as defined in the DOE Loan Facility. 
32
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
13. Borrowings 
(cont.)
Interest expense recognized on the DOE Loan Facility is as follows:
For the Three Months Ended September 30, 2025
For the Nine Months Ended September 30, 2025
Contractual interest expense
$
1,088

$
2,723

Amortization of debt issuance costs
417

1,617

    Total
$
1,505

$
4,340

The carrying value for the DOE Loan Facility is as follows:
September 30, 2025
July 01, 2025
December 31, 2024
Principal (life to date draw-downs)
$
90,945

$
90,945

$
68,279

Capitalized PIK Interest
2,651

1,614

107

Unamortized debt issuance costs
(
2,892
)
(
3,310
)
(
2,934
)
     Aggregate carrying value
$
90,704

$
89,249

$
65,452

The DOE Loan Facility bears interest at the applicable U.S. Treasury rate plus a spread equal to 
0.375
%. The interest is paid in-kind ("Capitalized PIK Interest") on a quarterly basis, in accordance with the terms under the DOE Loan Facility. Therefore, as of September 30, 2025, accrued interest attributable for the DOE Loan Facility was $
180
. Cash payment of the Capitalized PIK Interest on the DOE Loan Facility commences in 2028.
Covenants
On May 28, 2025, the Company and the DOE entered into a Limited Consent Agreement (“DOE Limited Consent Agreement”), pursuant to which among other things, the applicability of the Consolidated Revenue and EBITDA financial covenants were deferred until March 31, 2027 and certain provisions were added to conform with comparable provisions in the Delayed Draw Term Loan. Additionally, the DOE Limited Consent Agreement requires the Company to reserve 24 months of interest expense for the 2025 Convertible Notes. Refer to Note 5, 
Cash, Cash Equivalents and Restricted Cash 
for further information. 
The DOE Loan facility, as amended, contains the following financial covenant, (as defined in the DOE Loan facility) Minimum Liquidity. As of September 30, 2025, the Company was in compliance with the Minimum Liquidity financial covenant.
In addition, the DOE Loan Facility contains certain representations and warranties customary for the facilities extended under the DOE Loan Facility, including, among other things, representations and warranties regarding: (i) the organization and existence of the Company, (ii) authority and the absence of any conflicts, (iii) capitalization, (iv) solvency and (v) compliance with applicable law and the DOE Loan Program.
33
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
13. Borrowings 
(cont.)
Maturity 
- The Maturity Date is defined as the earlier of (i) June 15, 2034, and (ii) the date that all the loans shall become due and payable in full, whether by acceleration or otherwise; provided that, if on any Springing Maturity Date any Convertible Notes remain outstanding, the Maturity Date shall instead be the Springing Maturity. The Springing Maturity Date is defined as the 91st day prior to the Convertible Note Maturity. As of September 30, 2025, the 2025 Convertible Notes and AFG Convertible Notes, remain outstanding and are scheduled to mature on June 15, 2030 and September 30, 2034, respectively. 
AFG Convertible Notes - Related Party
On January 18, 2023, the Company entered into the Investment Agreement with the AFG Convertible Notes Purchasers relating to the issuance and sale to the AFG Convertible Notes Purchasers of $
13,750
 in aggregate principal amount of the Company’s AFG Convertible Notes.  The AFG Convertible Notes bear interest at a rate of 
26.5
% per annum, as amended, to be reduced to 
7.0
%, commencing on June 30, 2026 (the “Original Maturity Date”), which is entirely paid-in-kind (“PIK Interest”) semi-annually in arrears on June 30 and December 30. It is expected that the AFG Convertible Notes will mature on September 30, 2034, subject to earlier conversion, redemption or repurchase. The AFG Convertible Notes are convertible into shares of the Company’s common stock, par value $
0.0001
 per share, based on an initial conversion price of approximately $
1.67
 per share subject to customary anti-dilution and other adjustments. The Company has the right to settle conversions in shares of common stock, cash, or any combination thereof. 
The Conversion Option includes an exercise contingency, which requires the Company to obtain stockholder approval for conversions subject to the Exchange Cap. If stockholder approval of the issuance of additional shares of Common Stock is not obtained, following commercially reasonable efforts, the Company will be required to settle the conversion in excess of the Exchange Cap in cash. Since settlement in cash may be required in absence of stockholder approval, the embedded conversion feature fails the equity classification guidance in ASC 815 and is thus precluded from being classified in equity. Therefore, the embedded conversion feature is required to be bifurcated from the AFG Convertible Notes and accounted for at fair value at each reporting date, with changes in fair value recognized on the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss. The embedded derivative is presented on the Unaudited Condensed Consolidated Balance Sheets as a component of Notes payable - related party. The fair value of the embedded derivative was $
31,040
 and $
43,124
 as of September 30, 2025 and December 31, 2024, respectively. 
On July 29, 2025, the Company entered into a first supplemental indenture dated as of July 28, 2025 to the indenture dated May 25, 2023 (the “AFG Indenture”) with Wilmington Trust, National Association, as trustee, relating to the AFG Convertible Notes (the “First Supplemental Indenture”), to (1) extend the maturity date of the AFG Convertible Notes to September 30, 2034; (2) reduce the interest rate of the AFG Convertible Notes to 
7.0
%, commencing on June 30, 2026; (3) amend the optional redemption provision therein to allow for optional redemption pro rata excluding the Affiliated Purchaser; and (4) amend the meaning of Redemption Price therein to include the optional redemption price payable to the holders that will vary depending on the timing of the redemption relative to the Original Maturity Date of the AFG Convertible Notes. If redeemed on or before the Original Maturity Date, holders receive the capitalized principal plus all interest they would have earned through the Original Maturity Date, including interest on capitalized interest. If redeemed after the Original Maturity Date, holders receive the capitalized principal plus accrued interest up to, but not including, the redemption date. On August 1, 2025 the Company issued a Notice of Redemption of Non-Affiliated Holders for all outstanding AFG Convertible Notes. As such, there was no derivative liability associated with the non-affiliated AFG Convertible Notes at September 30, 2025. Refer to 
Conversion of AFG Convertible Notes 
below for further information.
Under ASC 470-50, 
Debt- Modifications and Extinguishment
s, the First Supplemental Indenture was accounted for as a substantial modification pertaining to the non-affiliated holders. As a result, the Company recognized a loss on debt extinguishment for the non-affiliated AFG Convertible Notes of $
3,589

in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2025.
34
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
13. Borrowings 
(cont.)
Interest expense recognized on the AFG Convertible Notes is as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025
2024
2025
2024
Contractual interest expense
$
247

$
1,308

$
3,209

$
3,617

Amortization of debt discount
(
848
)
246

(
290
)
682

Amortization of issuance costs
(
239
)
70

(
81
)
192

    Total
$
(
840
)
$
1,624

$
2,838

$
4,491

The balances for the AFG Convertible Notes are as follows:
September 30, 2025
December 31, 2024
Principal
$
3,728

$
22,353

Unamortized debt discount
(
397
)
(
1,906
)
Unamortized debt issuance costs
(
112
)
(
538
)
Embedded conversion feature
31,040

43,124

     Aggregate carrying value
$
34,259

$
63,033

The Company is obligated to repay all contractual interest attributable to the AFG Convertible Notes in-kind on a semi-annual basis, in accordance with the terms of the Investment Agreement. Therefore, as of September 30, 2025 and December 31, 2024, interest payable attributable to the AFG Convertible Notes was $
247
 and $
—
 respectively. For the nine months ended September 30, 2025 and September 30, 2024, interest that was paid in kind, capitalized and added to the principal amount of the AFG Convertible Note was $
2,962
 and $
2,309
, respectively. 
Conversion of AFG Convertible Notes
On August 1, 2025, the Company issued a Notice of Redemption of Non-Affiliated Holders for all outstanding AFG Convertible Notes, pursuant to which the Company intended to fully redeem the AFG Convertible Notes (other than those held by the Affiliated Purchaser) on August 18, 2025 for a redemption price equal to the then current capitalized principal amount of the AFG Convertible Notes (other than those held by the Affiliated Purchaser) plus the aggregate amount of all accrued and unpaid or un-capitalized interest payments on the capitalized principal amount of the AFG Convertible Notes (other than those held by the Affiliated Purchaser) that the holders of the AFG Convertible Notes to be redeemed would have been entitled to receive had the AFG Convertible Notes remained outstanding to June 30, 2026. In accordance with the terms of the AFG Indenture and the Notice of Redemption of Non-Affiliated Holders, each of the holders of the AFG Convertible Notes (other than those held by the Affiliated Purchaser) opted to exercise its conversion right to convert all of such holder’s outstanding AFG Convertible Notes into shares of Common Stock at a conversion rate equal to 598.8024 shares of Common Stock per $1,000 capitalized principal amount of AFG Convertible Notes. During the third quarter of 2025, the Company issued 
16,578,810
 shares of Common Stock in the aggregate to such holders of the AFG Convertible Notes (other than those held by the Affiliated Purchaser). 
Senior Secured Term Loan 
On July 29, 2022, the Company entered into a $
100,000
 Senior Secured Term Loan Credit Agreement with Atlas Credit Partners (ACP) Post Oak Credit I LLC, as administrative agent for the lenders and collateral agent for the secured parties. The Senior Secured Term Loan was scheduled to mature on the earlier of (i) July 29, 2026 and (ii) 
91
 days prior to the current maturity date of the 2021 Convertible Note of June 30, 2026. 
35
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
13. Borrowings 
(cont.)
The outstanding principal balance of the Senior Secured Term Loan bore interest, at the applicable margin plus, at the Company’s election, either (i) the benchmark secured overnight financing rate (“SOFR”), which is a per annum rate equal to (y) the Adjusted Term SOFR plus 
0.2616
%, or (ii) the alternate base rate (“ABR”), which is a per annum rate equal to the greatest of (x) the U.S. Prime Lending Rate, (y) the NYFRB Rate (as defined in the agreement) plus 
0.5
% and (z) the SOFR. The applicable margin under the Credit Agreement was 
8.5
% per annum with respect to SOFR loans and 
7.5
% per annum with respect to ABR loans. Interest on the Senior Secured Term Loan accrued at a variable interest rate and interest payments were due quarterly. 
Termination of the Senior Secured Term Loan
On June 21, 2024, the Atlas Credit Agreement, and the subsequent commitment increase agreements thereto, which provided for a $
100,000
 Senior Secured Term Loan Credit Agreement, were terminated pursuant to the terms of the Atlas Payoff Letter and the Insurer Letter Agreement, and all security interests and other liens granted to or held by the Atlas Lenders were terminated and released. 
In accordance with the Atlas Payoff Letter, the Company agreed to payoff the Senior Secured Term Loan for (a) approximately $
11,900
 (which was released from the interest escrow account maintained pursuant to the Atlas Credit Agreement and (b) $
1,000
 for the account of Atlas; provided that Atlas agreed to accept a participation in the Credit Agreement in lieu of such $
1,000
 payment, and (c) $
8,000
. In accordance with the Insurer Letter Agreement, the Company shall pay to the Atlas Insurers (i) on December 31, 2024, subject to the absence of certain events of default under the Credit Agreement, $
3,000
 and (ii) on June 30, 2025, subject to the absence of certain events of default under the Credit Agreement, $
4,000
. 
Absent termination, the Senior Secured Term Loan would have matured on the earlier of (i) July 29, 2026 and (ii) 
91
 days prior to the maturity of certain of the Company’s outstanding convertible notes. The aggregate principal amount of the Senior Secured Term Loan outstanding was $
100,000
 at the time of termination. All obligations have been satisfied as of September 30, 2025.
The following table summarizes interest expense recognized:
Three Months Ended September 30,
Nine Months Ended September 30,
2024
2024
Contractual interest expense
$
—

$
6,858

Amortization of debt discount
—

224

Amortization of debt issuance costs
—

1,980

Total 
$
—

$
9,062

Equipment Financing facility
The Company entered into an agreement on September 30, 2021 with Trinity Capital Inc. (“Trinity”) for a $
25,000
 equipment financing facility, the proceeds of which will be used to acquire certain manufacturing equipment, subject to Trinity’s approval. Each draw is executed under a separate payment schedule (a “Schedule”) that constitutes a separate financial instrument. The financing fees included in each Schedule are established through monthly payment factors determined by Trinity. Such monthly payment factors are based on the Prime Rate reported in The Wall Street Journal in effect on the first day of the month in which a Schedule is executed. 
The Company has drawn a portion of the facility as follows: 
Date of Draw
Gross Amount of Initial Draw
Coupon Interest Rate
Debt Issuance Costs
September 2021
$
7,000

14.3
%
$
175

September 2022
4,216

16.2
%
96

    Total Equipment Financing loans
$
11,216

$
271

36
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
13. Borrowings 
(cont.)
As of September 30, 2025 and December 31, 2024, total equipment financing carrying value was $
730
 and $
2,385
, respectively of which $
730
 and $
2,014
 are recorded as a current liability on the Unaudited Condensed Consolidated Balance Sheets, respectively. Interest expense attributable to the equipment financing agreement was $
39
 and $
177
 for the three and nine months ended September 30, 2025, respectively. Interest expense attributable to the equipment financing agreement was $
148
 and $
535
 for the three and nine months ended September 30, 2024, respectively.

14. 
Warrants Liability 
The amount of warrants outstanding and fair value for all warrants as of September 30, 2025 and December 31, 2024 are as follows:
September 30, 2025
December 31, 2024
Exercise Price
Number of Warrants Outstanding
Fair Value
Number of Warrants Outstanding
Fair Value
Warrants liability
IPO warrants
$
11.50
224,400

$
397

274,400

$
269

April 2023 warrants
$
3.14
16,000,000

152,320

16,000,000

56,400

May 2023 warrants
$
2.50
3,601,980

35,047

3,601,980

13,126

December 2023 warrants
$
1.60
20,915,736

215,432

29,799,992

119,796

Total 
40,742,116

$
403,196

49,676,372

$
189,591

Warrants liability - related party
SPA Warrant
$
0.01
1

467,837

1

188,857

Contingent warrants
(a)
N/A
—

—

—

77,773

Total 
1

467,837

1

266,630

(a) Contingent warrants represent future issuable shares of stock. See Note 3, 
Credit and Securities Purchase Transaction
 for further discussion
.
The change in fair value for IPO Warrants, April 2023 Warrants, May 2023 Warrants and December 2023 Warrants have been recognized in change in fair value of warrants on the Company’s Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss. The April, May, and December 2023 Warrants are classified as Warrants liability and the IPO warrants are included in Other current liabilities on the Unaudited Condensed Consolidated Balance Sheets. The change in fair value for the SPA Warrant and Contingent Warrants have been recognized in Change in fair value of derivatives - related parties on the Company’s Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss. The fair value for these warrants is included in Warrants liability - related party on the Unaudited Condensed Consolidated Balance Sheets. See Note 15, 
Fair Value Measurements 
for further information
.

37
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
14. Warrants Liability 
(cont.)
Warrants liability
The Company issued private placement warrants to B. Riley Financial, Inc. in conjunction with its initial public offering 2020 (“IPO warrants”). During the first quarter of 2025, 
50,000
 IPO warrants

that were issued to various counterparties became public warrants. 
In April 2023, the Company issued 
16,000,000
 shares of common stock and 
16,000,000
 private placement warrants to purchase shares of common stock. In May 2023, the Company issued another 
3,601,980
 shares of common stock and 
3,601,980
 private placement warrants to purchase shares of common stock (the “April 2023 warrants” and “May 2023 warrants”, respectively).
In December 2023, the Company issued in a combined public offering 
34,482,759
 shares of common stock and 
34,482,759
 accompanying common warrants to purchase shares of common stock (the "December 2023 warrants").  For the three and nine months ended September 30, 2025, 
3,991,154
 and 
8,884,256
 of the December 2023 warrants were exercised, respectively. For the three and nine months ended September 30, 2024, 
289,654
 of the December 2023 warrants were exercised.
The 2023 warrants do not qualify for equity classification guidance in ASC 815-40 and are measured at fair value at each reporting period.
Warrants liability - related party
SPA Warrant
As discussed in Note 3, 
Credit Agreement and Securities Purchase Transaction, 
the Company issued to the Purchaser, one warrant to purchase 
43,276,194
 shares of common stock. The warrant has a 
ten-year
 term, a $
0.01
 per share exercise price, and is exercisable at the Purchaser’s discretion for cash or on a cashless basis. Upon an acceleration under the Credit Agreement, the Company could be required to purchase the warrant from the holder at an amount equal to the most recently quoted price. Following stockholder approval on September 10, 2024, the Warrant Conversion Cap increased to 
49.9
%. The Credit and Securities Purchase Agreement contains a Springing Maturity Date feature that may cause such facilities to become current on the 91st day prior to the Convertible Note Maturity.
See Note 3, 
Credit Agreement and Securities Purchase Transaction
 for additional information on this transaction.
Contingent Warrants
Following the Initial Draw, on 
three
 separate predetermined draw dates upon the achievement of the corresponding performance milestone for each such draw date, the Company received additional funds under the Credit Agreement and issued securities under the SPA in an amount equal to the applicable percentage, up to an aggregate of 
33.0
% ownership limitation on a fully-diluted basis at such time the Delayed Draw Term Loan was fully drawn. Although these contingent warrants were not issued or exercisable until additional draws occurred, they meet the guidance under ASC 480 and are recognized at fair value with changes in fair value reported in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss. As of the balance sheet date, in the event the Company fails to meet the final component of the last milestone under the Credit Agreement, the equity to be issued to Cerberus would be limited to warrants for shares of common stock or shares of convertible preferred stock equal to 
1
% of the fully diluted outstanding shares of the Company on the final milestone measurement date. 
 See Note 22, 
Subsequent Events
, for further discussion of the final measurement date.
15. 
Fair Value Measurement
Accounting standards establish a hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
Level 1 - Quoted prices in active markets for identical assets or liabilities.
38
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
15. Fair Value Measurement
 (cont.)
Level 2 - Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability. 
The carrying value of cash and cash equivalents, restricted cash, accounts receivable and accounts payable are considered to be representative of their fair value due to the short maturity of these instruments. 
The following tables set forth the Company's financial liabilities measured at fair values based on the fair value hierarchy, as described above. These should also be read with Note 2,
 Summary of Significant Accounting Policies
, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
September 30, 2025
December 31, 2024
Level 1
Level 2
Level 3
Level 1
Level 2
Level 3
Liabilities
SPA Warrant 
(a)
$
—

$
—

$
467,837

$
—

$
—

$
188,857

Contingent warrants 
(a)
$
—

$
—

$
—

$
—

$
—

$
77,773

IPO, April, May and December 2023 Warrants 
(b)
$
—

$
397

$
402,799

$
—

$
269

$
189,322

Delayed Draw Term Loan
$
—

$
—

$
83,058

$
—

$
—

$
76,188

Embedded derivatives
(c)
$
—

$
—

$
31,040

$
—

$
—

$
44,396

Total liabilities
—

$
397

$
984,734

$
—

$
269

$
576,536

(a)  Included in Warrants liability - Related party on the Unaudited Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024.
(b)  All these instruments are Level 3, except for the IPO warrants (Level 2). These are included in Warrants liability on the Unaudited Condensed Consolidated Balance Sheets.
(c)   Included in Notes Payable - Related Party on the Unaudited Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024.
Each of the following recurring level 2 and level 3 instruments’ valuation model used to determine fair value is disclosed in the Company’s Annual Report on the Form 10-K for the year ended December 31, 2024.   
IPO Warrants
The IPO warrants are valued on the basis of the quoted price of the Company’s public warrants, adjusted for insignificant difference between the public warrants and the private placement warrants. 
April 2023 warrants, May 2023 warrants and December 2023 warrants
The April 2023 warrants, May 2023 warrants and December 2023 warrants all are valued using the Black-Scholes model at inception and on subsequent valuation dates. This model incorporates inputs such as the stock price of the Company, risk-free interest rate, volatility and time to expiration. The volatility is a significant unobservable input classified as Level 3 of the fair value hierarchy. 
The inputs used to determine the fair value of the April 2023 warrants, May 2023 warrants, and the December 2023 warrants are as follows:
39
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
15. Fair Value Measurement
 (cont.)
April 2023 warrants
September 30, 2025
December 31, 2024
Time to expiration
3.04
 years
3.79
 Years
Common stock price
$
11.39

$
4.86

Risk-free interest rate
3.6

%
4.3

%
Volatility
100.0

%
90.0

%
May 2023 warrants
September 30, 2025
December 31, 2024
Time to expiration
2.79
 Years
3.54
 Years
Common stock price
$
11.39

$
4.86

Risk-free interest rate
3.6

%
4.3

%
Volatility
100.0

%
90.0

%
December 2023 warrants
September 30, 2025
December 31, 2024
Time to expiration
3.21
 Years
3.96
 Years
Common stock price
$
11.39

$
4.86

Risk-free interest rate
3.6

%
4.3

%
Volatility
100.0

%
90.0

%
Embedded derivatives
The Company estimated the fair value of the embedded conversion features in the 2021 Convertible Note and the AFG Convertible Notes using a binomial lattice model at inception and on subsequent valuation dates. This model incorporates inputs such as the stock price of the Company, dividend yield, risk-free interest rate, the effective debt yield and expected volatility. The effective debt yield and volatility involve unobservable inputs classified as Level 3 of the fair value hierarchy. On June 3, 2025, the Company repurchased the full $
122,868
 aggregate principal amount outstanding for the 2021 Convertible Note in a privately negotiated transaction. As such there was no derivative liability associated with the 2021 Convertible Note at September 30, 2025. On August 1, 2025 the Company issued a Notice of Redemption of Non-Affiliated Holders for all outstanding AFG Convertible Notes. As such, there was no derivative liability associated with the non-affiliated AFG Convertible Notes at September 30, 2025. Refer to Note 13, 
Borrowings
 for further information on the conversion of AFG Convertible Notes.
The inputs used to determine the fair value of the embedded derivative liabilities are as follows:
2021 Convertible Note
June 03, 2025
December 31, 2024
Term
1.08
 Years
1.50
 Years
Dividend yield
—

%
—

%
Risk-free interest rate
4.1

%
4.2

%
Volatility
60.0

%
65.0

%
Common stock price
$
3.86

$
4.86

Effective debt yield
24.0

%
30.0

%
40
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
15. Fair Value Measurement
 (cont.)
AFG Convertible Note
September 30, 2025
July 28, 2025
December 31, 2024
Term
9.00
 Years
0.93
 Years
1.50
 Years
Dividend yield
—

%
—

%
—

%
Risk-free interest rate
4.0

%
4.1

%
4.2

%
Volatility
60.0

%
60.0

%
65.0

%
Common stock price
$
11.39

$
6.18

$
4.86

Effective debt yield
20.9

%
23.2

%
30.0

%
Accounting for instruments resulting from the Credit and Securities Purchase Transaction
The Loan commitment assets were measured at fair value as of June 21, 2024 (see Note 3, 
Credit and Securities Purchase Transaction
). The fair value was $
76,091
 at issuance calculated using the discounted cash flow model. They will not be subsequently remeasured at fair value.
The following table summarizes instruments that were initially and subsequently measured at fair value. (see Note 3, 
Credit and Securities Purchase Transaction
):
Instrument
Initial measurement date
Initial Fair Value
Initial Draw of the Delayed Draw Term Loan
6/21/2024
$
25,653

SPA Warrant
6/21/2024
$
32,903

Contingent Warrants
6/21/2024
$
62,191

August Draw of the Delayed Draw Term Loan
8/29/2024
$
12,528

October Draw of the Delayed Draw Term Loan
10/31/2024
$
28,340

January Draw of the Delayed Draw Term Loan
1/24/2025
$
17,312

The fair value of each draw of the Delayed Draw Term Loan was estimated using a discounted cash flow (“DCF”) method, based on the contractual cash flows discounted at a debt yield and considering the probability of achieving certain milestones. 
The fair value for the SPA warrant is estimated based on its intrinsic value, using the Eos common stock closing price adjusted by a discount for lack of marketability (“DLOM”), less the exercise price of $
0.01
 for the SPA Warrant. A DLOM was applied considering the SPA Warrants are unregistered. 
The fair value of the Contingent Warrants is estimated based on the underlying Eos common stock closing price adjusted by a DLOM using Black-Scholes option pricing model, considering the probability of achieving certain milestones. A DLOM was applied considering the underlying shares of the Contingent Warrants were unregistered. 
The fair values for all the above instruments are designated as level 3 measurements as they rely on significant unobservable inputs. The significant unobservable inputs for each of these instruments are disclosed in the tables below. All other inputs used are observable.

Quantitative information about all significant unobservable inputs used in the fair value measurement for non-recurring level 3 measurements:
Loan Commitment Assets:
June 21, 2024
Milestones achievement expectations
Very high probability
Debt yield
47.5

%
41
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
15. Fair Value Measurement
 (cont.)
Quantitative information about all significant unobservable inputs used in the fair value measurement for recurring level 3 measurements:
Delayed Draw Term Loan Initial Tranche
June 21, 2024
December 31, 2024
September 30, 2025
Debt yield
47.5

%
30.0

%
20.8

%
Contingent Warrants- all tranches
June 21, 2024
December 31, 2024
Milestones achievement expectations
Very high probability
Very high probability
Volatility
70.0

%
65.0

%
Discount for lack of marketability (“DLOM”)
10.0

%
10.0

%
SPA Warrant
June 21, 2024
December 31, 2024
September 30, 2025
Discount for lack of marketability (“DLOM”)
10.0

%
10.0

%
5.0

%
Delayed Draw Term Loan August Draw
August 31, 2024
December 31, 2024
September 30, 2025
Debt yield
42.5

%
30.0

%
20.8

%
Delayed Draw Term Loan October Draw
October 31, 2024
December 31, 2024
September 30, 2025
Debt yield
42.5

%
30.0

%
20.8

%
Delayed Draw Term Loan January Draw
January 24, 2025
September 30, 2025
Debt yield
30.0

%
20.8

%
Delayed Draw Term Loan Prepayment
June 4, 2025
Debt yield
25.0

%
42
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
15. Fair Value Measurement
 (cont.)
Level 3 Rollforward for Liabilities Measured at Fair Value on a Recurring Basis
The following table summarizes the changes in the fair value of liabilities that are included within the Company’s accompanying Unaudited Condensed Consolidated Balance Sheets and are designated as Level 3:
Three Months Ended September 30,
Nine Months Ended September 30,
2025
2024
2025
2024
Delayed Draw Term Loan
Balance at beginning of the period
$
61,705

$
25,893

$
76,188

$
—

Additions - Initial Draw
—

—

—

25,653

Additions - August Draw
—

12,528

—

12,528

Additions - January Draw
—

—

17,312

—

Prepayment of the Term Loan
—

—

(
28,582
)
—

Change in fair value of Term Loan
21,353

7,678

18,140

7,918

Balance at end of the period
$
83,058

$
46,099

$
83,058

$
46,099

SPA Warrant and Contingent Warrants
Balance at beginning of the period
$
198,984

$
141,296

$
266,630

$
—

Additions
—

—

—

95,094

Conversion to preferred stock
—

(
74,686
)
(
102,185
)
(
74,686
)
Change in fair value of warrants
268,853

200,439

303,392

246,641

Balance at end of the period
$
467,837

$
267,049

$
467,837

$
267,049

April, May, and December 2023 Warrants
Balance at beginning of the period
$
181,093

$
32,450

$
189,322

$
27,406

Additions
—

—

—

—

Exercised warrants
(
18,827
)
—

(
39,166
)
—

Change in fair value of warrants
240,533

66,466

252,643

71,510

Balance at end of the period
$
402,799

$
98,916

$
402,799

$
98,916

Embedded derivatives
Balance at beginning of the period
$
51,639

$
5,414

$
44,396

$
4,423

Extinguishment of the 2021 Convertible Notes embedded derivatives
—

—

(
87
)
—

Extinguishment of the AFG Convertible Notes embedded derivatives
(
79,587
)
—

(
79,587
)
—

Change in fair value of derivatives 
58,988

12,595

66,318

13,586

Balance at end of the period
$
31,040

$
18,009

$
31,040

$
18,009

43
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
15. Fair Value Measurement
 (cont.)
The estimated fair value of financial instruments not carried at fair value in the Unaudited Condensed Consolidated Balance Sheets was as follows:
Level in fair value hierarchy
September 30, 2025
December 31, 2024
Carrying Value
Fair Value
Carrying Value
Fair Value
Notes receivable
3
$
—

$
—

$
847

$
740

Loan commitment assets
3
—

—

21,731

21,051

2021 Convertible Note*
3
—

—

109,838

91,951

2025 Convertible Notes
3
239,704

595,019

—

—

AFG Convertible Notes*
3
34,259

32,613

63,033

65,053

Equipment financing facility
3
730

721

2,385

2,097

Preferred Stock
3
1,223,364

1,279,075

488,696

454,581

DOE Loan Facility
3
90,704

94,443

65,452

67,740

  Total
$
1,588,761

$
2,001,871

$
751,982

$
703,213

*Includes the embedded derivative liabilities.
16. 
Commitments and Contingencies
Minimum Volume Commitment
In June 2022, the Company entered into a long-term supply agreement with a minimum volume commitment with a third party which provides services to process certain raw materials. Any purchase order issued under this supply agreement would have been non-cancellable. To the extent the Company failed to order the guaranteed minimum volume defined in the contract at the end of the term, the Company would have been required to pay the counterparty an amount equal to the shortfall, if any, multiplied by a fee. As part of the negotiations, during the fourth quarter of 2024, the Company paid the counterparty $
1,250
 as a shortfall penalty and transferred equipment with a net book value of approximately $
600
. As a result, the Company has been released of any minimum volume commitments as part of the original agreement. 
During the second quarter of 2025, the Company entered into a new long-term supply agreement with the third party for the processing of certain raw materials. The new long term-term supply agreement does not include any minimum volume commitments. Purchase orders that have been accepted by the third party shall not be modified or canceled except upon written agreement of the parties. 
Legal Proceedings
As of September 30, 2025, there have been no material developments or changes in the status of legal proceedings
.
17. 
Stock-Based Compensation
Stock-based compensation expense included in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss was as follows:
Three Months Ended September 30,
Nine Months Ended September 30,
2025
2024
2025
2024
Restricted stock units
$
4,134

$
2,461

$
13,479

$
6,995

Performance-based restricted stock units
829

3,681

6,185

3,681

Stock options
—

—

—

264

Total
$
4,963

$
6,142

$
19,664

$
10,940

44
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
17. Stock-Based Compensation 
(cont.)
The stock compensation expense has been recorded in cost of goods sold, research and development expenses and selling, general and administrative expenses.
Restricted Stock Units (“RSU”)
As of September 30, 2025, there was $
28,634
 of unrecognized compensation expense attributable to unvested RSUs, expected to be recognized over a weighted-average remaining vesting period of 
2.1
 years.
Performance-Based Restricted Stock Units (“PRSU”)
During the third quarter of 2024, the Company granted contingent shares to select key executives that may be earned based on the Company’s total shareholder return (“TSR”) over a 
two
 and 
three-year
 period following the grant date (“2024 TSR Awards”). During the second quarter of 2025, the Company also granted contingent shares to select key employees that may be earned based on the Company’s TSR over three individual one-year periods and a cumulative three-year period following the grant date (“2025 TSR Awards”). 
The payment of TSR awards is based on performance achieved in accordance with the scale set forth in the plan agreement and may range from 
0
% to 
200
% of the initial grant. TSR awards are paid out in stock at the end of the vesting period based on the Company’s stock performance. The performance is measured by determining the percentile rank of the total shareholder return of the Company’s common stock relative to the TSR of the Russell 2000 index peer group for the performance period following the grant date. This peer group includes the entire Russell 2000 index as it existed at the beginning of the performance period, excluding any companies that were removed from the index during the performance period. The fair value of the TSR awards is estimated using a Monte Carlo simulation in an option pricing framework.
The following summarizes the key assumptions used to estimate the fair value of the TSR awards that were granted, and the resulting weighted average grant date fair value. 
2025 TSR Awards
2024 TSR Awards
Company share price
$
4.54

$
1.74

Company volatility
117.2

%
115.3

%
Company correlation
30.6

%
36.1

%
Company dividend yield
—

%
—

%
Weighted average performance term
2.3
 years
2.4
 years
Weighted average risk-free interest rate
3.7

%
4.3

%
Peer group average volatility
55.9

%
54.3

%
Peer group average correlation
47.1

%
44.2

%
Weighted average grant date fair value
$
6.84

$
3.19

During the second quarter of 2025, the Company granted shares contingent upon the achievement of certain performance targets for fiscal year 2025 and continued employment through the vesting period. 
During the third quarter of 2024, the Company had also granted shares contingent upon the achievement of certain performance milestones related to the Credit Agreement that may be earned over the performance period following the grant date. The Company vested the PRSUs associated with the specific milestones achieved and forfeited the PRSUs associated with the final milestone.
As of September 30, 2025, there was $
6,176
 of unrecognized compensation expense attributable to unvested PRSUs, expected to be recognized over a weighted-average remaining vesting period of 
2.3
 years.
45
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
18. 
Income Taxes
Income tax expense (benefit) was $
4
 and $(
16
) for the three months ended September 30, 2025 and 2024, and $
15
 and $
17
 for the nine months ended September 30, 2025 and 2024, respectively, related to taxable earnings from foreign operations. The 2024 expense also includes state margin tax adjustments. The income tax expense differs from the amount computed by applying the statutory U.S. federal income tax rate of 21% to the loss before income taxes. This is due to fair value adjustments - debt and warrants, derecognition of loan commitment asset, Section 162(m) disallowance, foreign operations and pre-tax losses for which no tax benefit can be recognized for U.S. income tax purposes.
The Company estimates and applies the annual effective tax rate to its ordinary earnings each interim period. Any significant unusual or infrequent items are not included in the estimation of the annual effective tax rate; instead, these items and their related income tax expense are separately stated in the interim period in which they occur. The quarterly estimate of the annual effective tax rate and related tax expense is subject to variation due to a multitude of factors, including, but are not limited to, the inability to accurately predict the Company’s pre-tax and taxable income and loss.
At each balance sheet date, management assesses the likelihood that the Company will be able to realize its deferred tax assets. Management considered all available positive and negative evidence in assessing the need for a valuation allowance. The realization of deferred tax assets depends on the generation of sufficient taxable income of the appropriate character and in the appropriate taxing jurisdiction during the future periods in which the related temporary differences become deductible. Management has determined that it is unlikely that the Company will be able to utilize its U.S. deferred tax assets at September 30, 2025 and December 31, 2024 due to cumulative losses. Therefore, the Company has a valuation allowance against its net U.S. deferred tax assets.
As of September 30, 2025 and December 31, 2024, the Company has unrecognized tax benefits associated with uncertain tax positions that, if recognized, would not affect the effective tax rate on income from continuing operations. The Company is currently under examination by the IRS related to tax year 2022. The Company is not under examination by any other taxing jurisdictions and none of the unrecognized tax benefits are expected to reverse within the next 12 months.
The Company files income tax returns in U.S. federal and various state jurisdictions, as well as in Italy and India. The open tax years for federal returns are 2021 and forward and open tax years for state returns are generally 2019 and forward. In addition, net operating losses generated in closed years and utilized in open years are subject to adjustment by the tax authorities. 
On July 4, 2025, the One Big Beautiful Bill Act was signed into law, extending key provisions of the 2017 Tax Cuts and Jobs Act including, but not limited to, federal bonus depreciation, deductions for domestic research and development expenditures and the business interest expense limitation. The Company has evaluated the OBBBA enacted during the quarter and determined there is no impact on the financial statements. The Company is evaluating the future impact of the OBBBA; however, it does not anticipate a material impact.
See Note 11, 
Government Grants 
for impact of the OBBBA on the energy-related tax incentives.
19. 
Shareholders’ Deficit
Preferred Stock 
The Company is authorized to issue 
1,000,000
 shares of preferred stock with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s Board of Directors. The preferred stock has a par value of $
0.0001
. As of September 30, 2025 and December 31, 2024, there were 
no
 shares of preferred stock issued or outstanding.
46
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
19. Shareholders’ Deficit 
(cont.)
Common Stock
The Company is authorized to issue 
600,000,000
 shares of common stock at $
0.0001
 par value as of September 30, 2025. The holders of the Company’s common stock are entitled to 
one
 vote for each share held. At September 30, 2025 and December 31, 2024, there were 
281,688,395
 and 
221,791,205
 shares of common stock issued and outstanding, respectively. 
Treasury Stock
The Company recorded treasury stock of $
0
 and $
771
 for the three months ended September 30, 2025 and 2024 and $
488
 and $
1,122
 for the nine months ended September 30, 2025 and 2024, respectively, for shares withheld from employees to cover the payroll tax liability of RSUs vested. The treasury stock was immediately retired. 
Public Warrants
The Company sold warrants to purchase 
9,075,000
 shares of the Company’s common stock in a public offering on May 22, 2020 (the “Public Warrants”). Each Public Warrant entitles the holder to purchase a share of common stock at a price of $
11.50
 per share. For the three and nine months ended September 30, 2025, 
100
 of the Public Warrants were exercised. For the three and nine months ended September 30, 2024 
no
 Public Warrants were exercised. During the nine months ended September 30, 2025, 
50,000
 IPO warrants that were issued to various counterparties became public warrants. As of September 30, 2025 and December 31, 2024, there were 
7,102,154
 and 
7,052,254
 public warrants outstanding for both periods, respectively. 
At-the-Market Offering Program
The Company has a sales agreement with Cowen and Company, LLC (“Cowen”), with respect to an at-the-market offering (“ATM”) program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, having an aggregate offering price of up to $
200,000
 through Cowen as its sales agent and/or principal. 
During the three months ended September 30, 2024, 
no
 sales were made. During the nine months ended September 30, 2024 the Company sold 
16,627,523
 shares raising proceeds of $
14,089
, net of fees paid to Cowen, at an average selling price of $
0.87
 per share. 
No
 sales were made during the three and nine months ended September 30, 2025.
Public Offering
The Company entered into an underwriting agreement on May 29, 2025, with Jefferies LLC and J.P. Morgan Securities LLC as representatives of the several underwriters (collectively, the “Underwriters”) pursuant to which the Company agreed to sell 
18,750,000
 shares of the Company’s common stock at a public offering price of $
4.00
 per share. In addition, the Company granted the Underwriters an option, exercisable within 30 days after May 29, 2025, to purchase up to an additional 
2,812,500
 shares of the Company’s common stock. On May 30, 2025, the Underwriters exercised such option to purchase additional shares in full. The issuance and sale of 
21,562,500
 shares of the Company’s common stock was completed on June 2, 2025, raising proceeds of $
81,075
, net of fees paid to Jefferies LLC and J.P. Morgan Securities LLC.
AFG Convertible Notes
47
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
19. Shareholders’ Deficit 
(cont.)
During the quarter ended September 30, 2025 , the Company issued a Notice of Redemption of Non-Affiliated Holders for all outstanding AFG Convertible Notes, pursuant to which the Company intended to fully redeem the AFG Convertible Notes (other than those held by the Affiliated Purchaser) on August 18, 2025 for a redemption price equal to the then current capitalized principal amount of the AFG Convertible Notes (other than those held by the Affiliated Purchaser) plus the aggregate amount of all accrued and unpaid or un-capitalized interest payments on the capitalized principal amount of the AFG Convertible Notes (other than those held by the Affiliated Purchaser) that the holders of the AFG Convertible Notes to be redeemed would have been entitled to receive had the AFG Convertible Notes remained outstanding to June 30, 2026. In accordance with the terms of the AFG Indenture and the Notice of Redemption of Non-Affiliated Holders, each of the holders of the AFG Convertible Notes (other than those held by the Affiliated Purchaser) opted to exercise its conversion right to convert all of such holder’s outstanding AFG Convertible Notes into shares of Common Stock at a conversion rate equal to 598.8024 shares of Common Stock per $1,000 capitalized principal amount of AFG Convertible Notes. During the third quarter of 2025, the Company issued 
16,578,810
 shares of Common Stock in the aggregate to such holders of the AFG Convertible Notes (other than those held by the Affiliated Purchaser).

20. 
Earnings Per Share
Generally, basic earnings per share (“EPS”) is computed by dividing earnings available to common shareholders by the weighted average number of shares of common stock outstanding during the period. The SPA Warrant, Series B Preferred Stock, 2023 Warrants, and 2025 Convertible Notes are participating securities that do not have the obligation to share in the losses of the Company. Therefore, the more dilutive of the “if-converted” and “two-class” method must be applied when calculating EPS for the common shares.  
Management has elected to recognize changes in the redemption value of the Series B Preferred Stock. At each balance sheet date, the redemption value of the Series B Preferred Stock will be calculated, and if the redemption value is greater than the carrying value, the carrying value will be accreted to the redemption value. The remeasurement is recorded as a deemed dividend, which, in the absence of Retained earnings, reduces additional paid in capital and earnings available to common shareholders in computing basic and diluted EPS. Other potentially dilutive common shares and the related impact to earnings are considered when calculating EPS on a diluted basis.
Since the Company incurred a net loss for the three and nine months ended September 30, 2025 and September 30, 2024, the potential dilutive shares from stock options, restricted stock units, warrants, and convertible notes were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented. Therefore, basic and diluted EPS are computed using the same number of weighted-average shares for the three and nine months ended September 30, 2025 and September 30, 2024. 
The following potentially dilutive shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the three and nine months ended September 30, 2025 and September 30, 2024:
Three and Nine Months Ended September 30,
2025
2024
Stock options, RSUs, PRSUs
15,920,169

26,966,240

Public and private placement warrants
91,120,464

104,397,933

Convertible Notes (if converted)
57,603,462

17,782,644

Series B Preferred Stock
116,311,460

60,746,526

48
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
21. 
Segment Reporting
The Company’s chief operating decision-maker (“CODM”) is its Chief Executive Officer and President. Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the CODM in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. As such, the Company has determined that it operates in 
one
 operating and 
one
 reportable segment.
The Company designs, develops, manufactures, and markets innovative zinc-based energy storage solutions for utility-scale, microgrid and commercial & industrial (C&I) applications. The Company operates and holds long-lived assets in a single geographical region, with nearly all of its revenue coming from customers in the United States. 
The CODM reviews financial information on a consolidated basis and uses Gross profit (loss) and Net income (loss) to assess financial performance considering budget-to-actual variances when making key decisions on how to allocate company resources. 
The Company’s segment information is summarized as follows:
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
2025
2024
2025
2024
Product revenue
$
30,209

$
368

$
54,191

$
7,465

Service revenue
303

486

2,014

888

Total revenue
30,512

854

56,205

8,353

Less:
Cost of goods sold
64,437

25,764

145,622

68,114

Gross profit (loss)
(
33,925
)
(
24,910
)
(
89,417
)
(
59,761
)
Less:
Research and development
6,925

7,428

20,963

16,878

General and administrative
19,786

17,796

66,269

43,331

Other segment items
(a)
580,757

292,732

672,545

297,776

Net income (loss)
$
(
641,393
)
$
(
342,866
)
$
(
849,194
)
$
(
417,746
)
(a) Other segment items include loss from write-down of property, plant and equipment, interest expense, net, change in fair value of debt, change in fair value of warrants, change in fair value of derivatives, (Loss) gain on debt extinguishment and costs related to the credit and securities purchase transaction.

Additional segment financial information is summarized as follows:
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
2025
2024
2025
2024
Segment assets
$
328,210

$
216,841

$
328,210

$
216,841

Depreciation and amortization
$
3,365

$
2,691

$
8,980

$
5,259

Interest income
$
1,161

$
12

$
2,826

$
282

Interest expense
$
5,167

$
5,436

$
19,416

$
23,251

Capital expenditures
(b)
$
17,757

$
9,763

$
29,716

$
20,062

(b) Includes Intangible assets.
49
Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(In thousands, except share and per share amounts)
22. 
Subsequent Events
At the Special Meeting of Stockholders of the Company, held on October 16, 2025, the Company’s stockholders approved, for purposes of complying with Nasdaq Listing Rules, including, but not limited to, Rule 5635, the Company’s issuance of shares of the Company’s common stock to the Affiliated Purchaser upon redemption or conversion of the AFG Convertible Notes pursuant to the AFG Indenture as supplemented by the First Supplemental Indenture. As a result, on October 24, 2025 the Company issued a notice of redemption to the Affiliated Purchaser for all outstanding AFG Convertible Notes held by the Affiliated Purchaser, pursuant to which the Company intended to fully redeem the remaining AFG Convertible Notes on November 10, 2025 for a redemption price equal to the then current capitalized principal amount of the AFG Convertible Notes plus the aggregate amount of all accrued and unpaid or un-capitalized interest payments on the capitalized principal amount of the AFG Convertible Notes that the Affiliated Purchaser would have been entitled to receive had the AFG Convertible Notes remained outstanding at June 30, 2026. In accordance with the terms of the AFG Indenture and the notice of redemption, on October 28, 2025, the Affiliated Purchaser opted to exercise its conversion right to convert all of its outstanding AFG Convertible Notes into shares of Common Stock at a conversion rate equal to 598.8024 shares of Common Stock per $1,000 capitalized principal amount of AFG Convertible Notes. On November 4, 2025, the Company issued 
2,863,291
 shares of Common Stock to the Affiliated Purchaser.
On October 20, 2025, the Company entered into a non-cancelable lease agreement for approximately 
41,000
 rentable square feet of office space located in Pittsburgh, Pennsylvania. The lease term is 
12.0
 years with total minimum lease payments of approximately $
16.4
 million.
On October 20, 2025, the Company entered into a non-cancelable lease agreement for approximately 
432,000
 rentable square feet of manufacturing space in Marshall Township, Pennsylvania. The lease term is 
10.5
 years with total minimum lease payments of approximately $
42.4
 million.
On October 31, 2025, the Company issued a press release announcing, among other matters, the satisfaction of its final performance milestones comprising of Sales Milestone 4 for the Fourth Milestone Test Date, as defined under the Credit Agreement, pursuant to the terms thereof. No additional preferred stock or warrants will be issued to Cerberus at this time.
50
Table of Contents
,MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion should be read in conjunction with the accompanying Unaudited Condensed Consolidated Financial Statements for the nine months ended September 30, 2025 and 2024 and the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, including the financial statements and notes thereto.
Overview
The Company offers an innovative Znyth™ technology battery energy storage system ("BESS") designed to provide the operating flexibility to manage increased grid complexity and price volatility resulting from an overall increase in renewable energy generation and a congested grid coming from an increase in electricity demand growth. The Company’s BESS utilizes a validated chemistry with accessible non-precious earth components in a durable design that is intended to deliver results in even the most extreme temperatures and conditions. The system is designed to be safe, flexible, scalable, sustainable and manufactured in the United States using raw materials primarily sourced in the United States. We believe the Company’s Z3™ battery module is the core of its innovative systems. The Z3 battery module is the only US designed and manufactured battery module that today provide utilities, independent power producers, renewables developers and C&I customers with an alternative to lithium-ion and lead-acid monopolar batteries for critical 3- to 12-hour discharge duration applications. We believe the Z3 battery will transform how utility, industrial and commercial customers store power.
In addition to its BESS, the Company currently offers: (a) a Battery Management System (“BMS”) which provides a remote asset monitoring capability and service to track the performance and health of the Company’s BESS and to proactively identify future system performance issues through predictive analytics; (b) project management services to ensure the process of implementing the Company’s BESS are coordinated in conjunction with the customer’s overall project plans; (c) commissioning services that ensure the customer’s installation of the BESS meets the performance expected by the customer; and (d) long-term maintenance plans to maintain optimal operating performance of the Company’s systems
.
The Company’s growth strategy contemplates increasing sales of battery energy storage systems and related software and services through a direct sales team and sales channel partners. The Company’s current and target customers include utilities, project developers, independent power producers and commercial and industrial companies. 
Strategy
The Company continues to invest in the design, development, and production of its next-generation product, the Eos Z3 battery. This new battery builds upon the same electrochemistry that has remained largely unchanged for nearly a decade. The Eos Z3 is engineered to reduce costs and weight while enhancing manufacturability and overall system performance. Compared to the previous Gen 2.3, the Z3 features a more cost-effective design with a simplified tub structure, 50% fewer cells, and 98% fewer welds per battery module. We believe that the Eos Z3 will offer customers twice the energy density per square foot, while maintaining the same level of safety and reliability as the previous generation.
The transition to the Eos Z3 is progressing as planned, with the first fully-automated battery manufacturing line now installed and in commercial production. The Z3 uses the same chemistry, known for its ability to endure over 3 million cycles, but introduces a new mechanical design aimed at improving performance, reducing costs, and enhancing manufacturability. The Company began delivering Z3 battery modules in the third quarter of 2023. The Z3 incorporates valuable lessons learned from the past fifteen years, which the Company expects will drive efficiencies as it scales its state-of-the-art manufacturing capabilities.
The Company believes that the simplicity, flexibility, and safety of its products are key attributes desired by the market. Moreover, the Company recognizes the competitive advantage offered by the Inflation Reduction Act, which provides production tax credits (PTC) for domestically manufactured battery components, as well as tax credits for customers involved in projects meeting domestic content requirements. The Company also plans to collaborate with a consortium of community leaders, universities, and supply chain partners to pursue funding opportunities under the Bipartisan Infrastructure Law of 2021.
51
Table of Contents
U.S. Department of Energy (“DOE”)
On November 26, 2024, the Company entered into the DOE Loan Facility. The DOE Loan Facility is a key step in advancing the Company's Project American Made Zinc Energy ("AMAZE") and is expected to fund the expansion of Eos’ manufacturing capacity to 8 GWh by 2027 to meet the growing demand for longer duration battery energy storage systems. 
The DOE Loan Facility provides for a multi draw term loan facility under a series of at least two and, if the Company elects, up to four tranches of the loan (each, a “Tranche”), subject to the achievement of certain funding conditions, with each Tranche corresponding to the production, maintenance and development, and operation of a given production line to be funded using the proceeds of such Tranche and the principal amount of each Tranche consisting of a maximum principal amount designated for such Tranche in the DOE Loan Facility. Each Tranche provides the Company funding for 80% of the Eligible Project Costs (as defined in the DOE Loan Facility) associated with the corresponding production line, with the Company responsible for funding the remaining 20% of the Eligible Project Costs. 
Through September 30, 2025, the Company has received funding under the DOE Loan Facility for an aggregate amount of $90.9 million. The initial draw of $68.3 million was made at an interest rate of 4.791%, for eligible project costs incurred through December 6, 2024. The second draw of $22.7 million was made at an interest rate of 4.286%, for eligible project costs incurred through June 4, 2025. These costs are a portion of Tranche 1 of the DOE Loan Facility. Tranche 1 provides up to $90.9 million for eligible costs in connection with the design, construction, installation, startup and shakedown of a battery automation line and related tools, with a projected annual production capacity of approximately 1.25 GWh ("Line 1"). The DOE Loan Facility provides for up to $303.5 million in funding, including capitalized interest. On June 12, 2025, the Company delivered to the DOE and the FFB a second advance request, and on July 1, 2025, the FFB funded $22.7 million under the DOE Loan Facility (the “second loan advance”).
Inflation Reduction Act of 2022 (“IRA”)
On August 16, 2022, President Biden signed the Inflation Reduction Act of 2022 into law. The IRA has significant economic incentives for both energy storage customers and manufacturers for projects placed in service after December 31, 2022. One of the most important features of the IRA is that it offers a 10-year term tax credit, whereas historically similar industrial credits have been shorter in duration. Customers p
lacing new energy storage facilities in service, which include our Gen 2.3 and Z3™ BESS, could qualify for an investment tax credit (“ITC”). In December 2024, the IRS and U.S. Department of the Treasury published final regulations that clarified certain investment tax credit eligibility requirements for Section 48 energy investment tax credits that were enacted as part of the IRA. The IRA offers an extra ten percent credit if the project is in an “energy community” and another ten percent credit if the project satisfies domestic content requirements. The ten percent bonus for domestic content could represent a strategic advantage for the Company resulting from the Company’s near-sourcing and Made in America strategy, and we believe that projects utilizing Eos batteries qualify for the bonus and meet safe harbor requirements. The Company is observing accelerated customer activity in 2025 as customers seek to commence construction and incur qualifying costs prior to the end of 2025 in order to secure eligibility for the current ITC safe harbor provisions, before fully transitioning to the technology-neutral Section 48E framework effective for projects initiated thereafter.
Production Tax Credits under Internal Revenue Code 45X (“PTC”) can be claimed on battery components ma
nufactured in the U.S. and sold to U.S. or foreign customers. These tax credits available to manufacturers include a credit for ten percent of the cost incurred to make electrode active materials in addition to credits of $35 per kWh of capacity of battery cells and $10 per kWh of capacity of battery modules. These credits are cumulative, meaning that companies will be able to claim each of the available tax credits based on the battery components produced and sold through 2029, after which the PTC will begin to gradually phase down through 2032.
The OBBBA also introduces new limitations related to the sourcing of materials from foreign entities of concern (“FEOCs”) starting after December 31, 2025. These provisions restrict eligibility for credits where material assistance is received from such entities. The Company is evaluating the future impact of the OBBBA; however, it does not anticipate a material impact from either the material sourcing or ownership-related provisions. The Company will evaluate additional guidance as it becomes available. 
Company Highlights
•
In January 2025, the Company successfully achieved all operational milestones that guaranteed the final $40.5 million under the fully funded $210.5 million Delayed Draw Term Loan ("DDTL") to further solidify its position as a leader in American energy storage systems. Successfully meeting these performance milestones will enable the Company to fuel its ongoing operations, U.S. production expansion, and the creation of an American energy storage powerhouse, without the need to raise additional capital via debt or additional equity offerings.
52
Table of Contents
•
With the Delayed Draw Term Loan fully funded, combined with DOE Loan Facility's first disbursement in December 2024, Eos has a strong foundation and sufficient capital to continue implementing Project AMAZE. The Company is executing its strategy to scale production into strong customer demand for long duration energy storage. Cash from customer projects now play an important role in funding working capital and our American-made system can play a critical role in America achieving energy independence. The $210.5 million Delayed Draw Term Loan is now fully funded, driven by the Company consistently achieving key operational milestones related to the Company’s state-of-the-art manufacturing line, raw materials cost-out, Z3 technology performance improvement and orders backlog cash conversion. The Company surpassed its January raw materials cost-out target by 6% while delivering manufacturing cycle times below 10 seconds to further demonstrate continued operational efficiency and progress.
•
In March 2025, the Company announced an $8 million standalone BESS order for the Naval Base of San Diego. Fully funded by a grant from the California Energy Commission (“CEC”), this order highlights Eos’ critical role in supporting U.S. national security infrastructure with American-made energy storage. 
•
In March 2025, the Company announced Nathan Kroeker’s transition from Chief Financial Officer role to become Eos' Chief Commercial Officer. Nathan's background as Chief Financial Officer gives him a unique advantage in understanding both the financial and commercial landscapes of the industry, allowing him to create customer-centric solutions that are not only impactful, but also financially sustainable.
•
In March 2025, the Company announced that Joseph Nigro, former CFO of Exelon Corporation (NADSDAQ: EXC) and CEO of Constellation Energy (then operating division of Exelon), joined the Company’s Board of Directors.
•
In April 2025, the Company announced it has signed a memorandum of understanding with Frontier Power Ltd. (“Frontier”), a UK-based energy developer, for a 5 GWh energy storage framework agreement. The agreement marks Eos’ entrance into a new international market and supports Frontier’s plans to submit multiple bids utilizing Eos’ Znyth™ battery technology in the first application window of Ofgem’s new long-duration energy storage (LDES) cap and floor scheme.
•
In May 2025, the Company announced it has secured an order with Faraday Microgrids to deploy a 3 MW / 15 MWh Eos Z3™ system for a commercial microgrid application on tribal land in California.
•
In May 2025, the Company announced an offering of 18,750,000 shares of common stock with an option, exercisable within 30 days after May 29, 2025, to purchase up to an additional 2,812,500 shares of the Company’s common stock at a price to the public of $4.00 per share, made pursuant to the Securities Act of 1933. The Underwriters exercised this option to purchase additional shares in full. The issuance and sale of 21,562,500 shares of the Company’s common stock was completed in June 2025, raising net proceeds of $81.1 million, after deducting underwriting discounts and commissions. 
•
In June 2025, the Company issued an offering of $225.0 million aggregate principal amount of 6.75% convertible senior notes due 2030 in a private offering. The Company granted initial purchasers an option to purchase, for settlement within a period of thirteen days from the date the 2025 Convertible Notes were first issued, up to an additional $25.0 million principal amounts which were exercised in full.
•
In July 2025, the Company received its second loan advance from the DOE Loan Programs Office in the amount of $22.7 million under the DOE loan facility. The Company has fully drawn the maximum allowable amount under the first tranche of $90.9 million in connection with the completion of its first state-of-the-art manufacturing line. 
•
In August 2025, the Company appointed industry veteran John Mahaz as Chief Operating Officer to lead the Company’s operations, supply chain and manufacturing strategy as the Company enters a critical phase of commercial scale-up. 
•
In September 2025, the Company announced the launch of its new proprietary battery management system, software, controls and analytics platform, DawnOS, designed to revolutionize the way energy storage systems are managed, optimized and integrated into the grid. Fully designed, engineered, and developed in the United States, DawnOS represents a new standard in American-made battery energy storage software – with technical excellence and national security designed into the platform.
53
Table of Contents
Results of Operations
Revenue
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
($ in thousands)
2025
2024
$ Change
% Change
2025
2024
$ Change
% Change
Revenue
$
30,512 
$
854 
29,658 
3473 
%
$
56,205 
$
8,353 
47,852 
573 
%
The Company generates revenues from the delivery of its BESS and service-related solutions. The Company expects revenues to increase as it scales production to meet customer demand. 
For the three months ended September 30, 2025, Revenue increased by $29.7 million or 3,473% from $0.9 million. For the nine months ended September 30, 2025, Revenue increased by $47.9 million or 573% from $8.4 million. The increase for the three and nine months was due to higher product sales and higher selling price. 
Cost of goods sold
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
($ in thousands)
2025
2024
$ Change
% Change
2025
2024
$ Change
% Change
Cost of goods sold
$
64,437 
$
25,764 
38,673 
150 
%
$
145,622 
$
68,114 
77,508 
114 
%
Cost of goods sold primarily consists of direct costs relating to labor, material and overhead directly tied to product assembly, procurement and construction (“EPC”), project delivery, commissioning and start-up test procedures. Indirect costs included in cost of goods sold are manufacturing overhead such as equipment maintenance, environmental health and safety, quality and production control procurement, transportation, logistics, depreciation and facility-related costs. As a nascent technology with a new manufacturing process that is early in its product lifecycle, the Company still faces significant costs associated with production start-up, commissioning of various components, modules and subsystems and other related costs. The Company expects its cost of goods sold to exceed revenues in the near term as it continues to scale production and prepares battery energy storage systems delivered to customers to go-live.
For the three months ended September 30, 2025, Cost of goods sold increased by $38.7 million or 150% from $25.8 million. For the nine months ended September 30, 2025, Cost of goods sold increased by $77.5 million or 114% from $68.1 million. The increase for the three and nine months ended September 30, 2025 was primarily due to an increase in product sales volume, partially offset by a decrease in unit production cost.
Research and development expenses
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
($ in thousands)
2025
2024
$ Change
% Change
2025
2024
$ Change
% Change
R&D expenses
$
6,925 
$
7,428 
(503)
(7)
%
$
20,963 
$
16,878 
4,085 
24 
%
Research and development expenses consist primarily of salaries and other personnel-related costs, materials, third-party services, depreciation and amortization of intangible assets.
For the three months ended September 30, 2025, Research and development costs decreased by $0.5 million or 7% from $7.4 million. For the nine months ended September 30, 2025, Research and development costs increased by $4.1 million or 24% from $16.9 million. The decrease for the three months was driven by a reduction in materials and supplies costs. The increase for the nine months was driven by higher payroll, stock based compensation and consulting costs for key growth areas in support of scaling the business, partially offset by a reduction in materials and supplies costs.
54
Table of Contents
Selling, general and administrative expenses
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
($ in thousands)
2025
2024
$ Change
% Change
2025
2024
$ Change
% Change
SG&A expenses
$
19,786 
$
17,796 
1,990 
11 
%
$
66,269 
$
43,331 
22,938 
53 
%
Selling, general and administrative expenses primarily consist of payroll, personnel cost, outside professional services, facilities, depreciation, travel, marketing and public company costs.
For the three months ended September 30, 2025, Selling, general and administrative expenses increased by $2.0 million or 11% from $17.8 million. For the nine months ended September 30, 2025, Selling, general and administrative expenses increased by $22.9 million or 53% from $43.3 million. The increase for the three and nine months was primarily driven by payroll and stock based compensation costs relating to expanded headcount in key growth areas in support of scaling the business. The increase in Selling, general and administrative expenses for the three and nine months ended September 30, 2025 includes one-time costs of $0.2 million and $3.9 million, respectively, which the Company does not expect to incur in future periods.
Loss from write-down of property, plant and equipment
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
($ in thousands)
2025
2024
2025
2024
Loss from write-down of property, plant and equipment
$
585 
$
3,192 
$
1,351 
$
3,528 
The Company incurred a loss of $0.6 million and $3.2 million from write-down of property, plant and equipment for the three months ended September 30, 2025 and 2024, respectively, and a loss of $1.4 million and $3.5 million for the nine months ended September 30, 2025 and 2024, respectively. The write-downs were mainly due to design changes from the Z3™-Phase 1 to Z3™-Phase 2 production in which the Phase 1 production assets could not be utilized or repurposed for Phase 2 production. Additionally, the loss from write-down of property, plant and equipment contains costs for disposal of miscellaneous equipment and tooling that cannot be repurposed for more automated processes.
Interest expense, net
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
($ in thousands)
2025
2024
2025
2024
Interest expense, net
$
(4,846)
$
(133)
$
(7,139)
$
(7,915)
Interest expense, net includes expenses for accrued interest, amortization of debt issuance costs and debt discounts, partially offset by capitalized interest costs on CIP assets. For the three months ended September 30, 2025, Interest expense, net increased by $4.7 million primarily due to interest expense relating to the 2025 Convertible Notes. For the nine months ended September 30, 2025, Interest expense, net decreased by $0.8 million, mainly due to lower interest expense recognized from the Senior Secured Term Loan due to the payoff of the Atlas Credit Facility in 2024, offset by interest expense relating to the 2025 Convertible Notes. 
Interest expense - related party
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
($ in thousands)
2025
2024
2025
2024
2021 Convertible Note Payable interest and amortization
$
— 
$
(3,667)
$
(6,613)
$
(10,563)
AFG Convertible Note interest and amortization
840 
(1,624)
(2,838)
(4,491)
     Interest expense, related party
$
840 
$
(5,291)
$
(9,451)
$
(15,054)
See Note 13, 
Borrowings
 to our Unaudited Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report for further discussion. 
55
Table of Contents
Change in fair value of debt - related party
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
($ in thousands)
2025
2024
2025
2024
Change in fair value of debt - related party
$
(3,570)
$
(3,036)
$
22,112 
$
(3,276)
For the three months ended September 30, 2025, the Change in fair value of debt - related party decreased by $0.5 million, primarily due to the passage of time. For the nine months ended September 30, 2025, the Change in fair value of debt - related party increased by $25.4 million. The increase was primarily due to a decrease in the loan principal balance partially offset by the reduction in the contractual interest rate from 15% to 7% per annum of the Delayed Draw Term Loan.
Change in fair value of warrants
For the three and nine months ended September 30, 2025 and 2024, the change in fair value of warrants was composed of the items below:
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
($ in thousands)
2025
2024
2025
2024
IPO warrants
$
(292)
$
(2)
$
(193)
$
1 
April 2023 warrants
(91,840)
(16,810)
(95,921)
(17,902)
May 2023 warrants
(21,036)
(4,099)
(21,921)
(4,373)
December 2023 warrants
(127,657)
(45,557)
(134,801)
(49,235)
     Change in fair value of warrants
$
(240,825)
$
(66,469)
$
(252,836)
$
(71,510)
Change in fair value of derivatives - related parties
Gain (Loss)
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
($ in thousands)
2025
2024
2025
2024
Change in fair value of embedded derivatives - related parties
$
(58,988)
$
(12,595)
$
(66,318)
$
(13,586)
Change in fair value of warrants - related parties
(268,853)
(200,439)
(303,392)
(246,641)
     Change in fair value of derivatives - related parties
$
(327,841)
$
(213,034)
$
(369,710)
$
(260,227)
The change in the fair value of embedded derivatives - related parties, was due to our convertible debt (See Note 13
, Borrowings
) and the change in fair value of warrants - related parties was due to changes in fair value of our SPA Warrant and contingent warrants (See Note 14
, Warrants Liability
).
(Loss) gain on debt extinguishment
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
($ in thousands)
2025
2024
2025
2024
(Loss) gain on debt extinguishment
$
(3,589)
$
— 
$
(52,652)
$
68,478 
For the three months ended September 30, 2025, the Company recognized a loss on debt extinguishment of $3.6 million from the modification of the non-affiliate portion of the AFG Convertible Notes. For the nine months ended September 30, 2025, the Company recognized a loss on debt extinguishment of $52.7 million from the payoff of the 2021 Convertible Notes, prepayment of the Delayed Draw Term Loan and modification of the non-affiliate portion of the AFG Convertible Notes.
For the nine

months ended September 30, 2024, the Company recognized a gain on debt extinguishment of $68.5 million from the payoff of the Senior Secured Term Loan.
56
Table of Contents
Other expense
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
($ in thousands)
2025
2024
2025
2024
Other expense
$
(337)
$
(1,593)
$
(1,503)
$
(4,727)
For the three months ended September 30, 2025, Other expense of $0.3 million primarily relates to costs associated with professional fees related to the amendment of the AFG Convertible Notes. For the nine months ended September 30, 2025, Other expense of $1.5 million primarily relates to costs associated with professional fees related to the Cerberus Amendments, extinguishment of the 2021 Convertible Notes, recognition of financing issuance costs from the Credit and Securities Purchase Transaction and professional fees associated with the amendment of the AFG Convertible Notes. 
For the three and nine months ended September 30, 2024, Other expense of $1.6 million and $4.7 million, respectively, primarily relates to recognition of financing issuance costs from the Credit and Securities Purchase Transaction.
Income tax expense (benefit)
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
($ in thousands)
2025
2024
2025
2024
Income tax expense (benefit)
$
4 
$
(16)
$
15 
$
17 
The Company incurred income tax expense for the three and nine months ended September 30, 2025 and 2024, attributable to taxable earnings from the Company’s foreign operations which were insignificant for all periods presented. 
Liquidity and Going Concern
As a growth company in the early commercialization stage of its lifecycle, Eos is subject to inherent risks and uncertainties associated with the development of an enterprise. In this regard, substantially all of the Company’s efforts to date have been devoted to the development and manufacturing of battery energy storage systems and complementary products and services, recruitment of management and technical staff, deployment of capital to expand the Company’s operations to meet customer demand and raising capital to fund the Company’s development. However, as a result of these efforts, the Company has incurred significant losses and negative cash flows from operations since its inception and expects to continue to incur such losses and negative cash flows for the foreseeable future until such time that the Company can reach a scale of profitability to sustain its operations.
In order to execute its development strategy, the Company has historically relied on outside capital through the issuance of equity, debt and borrowings under financing arrangements (collectively “outside capital”) to fund its cost structure. While the Company believes its recent entry into new credit facilities as discussed below has significantly improved its capital position and provides a path to sustainable operations and profitability, there can be no assurance the Company will be able to achieve such profitability or do so in a manner that does not require additional outside capital. Moreover, while the Company has historically been successful in raising outside capital, there can be no assurance the Company will be able to continue to obtain outside capital in the future or do so on terms that are acceptable to the Company.
As disclosed in Note 3, Credit and Securities Purchase Transaction, on June 21, 2024, the Company entered into a financing transaction with CCM Denali Debt Holdings, LP, an affiliate of Cerberus Capital Management LP (herein after referred to as “Cerberus”, “Denali”, “Lender”, “Holder”). As a result of this transaction, Cerberus agreed to provide a $210.5 million secured multi-draw facility to be made in four installments (the “Delayed Draw Term Loan”) as well as a $105.0 million revolving credit facility (“Revolving Facility”), to be made available beginning June 21, 2026, at Cerberus’ sole discretion and only if the Delayed Draw Term Loan is fully funded. As of the date the accompanying Unaudited Condensed Consolidated Financial Statements were issued (the “issuance date”), the Delayed Draw Term Loan was fully funded. As part of the Credit and Securities Purchase Transaction, Cerberus received warrants and preferred stock resulting in a 33% ownership position in the Company as of January 24, 2025, the most recent milestone measurement date.
57
Table of Contents
As disclosed in Note 13, 
Borrowings
, on November 26, 2024, the Company successfully closed on the DOE Loan Facility, which provides the Company with up to $303.5 million in funding, including capitalized interest, subject to the achievement of certain funding conditions. The DOE Loan Facility provides for a multi draw term loan facility under a series of at least two tranches and, if the Company elects, up to four tranches, subject to the achievement of certain conditions. Each tranche corresponds to the production, maintenance and development, and operation of a given production line to be funded using the proceeds of such tranche. The DOE Loan Facility specifies the maximum amount subject to each tranche (Tranche 1: $102.0 million; Tranche 2: $117.3 million; Tranche 3: $71.8 million; and Tranche 4: $12.3 million), and any amounts which are not withdrawn under a specified tranche cannot be allocated to another tranche. On April 16, 2025, the Company amended the DOE Loan Facility in order to clarify the maximum Tranche Commitment principal amounts by excluding capitalized interest (Tranche 1: $90.9 million; Tranche 2: $106.7 million; Tranche 3: $67.5 million; and Tranche 4: $12.3 million). The Amendment does not materially alter rights, obligations, or meaning of the DOE Loan Facility. Through September 30, 2025, the Company had drawn down $90.9 million under Tranche 1.
As disclosed in Note 19, 
Shareholders’ Deficit, t
he Company entered into an underwriting agreement on May 29, 2025, with Jefferies LLC and J.P. Morgan Securities LLC as representatives of the several underwriters (collectively, the “Underwriters”) pursuant to which the Company agreed to sell 18,750,000 shares of the Company’s common stock at a public offering price of $4.00 per share. In addition, the Company granted the Underwriters an option, exercisable within 30 days after May 29, 2025, to purchase up to an additional 2,812,500 shares of the Company’s common stock. On May 30, 2025, the Underwriters exercised such option to purchase additional shares in full. The issuance and sale of 21,562,500 shares of the Company’s common stock was completed on June 2, 2025, raising proceeds of $81.1 million, net of fees paid to Jefferies LLC and J.P. Morgan Securities LLC.
As disclosed in Note 13, Borrowings, on June 3, 2025, the Company issued $225 million principal amounts of Convertible Notes due 2030 (herein after referred to as the “2025 Convertible Notes”). The Company granted initial purchasers an option to purchase, for settlement within a period of thirteen days from the date the 2025 Convertible Notes were first issued, up to an additional $25 million principal amounts, which was exercised in full. The 2025 Convertible Notes accrues interest at a rate of 6.75% per annum, payable semi-annually in arrears on June 15 and December 15. The 2025 Convertible Notes will mature on June 15, 2030, subject to earlier conversion, redemption or repurchase.
As of the issuance date, management evaluated the significance of the following negative financial conditions in accordance with Accounting Standard Codification 205-40, Going Concern:   
•
Since its inception, the Company has incurred significant losses and negative cash from operations in order to fund its development. During the nine months ended September 30, 2025, the Company had incurred a net loss of $849.2 million, Adjustments to reconcile net loss to cash used in operations are primarily from non-cash items on the Unaudited Condensed Consolidated Statements of Cash Flows. The non-cash items totaled $691.7 million. During the nine months ended September 30, 2025, the Company incurred negative cash flows from operations of $160.9 million and had an accumulated deficit of $2,415.4 million as of September 30, 2025.
•
As of September 30, 2025, the Company had $58.7 million of unrestricted cash and cash equivalents available to fund the Company’s operations

and working capital of $85.4 million.
•
On June 21, 2024, upon closing of the Credit and Securities Purchase Transaction, Cerberus funded the Company $75.0 million of the initial draw, and the Company received $71.3 million net of the 5.0% original issue discount. On August 29, 2024, Cerberus funded the Company $30.0 million (“August Draw”), and the Company received $28.5 million, net of the 5.0% original issue discount. On November 1, 2024, Cerberus funded the Company $65.0 million related to the October 31, 2024 tranche (“October Draw” or “October Tranche”), and the Company received $61.8 million, net of the 5.0% original issue discount. On January 24, 2025, Cerberus funded the Company the final $40.5 million and the Company received $38.5 million, net of the 5.0% original issue discount, related to the January 31, 2025 tranche (“January 2025 Draw”). Subsequent to the January 2025 Draw, the Delayed Draw Term Loan has been fully funded.
•
As of September 30, 2025, the Company had drawn down $90.9 million under the DOE Loan Facility, utilizing the full commitment available for Tranche 1. The initial draw of $68.3 million was made to cover eligible project costs incurred through December 6, 2024, followed by a second draw of $22.7 million for eligible project costs incurred through June 4, 2025. Tranche 1 provided funding for eligible costs in connection with the design, construction, installation, startup and shakedown of a battery automation line and related tools. In the event the Company does not achieve certain funding milestone conditions and the DOE chooses not to continue funding for the remaining tranches, the Company would need to seek alternative sources of capital, which may not be available on favorable terms or at all. 
58
Table of Contents
•
The Credit and Securities Purchase Transaction and the DOE Loan Facility contain certain quarterly financial covenants, which include (a) Minimum Liquidity, (b) Minimum Consolidated EBITDA, and (c) Minimum Consolidated Revenue (collectively, the “financial covenants”). As of September 30, 2025, the only financial covenant in effect was Minimum Liquidity. As of September 30, 2025, the Company was in compliance with this covenant and non-financial covenants, and the Company expects to remain in compliance with the Minimum Liquidity covenant over the next twelve months beyond the issuance date. The applicability of the Consolidated Revenue and EBITDA financial covenants were deferred until March 31, 2027.
•
In the event the Company’s ongoing efforts to raise additional outside capital are unsuccessful, the Company will be unable to meet its obligations as they come due over the next twelve months beyond the issuance date. In such an event, management will be required to seek other strategic alternatives, which may include, among others, a significant curtailment in the Company’s operations, a sale of certain of the Company’s assets, a sale of the entire Company to strategic or financial investors and/or allowing the Company to become insolvent.  
These uncertainties raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying Unaudited Condensed Consolidated Financial Statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying Unaudited Condensed Consolidated Financial Statements do not include any adjustments that may result from the outcome of these uncertainties.
Financing Arrangements
The Company has historically relied on outside capital to fund its cost structure and expects this reliance to continue for the foreseeable future until the Company reaches profitability through its planned revenue generating activities. During the nine months ended September 30, 2025, the Company closed on the following capital transactions:
•
In 2024, the Company secured a strategic investment of up to $315.5 million from Cerberus. The investment by Cerberus is structured as a $210.5 million Delayed Draw Term Loan to be made in four installments. On June 21, 2024 the first installment of $75.0 million was funded, and on August 29, 2024, the second draw of $30.0 million was funded, on October 31, 2024 the third draw of $65.0 million was funded, and on January 24, 2025, the final draw of $40.5 million was funded. As part of the strategic investment, a $105.0 million Revolving Facility can be made available to the Company at the Lenders’ sole discretion and only if the Delayed Draw Term Loan is fully funded. 
•
In May 2025, the Company announced an offering of 18,750,000 shares of common stock with an option, exercisable within 30 days after May 29, 2025, to purchase up to an additional 2,812,500 shares of the Company’s common stock at a price to the public of $4.00 per share. The Underwriters exercised this option to purchase additional shares in full. The issuance and sale of 21,562,500 shares of the Company’s common stock was completed in June 2025, raising net proceeds of $81.1 million.
•
In June 2025, the Company issued an offering of $225.0 million aggregate principal amount of 6.75% convertible senior notes due 2030 in a private offering. The Company granted initial purchasers an option to purchase, for settlement within a period of thirteen days from the date the 2025 Convertible Notes were first issued, up to an additional $25.0 million principal amounts which were exercised in full. In June 2025, $250.0 million aggregate principal amount of the 2025 Convertible Notes were issued, raising net proceeds of $240.0 million. 
Capital Expenditures
The Company expects capital expenditures and working capital requirements to increase as it seeks to execute its growth strategy, total capital expenditures for the nine months ended September 30, 2025 and September 30, 2024 were $29.7 million and $20.1 million, respectively. See Note 7,
 Property, Plant and Equipment
 and Note 8, 
Intangible Assets
 for further discussion.
59
Table of Contents
Discussion and Analysis of Cash Flows
The Company relies heavily on private placement of convertible notes, term loans, equipment financing and issuance of common stock and warrants. Our short-term working capital needs are primarily related to funding of debt interest payments, repayment of debt principal, product manufacturing, research and development and general corporate expenses. The Company’s long-term working capital needs are primarily related to repayment of long-term debt obligations and capital expenses for capacity expansion and maintenance, equipment upgrades and repair of equipment. 
The following table summarizes the Company’s cash flows from operating, investing and financing activities for the periods presented.

Nine Months Ended September 30,
($ in thousands)
2025
2024
$ Change
Net cash used in operating activities
$
(160,926)
$
(111,252)
$
(49,674)
Net cash used in investing activities
$
(29,716)
$
(20,062)
$
(9,654)
Net cash provided by financing activities
$
214,079 
$
77,285 
$
136,794 
Cash flows from operating activities:
Cash flows used in operating activities primarily comprise of costs related to research and development, manufacturing of products, project commissioning and other general and administrative activities. 
Net cash used in operating activities was $160.9 million for the nine months ended September 30, 2025, adjusted for non-cash items of $691.7 million, primarily related to stock compensation expense, loss on debt extinguishment, and changes in fair value of debt, warrants and derivatives. The net cash outflows from changes in operating assets and liabilities was $3.4 million, primarily driven by an increase in grant receivable of $10.0 million, decrease in contract liabilities of $7.2 million, increase in inventory of $6.7 million and increase in vendor deposits of $5.0 million, partially offset by increase in accounts payable of $22.2 million.
Net cash used in operating activities was $111.3 million for the nine months ended September 30, 2024, primarily driven by a net loss of $417.7 million, adjusted for non-cash items of $308.4 million, primarily related to stock compensation expense, depreciation and amortization, non-cash interest expense, gain on debt extinguishment, changes in fair value of debt, warrants and derivatives. The net cash outflows from changes in operating assets and liabilities was $1.9 million, primarily driven by an increase in inventory of $8.8 million and an increase in contract assets of $4.7 million, partially offset by an increase in contract liabilities of $5.4 million and an increase in interest payable - related party of $3.1 million. 
Cash flows from investing activities:
Net cash flows used in investing activities for the

nine months ended September 30, 2025 was $29.7 million, primarily related to $28.8 million of payments made for purchases of property, plant and equipment for the improvement of manufacturing facilities and $0.9 million of investment made for internally developed software. 
Net cash flows used in investing activities for the

nine months ended September 30, 2024 was $20.1 million for payments made for purchases of property, plant and equipment.
Cash flows from financing activities:
Net cash provided by financing activities was $214.1 million for the nine months ended September 30, 2025, primarily due to the proceeds received from the following transactions: issuance of 2025 Convertible Notes of $240.0 million, public offering of $81.1 million, Credit and Securities Purchase Transaction of $38.5 million, DOE Loan of $22.7 million, and exercise of warrants of $14.2 million. The proceeds were partially offset by payoff of the 2021 Convertible Notes Payable and Delayed Draw Term Loan of $180.9 million, debt and equity issuance costs of $4.6 million, and payments on the equipment financing facility of $1.3 million.  Proceeds from the public offering and issuance of the 2025 Convertible Notes were used to repurchase the 2021 Convertible Notes and prepay a portion of the DDTL.
Net cash provided by financing activities was $77.3 million for the nine months ended September 30, 2024, primarily due to the proceeds received from the Credit and Securities Purchase Transaction of $98.6 million and from the issuance of common stock of $14.1 million. The proceeds were partially offset by payoff of the Senior Secured Term Loan of $19.9 million, debt issuance costs - related party of $12.2 million, payments on the equipment financing facility of $2.4 million and share repurchases from employees for tax withholding of $1.1 million. 
60
Table of Contents
Contractual Obligations
The Company has certain obligations and commitments to make future payments under contracts. As of September 30, 2025, this is composed of the following:
•
Future lease payments, including interest, under non-cancellable operating and financing leases of $3.2 million. The leases expire at various dates prior to 2030. 
•
Principal and Interest payments related to the following debt obligations (see Note 13, 
Borrowings 
to our Unaudited Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report):
Future Debt Payments
Delayed Draw Term Loan - due June 2034 
(1) (2)
$
348,441 
AFG Convertible Notes - due September 2034
8,436 
Equipment financing facility - due April 2026
765 
DOE Loan Facility - due June 2034 
(1) (2)
120,284 
2025 Convertible Notes - due June 2030
336,114 
  Total 
$
814,040 
(1)
 As of September 30, 2025, the Company is obligated to repay future contractual interest payments for these borrowings in-kind.
(2)
 The DDTL and DOE Loan Facility contain Springing Maturity dates that could make the debt due March 14, 2030. 
Critical Accounting Estimates (“CAE”)
The Company’s Unaudited Condensed Consolidated Financial Statements are prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP). In preparing the Company’s Unaudited Condensed Consolidated Financial Statements, management makes assumptions, judgments and estimates on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions or conditions. We regularly reevaluate our assumptions, judgments and estimates. The Company’s significant accounting policies are described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
Critical accounting estimates are those estimates that involve a significant level of estimation uncertainty and could have a material impact on our financial condition or results of operations.
There have been no material changes in the CAE’s in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes in the Company’s market risk exposures for the nine months ended September 30, 2025, as compared to those discussed in its Annual Report on Form 10-K for the year ended December 31, 2024.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation and supervision of our Chief Executive Officer and our Chief Financial Officer, have evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)) under the Exchange Act as of the end of the period covered by this report. Based upon that evaluation and consistent with the evaluations previously reported in prior periods, the CEO and CFO have concluded that, as of the end of the period covered by this Report our disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended September 30, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
61
Table of Contents
Part II - Other information
Item 1. Legal Proceedings
From time to time, the Company may be involved in litigation relating to claims arising out of the Company’s operations. While the outcomes of these types of claims are uncertain, management does not expect that the ultimate costs to resolve these matters will have a material adverse effect on our consolidated financial position, results of operations or cash flows.
As of September 30, 2025, there have been no material developments or changes in the status of legal proceedings.
Item 1A. Risk Factors
As of the date of this Quarterly Report on Form 10-Q, there have been no additional material changes to the risk factors disclosed in our annual report on Form 10-K for the fiscal year ended December 31, 2024. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None
Item 3. Defaults Upon Senior Securities
None
Item 4. Mine Safety Disclosures
None
Item 5. Other Information
Rule 10b5-1 Trading Plans
Our directors and officers (as defined in Section 16 of the Exchange Act (“Section 16”)) may from time to time enter into plans for the purchase or sale of Eos stock that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. 
During the three months ended September 30, 2025, the following Section 16 officers 
adopted
 new Rule 10b5-1 trading arrangements (as defined in Item 408(a) of Regulation S-K):
•
Joseph Mastrangelo
, 
Chief Executive Officer and Director
: Adopted a new Rule 10b5-1 trading plan on 
September 11, 2025
.
•
Nathan Kroeker
, 
Chief Commercial Officer and Interim Chief Financial Officer
: Adopted a new Rule 10b5-1 trading plan on 
September 15, 2025
.
•
Michael Silberman
, 
Chief Legal Officer and Corporate Secretary
: Adopted a new Rule 10b5-1 trading plan on 
September 15, 2025
.
•
Sumeet Puri
, 
Chief Accounting Officer
: Adopted a new Rule 10b5-1 trading plan on 
September 12, 2025
.
The Rule 10b5-1 trading arrangements described above terminate on 
September 30, 2026
 and provide for the sale of a predetermined percentage of each Section 16 officer’s restricted stock unit award vesting, sufficient to cover the tax liability for each such Section 16 officer. 
In addition, during the three months ended September 30, 2025, the following Section 16 officers 
terminated
 previously existing Rule 10b5-1 trading arrangements:
•
Nathan Kroeker
, 
Chief Commercial Officer and Interim Chief Financial Officer
: Terminated a prior Rule 10b5-1 trading plan on 
September 15, 2025
.
•
Michael Silberman
, 
Chief Legal Officer and Corporate Secretary
: Terminated a prior Rule 10b5-1 trading plan on 
September 15, 2025
.
62
Table of Contents
(a) Exhibits
Incorporated by Reference
Exhibit Number
Description of Document
Schedule/Form
File Number
Exhibits
Filing Date
3.1
Third Amended and Restated Certificate of Incorporation of the Company, as amended
Form 10-K
File No. 001-39291
3.1
February 28, 2023
3.2
Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation of the Company, as amended
Form 10-Q
File No. 001-39291
3.2
May 14, 2024
3.3
Second Amended and Restated Bylaws of the Company
Form 8-K
File No. 001-39291
3.1
May 19, 2022
3.4
Series A-1 Preferred Stock Certificate of Designation
Form 8-K
File No. 001-39291
3.1
June 24, 2024
3.5
Series A-2 Preferred Stock Certificate of Designation.
Form 8-K
File No. 001-39291
3.1
August 30, 2024
3.6
Certificate of Designation of Series B-1 Non-Voting Convertible Preferred Stock
Form 8-K
File No. 001-39291
3.1
September 12, 2024
3.7
Certificate of Designation of Series B-2 Non-Voting Convertible Preferred Stock
Form 8-K
File No. 001-39291
3.2
September 12, 2024
3.8
Certificate of Designation of Series B-3 Non-Voting Convertible Preferred Stock
Form 8-K
File No. 001-39291
3.1
November 4, 2024
3.9
Certificate of Designation of Series B-4 Non-Voting Convertible Preferred Stock
Form 8-K
File No. 001-39291
3.1
January 27, 2025
4.1
First Supplemental Indenture, dated July 28, 2025, between the Company and Wilmington Trust, as trustee
Form 10-Q
File No. 001-39291
4.3
July 30, 2025
10.1#
Fourth Amendment to Credit and Guaranty Agreement, dated July 29, 2025, by and among the Company, CCM Denali Debt Holdings, LP and Cerberus US Servicing, LLC
Form 10-Q
File No. 001-39291
10.5
July 30, 2025
31.1*
Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*
Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32*
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
63
Table of Contents
Incorporated by Reference
Exhibit Number
Description of Document
Schedule/Form
File Number
Exhibits
Filing Date
101.SCH
XBRL Taxonomy Extension Schema Document
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
XBRL Taxonomy Extension Label Linkbase Document
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document 
104
Cover page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
___________________________
*
Filed herewith.
#    Portions of this exhibit have been omitted pursuant to Item 601(b)(10) of Regulation S-K because they are both (i) not material and (ii) contain the type of information that the Company customarily and actually treats as private or confidential.
64
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
EOS ENERGY ENTERPRISES, INC.
Date: November 5, 2025
By:
/s/ Joseph Mastrangelo
Name:
Joseph Mastrangelo
Title:
Chief Executive Officer and Director
(Principal Executive Officer)
Date: November 5, 2025
By:
/s/ Nathan Kroeker
Name:
Nathan Kroeker
Title:
Interim Chief Financial Officer
(Principal Financial Officer)
65